BindingDB Reactant_set_id	Ligand SMILES	Ligand InChI	Ligand InChI Key	BindingDB MonomerID	BindingDB Ligand Name	Target Name	Target Source Organism According to Curator or DataSource	Ki (nM)	IC50 (nM)	Kd (nM)	EC50 (nM)	kon (M-1-s-1)	koff (s-1)	pH	Temp (C)	Curation/DataSource	Article DOI	BindingDB Entry DOI	PMID	PubChem AID	Patent Number	Authors	Date of publication	Date in BindingDB	Institution	Link to Ligand in BindingDB	Link to Target in BindingDB	Link to Ligand-Target Pair in BindingDB	Ligand HET ID in PDB	PDB ID(s) for Ligand-Target Complex	PubChem CID	PubChem SID	ChEBI ID of Ligand	ChEMBL ID of Ligand	DrugBank ID of Ligand	IUPHAR_GRAC ID of Ligand	KEGG ID of Ligand	ZINC ID of Ligand	Number of Protein Chains in Target (>1 implies a multichain complex)	BindingDB Target Chain Sequence 1	PDB ID(s) of Target Chain 1	UniProt (SwissProt) Recommended Name of Target Chain 1	UniProt (SwissProt) Entry Name of Target Chain 1	UniProt (SwissProt) Primary ID of Target Chain 1	UniProt (SwissProt) Secondary ID(s) of Target Chain 1	UniProt (SwissProt) Alternative ID(s) of Target Chain 1	UniProt (TrEMBL) Submitted Name of Target Chain 1	UniProt (TrEMBL) Entry Name of Target Chain 1	UniProt (TrEMBL) Primary ID of Target Chain 1	UniProt (TrEMBL) Secondary ID(s) of Target Chain 1	UniProt (TrEMBL) Alternative ID(s) of Target Chain 1	BindingDB Target Chain Sequence 2	PDB ID(s) of Target Chain 2	UniProt (SwissProt) Recommended Name of Target Chain 2	UniProt (SwissProt) Entry Name of Target Chain 2	UniProt (SwissProt) Primary ID of Target Chain 2	UniProt (SwissProt) Secondary ID(s) of Target Chain 2	UniProt (SwissProt) Alternative ID(s) of Target Chain 2	UniProt (TrEMBL) Submitted Name of Target Chain 2	UniProt (TrEMBL) Entry Name of Target Chain 2	UniProt (TrEMBL) Primary ID of Target Chain 2	UniProt (TrEMBL) Secondary ID(s) of Target Chain 2	UniProt (TrEMBL) Alternative ID(s) of Target Chain 2	BindingDB Target Chain Sequence 3	PDB ID(s) of Target Chain 3	UniProt (SwissProt) Recommended Name of Target Chain 3	UniProt (SwissProt) Entry Name of Target Chain 3	UniProt (SwissProt) Primary ID of Target Chain 3	UniProt (SwissProt) Secondary ID(s) of Target Chain 3	UniProt (SwissProt) Alternative ID(s) of Target Chain 3	UniProt (TrEMBL) Submitted Name of Target Chain 3	UniProt (TrEMBL) Entry Name of Target Chain 3	UniProt (TrEMBL) Primary ID of Target Chain 3	UniProt (TrEMBL) Secondary ID(s) of Target Chain 3	UniProt (TrEMBL) Alternative ID(s) of Target Chain 3	BindingDB Target Chain Sequence 4	PDB ID(s) of Target Chain 4	UniProt (SwissProt) Recommended Name of Target Chain 4	UniProt (SwissProt) Entry Name of Target Chain 4	UniProt (SwissProt) Primary ID of Target Chain 4	UniProt (SwissProt) Secondary ID(s) of Target Chain 4	UniProt (SwissProt) Alternative ID(s) of Target Chain 4	UniProt (TrEMBL) Submitted Name of Target Chain 4	UniProt (TrEMBL) Entry Name of Target Chain 4	UniProt (TrEMBL) Primary ID of Target Chain 4	UniProt (TrEMBL) Secondary ID(s) of Target Chain 4	UniProt (TrEMBL) Alternative ID(s) of Target Chain 4	BindingDB Target Chain Sequence 5	PDB ID(s) of Target Chain 5	UniProt (SwissProt) Recommended Name of Target Chain 5	UniProt (SwissProt) Entry Name of Target Chain 5	UniProt (SwissProt) Primary ID of Target Chain 5	UniProt (SwissProt) Secondary ID(s) of Target Chain 5	UniProt (SwissProt) Alternative ID(s) of Target Chain 5	UniProt (TrEMBL) Submitted Name of Target Chain 5	UniProt (TrEMBL) Entry Name of Target Chain 5	UniProt (TrEMBL) Primary ID of Target Chain 5	UniProt (TrEMBL) Secondary ID(s) of Target Chain 5	UniProt (TrEMBL) Alternative ID(s) of Target Chain 5	BindingDB Target Chain Sequence 6	PDB ID(s) of Target Chain 6	UniProt (SwissProt) Recommended Name of Target Chain 6	UniProt (SwissProt) Entry Name of Target Chain 6	UniProt (SwissProt) Primary ID of Target Chain 6	UniProt (SwissProt) Secondary ID(s) of Target Chain 6	UniProt (SwissProt) Alternative ID(s) of Target Chain 6	UniProt (TrEMBL) Submitted Name of Target Chain 6	UniProt (TrEMBL) Entry Name of Target Chain 6	UniProt (TrEMBL) Primary ID of Target Chain 6	UniProt (TrEMBL) Secondary ID(s) of Target Chain 6	UniProt (TrEMBL) Alternative ID(s) of Target Chain 6	BindingDB Target Chain Sequence 7	PDB ID(s) of Target Chain 7	UniProt (SwissProt) Recommended Name of Target Chain 7	UniProt (SwissProt) Entry Name of Target Chain 7	UniProt (SwissProt) Primary ID of Target Chain 7	UniProt (SwissProt) Secondary ID(s) of Target Chain 7	UniProt (SwissProt) Alternative ID(s) of Target Chain 7	UniProt (TrEMBL) Submitted Name of Target Chain 7	UniProt (TrEMBL) Entry Name of Target Chain 7	UniProt (TrEMBL) Primary ID of Target Chain 7	UniProt (TrEMBL) Secondary ID(s) of Target Chain 7	UniProt (TrEMBL) Alternative ID(s) of Target Chain 7	BindingDB Target Chain Sequence 8	PDB ID(s) of Target Chain 8	UniProt (SwissProt) Recommended Name of Target Chain 8	UniProt (SwissProt) Entry Name of Target Chain 8	UniProt (SwissProt) Primary ID of Target Chain 8	UniProt (SwissProt) Secondary ID(s) of Target Chain 8	UniProt (SwissProt) Alternative ID(s) of Target Chain 8	UniProt (TrEMBL) Submitted Name of Target Chain 8	UniProt (TrEMBL) Entry Name of Target Chain 8	UniProt (TrEMBL) Primary ID of Target Chain 8	UniProt (TrEMBL) Secondary ID(s) of Target Chain 8	UniProt (TrEMBL) Alternative ID(s) of Target Chain 8	BindingDB Target Chain Sequence 9	PDB ID(s) of Target Chain 9	UniProt (SwissProt) Recommended Name of Target Chain 9	UniProt (SwissProt) Entry Name of Target Chain 9	UniProt (SwissProt) Primary ID of Target Chain 9	UniProt (SwissProt) Secondary ID(s) of Target Chain 9	UniProt (SwissProt) Alternative ID(s) of Target Chain 9	UniProt (TrEMBL) Submitted Name of Target Chain 9	UniProt (TrEMBL) Entry Name of Target Chain 9	UniProt (TrEMBL) Primary ID of Target Chain 9	UniProt (TrEMBL) Secondary ID(s) of Target Chain 9	UniProt (TrEMBL) Alternative ID(s) of Target Chain 9	BindingDB Target Chain Sequence 10	PDB ID(s) of Target Chain 10	UniProt (SwissProt) Recommended Name of Target Chain 10	UniProt (SwissProt) Entry Name of Target Chain 10	UniProt (SwissProt) Primary ID of Target Chain 10	UniProt (SwissProt) Secondary ID(s) of Target Chain 10	UniProt (SwissProt) Alternative ID(s) of Target Chain 10	UniProt (TrEMBL) Submitted Name of Target Chain 10	UniProt (TrEMBL) Entry Name of Target Chain 10	UniProt (TrEMBL) Primary ID of Target Chain 10	UniProt (TrEMBL) Secondary ID(s) of Target Chain 10	UniProt (TrEMBL) Alternative ID(s) of Target Chain 10	BindingDB Target Chain Sequence 11	PDB ID(s) of Target Chain 11	UniProt (SwissProt) Recommended Name of Target Chain 11	UniProt (SwissProt) Entry Name of Target Chain 11	UniProt (SwissProt) Primary ID of Target Chain 11	UniProt (SwissProt) Secondary ID(s) of Target Chain 11	UniProt (SwissProt) Alternative ID(s) of Target Chain 11	UniProt (TrEMBL) Submitted Name of Target Chain 11	UniProt (TrEMBL) Entry Name of Target Chain 11	UniProt (TrEMBL) Primary ID of Target Chain 11	UniProt (TrEMBL) Secondary ID(s) of Target Chain 11	UniProt (TrEMBL) Alternative ID(s) of Target Chain 11	BindingDB Target Chain Sequence 12	PDB ID(s) of Target Chain 12	UniProt (SwissProt) Recommended Name of Target Chain 12	UniProt (SwissProt) Entry Name of Target Chain 12	UniProt (SwissProt) Primary ID of Target Chain 12	UniProt (SwissProt) Secondary ID(s) of Target Chain 12	UniProt (SwissProt) Alternative ID(s) of Target Chain 12	UniProt (TrEMBL) Submitted Name of Target Chain 12	UniProt (TrEMBL) Entry Name of Target Chain 12	UniProt (TrEMBL) Primary ID of Target Chain 12	UniProt (TrEMBL) Secondary ID(s) of Target Chain 12	UniProt (TrEMBL) Alternative ID(s) of Target Chain 12	BindingDB Target Chain Sequence 13	PDB ID(s) of Target Chain 13	UniProt (SwissProt) Recommended Name of Target Chain 13	UniProt (SwissProt) Entry Name of Target Chain 13	UniProt (SwissProt) Primary ID of Target Chain 13	UniProt (SwissProt) Secondary ID(s) of Target Chain 13	UniProt (SwissProt) Alternative ID(s) of Target Chain 13	UniProt (TrEMBL) Submitted Name of Target Chain 13	UniProt (TrEMBL) Entry Name of Target Chain 13	UniProt (TrEMBL) Primary ID of Target Chain 13	UniProt (TrEMBL) Secondary ID(s) of Target Chain 13	UniProt (TrEMBL) Alternative ID(s) of Target Chain 13	BindingDB Target Chain Sequence 14	PDB ID(s) of Target Chain 14	UniProt (SwissProt) Recommended Name of Target Chain 14	UniProt (SwissProt) Entry Name of Target Chain 14	UniProt (SwissProt) Primary ID of Target Chain 14	UniProt (SwissProt) Secondary ID(s) of Target Chain 14	UniProt (SwissProt) Alternative ID(s) of Target Chain 14	UniProt (TrEMBL) Submitted Name of Target Chain 14	UniProt (TrEMBL) Entry Name of Target Chain 14	UniProt (TrEMBL) Primary ID of Target Chain 14	UniProt (TrEMBL) Secondary ID(s) of Target Chain 14	UniProt (TrEMBL) Alternative ID(s) of Target Chain 14	BindingDB Target Chain Sequence 15	PDB ID(s) of Target Chain 15	UniProt (SwissProt) Recommended Name of Target Chain 15	UniProt (SwissProt) Entry Name of Target Chain 15	UniProt (SwissProt) Primary ID of Target Chain 15	UniProt (SwissProt) Secondary ID(s) of Target Chain 15	UniProt (SwissProt) Alternative ID(s) of Target Chain 15	UniProt (TrEMBL) Submitted Name of Target Chain 15	UniProt (TrEMBL) Entry Name of Target Chain 15	UniProt (TrEMBL) Primary ID of Target Chain 15	UniProt (TrEMBL) Secondary ID(s) of Target Chain 15	UniProt (TrEMBL) Alternative ID(s) of Target Chain 15	BindingDB Target Chain Sequence 16	PDB ID(s) of Target Chain 16	UniProt (SwissProt) Recommended Name of Target Chain 16	UniProt (SwissProt) Entry Name of Target Chain 16	UniProt (SwissProt) Primary ID of Target Chain 16	UniProt (SwissProt) Secondary ID(s) of Target Chain 16	UniProt (SwissProt) Alternative ID(s) of Target Chain 16	UniProt (TrEMBL) Submitted Name of Target Chain 16	UniProt (TrEMBL) Entry Name of Target Chain 16	UniProt (TrEMBL) Primary ID of Target Chain 16	UniProt (TrEMBL) Secondary ID(s) of Target Chain 16	UniProt (TrEMBL) Alternative ID(s) of Target Chain 16	BindingDB Target Chain Sequence 17	PDB ID(s) of Target Chain 17	UniProt (SwissProt) Recommended Name of Target Chain 17	UniProt (SwissProt) Entry Name of Target Chain 17	UniProt (SwissProt) Primary ID of Target Chain 17	UniProt (SwissProt) Secondary ID(s) of Target Chain 17	UniProt (SwissProt) Alternative ID(s) of Target Chain 17	UniProt (TrEMBL) Submitted Name of Target Chain 17	UniProt (TrEMBL) Entry Name of Target Chain 17	UniProt (TrEMBL) Primary ID of Target Chain 17	UniProt (TrEMBL) Secondary ID(s) of Target Chain 17	UniProt (TrEMBL) Alternative ID(s) of Target Chain 17	BindingDB Target Chain Sequence 18	PDB ID(s) of Target Chain 18	UniProt (SwissProt) Recommended Name of Target Chain 18	UniProt (SwissProt) Entry Name of Target Chain 18	UniProt (SwissProt) Primary ID of Target Chain 18	UniProt (SwissProt) Secondary ID(s) of Target Chain 18	UniProt (SwissProt) Alternative ID(s) of Target Chain 18	UniProt (TrEMBL) Submitted Name of Target Chain 18	UniProt (TrEMBL) Entry Name of Target Chain 18	UniProt (TrEMBL) Primary ID of Target Chain 18	UniProt (TrEMBL) Secondary ID(s) of Target Chain 18	UniProt (TrEMBL) Alternative ID(s) of Target Chain 18	BindingDB Target Chain Sequence 19	PDB ID(s) of Target Chain 19	UniProt (SwissProt) Recommended Name of Target Chain 19	UniProt (SwissProt) Entry Name of Target Chain 19	UniProt (SwissProt) Primary ID of Target Chain 19	UniProt (SwissProt) Secondary ID(s) of Target Chain 19	UniProt (SwissProt) Alternative ID(s) of Target Chain 19	UniProt (TrEMBL) Submitted Name of Target Chain 19	UniProt (TrEMBL) Entry Name of Target Chain 19	UniProt (TrEMBL) Primary ID of Target Chain 19	UniProt (TrEMBL) Secondary ID(s) of Target Chain 19	UniProt (TrEMBL) Alternative ID(s) of Target Chain 19	BindingDB Target Chain Sequence 20	PDB ID(s) of Target Chain 20	UniProt (SwissProt) Recommended Name of Target Chain 20	UniProt (SwissProt) Entry Name of Target Chain 20	UniProt (SwissProt) Primary ID of Target Chain 20	UniProt (SwissProt) Secondary ID(s) of Target Chain 20	UniProt (SwissProt) Alternative ID(s) of Target Chain 20	UniProt (TrEMBL) Submitted Name of Target Chain 20	UniProt (TrEMBL) Entry Name of Target Chain 20	UniProt (TrEMBL) Primary ID of Target Chain 20	UniProt (TrEMBL) Secondary ID(s) of Target Chain 20	UniProt (TrEMBL) Alternative ID(s) of Target Chain 20	BindingDB Target Chain Sequence 21	PDB ID(s) of Target Chain 21	UniProt (SwissProt) Recommended Name of Target Chain 21	UniProt (SwissProt) Entry Name of Target Chain 21	UniProt (SwissProt) Primary ID of Target Chain 21	UniProt (SwissProt) Secondary ID(s) of Target Chain 21	UniProt (SwissProt) Alternative ID(s) of Target Chain 21	UniProt (TrEMBL) Submitted Name of Target Chain 21	UniProt (TrEMBL) Entry Name of Target Chain 21	UniProt (TrEMBL) Primary ID of Target Chain 21	UniProt (TrEMBL) Secondary ID(s) of Target Chain 21	UniProt (TrEMBL) Alternative ID(s) of Target Chain 21	BindingDB Target Chain Sequence 22	PDB ID(s) of Target Chain 22	UniProt (SwissProt) Recommended Name of Target Chain 22	UniProt (SwissProt) Entry Name of Target Chain 22	UniProt (SwissProt) Primary ID of Target Chain 22	UniProt (SwissProt) Secondary ID(s) of Target Chain 22	UniProt (SwissProt) Alternative ID(s) of Target Chain 22	UniProt (TrEMBL) Submitted Name of Target Chain 22	UniProt (TrEMBL) Entry Name of Target Chain 22	UniProt (TrEMBL) Primary ID of Target Chain 22	UniProt (TrEMBL) Secondary ID(s) of Target Chain 22	UniProt (TrEMBL) Alternative ID(s) of Target Chain 22	BindingDB Target Chain Sequence 23	PDB ID(s) of Target Chain 23	UniProt (SwissProt) Recommended Name of Target Chain 23	UniProt (SwissProt) Entry Name of Target Chain 23	UniProt (SwissProt) Primary ID of Target Chain 23	UniProt (SwissProt) Secondary ID(s) of Target Chain 23	UniProt (SwissProt) Alternative ID(s) of Target Chain 23	UniProt (TrEMBL) Submitted Name of Target Chain 23	UniProt (TrEMBL) Entry Name of Target Chain 23	UniProt (TrEMBL) Primary ID of Target Chain 23	UniProt (TrEMBL) Secondary ID(s) of Target Chain 23	UniProt (TrEMBL) Alternative ID(s) of Target Chain 23	BindingDB Target Chain Sequence 24	PDB ID(s) of Target Chain 24	UniProt (SwissProt) Recommended Name of Target Chain 24	UniProt (SwissProt) Entry Name of Target Chain 24	UniProt (SwissProt) Primary ID of Target Chain 24	UniProt (SwissProt) Secondary ID(s) of Target Chain 24	UniProt (SwissProt) Alternative ID(s) of Target Chain 24	UniProt (TrEMBL) Submitted Name of Target Chain 24	UniProt (TrEMBL) Entry Name of Target Chain 24	UniProt (TrEMBL) Primary ID of Target Chain 24	UniProt (TrEMBL) Secondary ID(s) of Target Chain 24	UniProt (TrEMBL) Alternative ID(s) of Target Chain 24	BindingDB Target Chain Sequence 25	PDB ID(s) of Target Chain 25	UniProt (SwissProt) Recommended Name of Target Chain 25	UniProt (SwissProt) Entry Name of Target Chain 25	UniProt (SwissProt) Primary ID of Target Chain 25	UniProt (SwissProt) Secondary ID(s) of Target Chain 25	UniProt (SwissProt) Alternative ID(s) of Target Chain 25	UniProt (TrEMBL) Submitted Name of Target Chain 25	UniProt (TrEMBL) Entry Name of Target Chain 25	UniProt (TrEMBL) Primary ID of Target Chain 25	UniProt (TrEMBL) Secondary ID(s) of Target Chain 25	UniProt (TrEMBL) Alternative ID(s) of Target Chain 25	BindingDB Target Chain Sequence 26	PDB ID(s) of Target Chain 26	UniProt (SwissProt) Recommended Name of Target Chain 26	UniProt (SwissProt) Entry Name of Target Chain 26	UniProt (SwissProt) Primary ID of Target Chain 26	UniProt (SwissProt) Secondary ID(s) of Target Chain 26	UniProt (SwissProt) Alternative ID(s) of Target Chain 26	UniProt (TrEMBL) Submitted Name of Target Chain 26	UniProt (TrEMBL) Entry Name of Target Chain 26	UniProt (TrEMBL) Primary ID of Target Chain 26	UniProt (TrEMBL) Secondary ID(s) of Target Chain 26	UniProt (TrEMBL) Alternative ID(s) of Target Chain 26	BindingDB Target Chain Sequence 27	PDB ID(s) of Target Chain 27	UniProt (SwissProt) Recommended Name of Target Chain 27	UniProt (SwissProt) Entry Name of Target Chain 27	UniProt (SwissProt) Primary ID of Target Chain 27	UniProt (SwissProt) Secondary ID(s) of Target Chain 27	UniProt (SwissProt) Alternative ID(s) of Target Chain 27	UniProt (TrEMBL) Submitted Name of Target Chain 27	UniProt (TrEMBL) Entry Name of Target Chain 27	UniProt (TrEMBL) Primary ID of Target Chain 27	UniProt (TrEMBL) Secondary ID(s) of Target Chain 27	UniProt (TrEMBL) Alternative ID(s) of Target Chain 27	BindingDB Target Chain Sequence 28	PDB ID(s) of Target Chain 28	UniProt (SwissProt) Recommended Name of Target Chain 28	UniProt (SwissProt) Entry Name of Target Chain 28	UniProt (SwissProt) Primary ID of Target Chain 28	UniProt (SwissProt) Secondary ID(s) of Target Chain 28	UniProt (SwissProt) Alternative ID(s) of Target Chain 28	UniProt (TrEMBL) Submitted Name of Target Chain 28	UniProt (TrEMBL) Entry Name of Target Chain 28	UniProt (TrEMBL) Primary ID of Target Chain 28	UniProt (TrEMBL) Secondary ID(s) of Target Chain 28	UniProt (TrEMBL) Alternative ID(s) of Target Chain 28	BindingDB Target Chain Sequence 29	PDB ID(s) of Target Chain 29	UniProt (SwissProt) Recommended Name of Target Chain 29	UniProt (SwissProt) Entry Name of Target Chain 29	UniProt (SwissProt) Primary ID of Target Chain 29	UniProt (SwissProt) Secondary ID(s) of Target Chain 29	UniProt (SwissProt) Alternative ID(s) of Target Chain 29	UniProt (TrEMBL) Submitted Name of Target Chain 29	UniProt (TrEMBL) Entry Name of Target Chain 29	UniProt (TrEMBL) Primary ID of Target Chain 29	UniProt (TrEMBL) Secondary ID(s) of Target Chain 29	UniProt (TrEMBL) Alternative ID(s) of Target Chain 29	BindingDB Target Chain Sequence 30	PDB ID(s) of Target Chain 30	UniProt (SwissProt) Recommended Name of Target Chain 30	UniProt (SwissProt) Entry Name of Target Chain 30	UniProt (SwissProt) Primary ID of Target Chain 30	UniProt (SwissProt) Secondary ID(s) of Target Chain 30	UniProt (SwissProt) Alternative ID(s) of Target Chain 30	UniProt (TrEMBL) Submitted Name of Target Chain 30	UniProt (TrEMBL) Entry Name of Target Chain 30	UniProt (TrEMBL) Primary ID of Target Chain 30	UniProt (TrEMBL) Secondary ID(s) of Target Chain 30	UniProt (TrEMBL) Alternative ID(s) of Target Chain 30	BindingDB Target Chain Sequence 31	PDB ID(s) of Target Chain 31	UniProt (SwissProt) Recommended Name of Target Chain 31	UniProt (SwissProt) Entry Name of Target Chain 31	UniProt (SwissProt) Primary ID of Target Chain 31	UniProt (SwissProt) Secondary ID(s) of Target Chain 31	UniProt (SwissProt) Alternative ID(s) of Target Chain 31	UniProt (TrEMBL) Submitted Name of Target Chain 31	UniProt (TrEMBL) Entry Name of Target Chain 31	UniProt (TrEMBL) Primary ID of Target Chain 31	UniProt (TrEMBL) Secondary ID(s) of Target Chain 31	UniProt (TrEMBL) Alternative ID(s) of Target Chain 31	BindingDB Target Chain Sequence 32	PDB ID(s) of Target Chain 32	UniProt (SwissProt) Recommended Name of Target Chain 32	UniProt (SwissProt) Entry Name of Target Chain 32	UniProt (SwissProt) Primary ID of Target Chain 32	UniProt (SwissProt) Secondary ID(s) of Target Chain 32	UniProt (SwissProt) Alternative ID(s) of Target Chain 32	UniProt (TrEMBL) Submitted Name of Target Chain 32	UniProt (TrEMBL) Entry Name of Target Chain 32	UniProt (TrEMBL) Primary ID of Target Chain 32	UniProt (TrEMBL) Secondary ID(s) of Target Chain 32	UniProt (TrEMBL) Alternative ID(s) of Target Chain 32	BindingDB Target Chain Sequence 33	PDB ID(s) of Target Chain 33	UniProt (SwissProt) Recommended Name of Target Chain 33	UniProt (SwissProt) Entry Name of Target Chain 33	UniProt (SwissProt) Primary ID of Target Chain 33	UniProt (SwissProt) Secondary ID(s) of Target Chain 33	UniProt (SwissProt) Alternative ID(s) of Target Chain 33	UniProt (TrEMBL) Submitted Name of Target Chain 33	UniProt (TrEMBL) Entry Name of Target Chain 33	UniProt (TrEMBL) Primary ID of Target Chain 33	UniProt (TrEMBL) Secondary ID(s) of Target Chain 33	UniProt (TrEMBL) Alternative ID(s) of Target Chain 33	BindingDB Target Chain Sequence 34	PDB ID(s) of Target Chain 34	UniProt (SwissProt) Recommended Name of Target Chain 34	UniProt (SwissProt) Entry Name of Target Chain 34	UniProt (SwissProt) Primary ID of Target Chain 34	UniProt (SwissProt) Secondary ID(s) of Target Chain 34	UniProt (SwissProt) Alternative ID(s) of Target Chain 34	UniProt (TrEMBL) Submitted Name of Target Chain 34	UniProt (TrEMBL) Entry Name of Target Chain 34	UniProt (TrEMBL) Primary ID of Target Chain 34	UniProt (TrEMBL) Secondary ID(s) of Target Chain 34	UniProt (TrEMBL) Alternative ID(s) of Target Chain 34	BindingDB Target Chain Sequence 35	PDB ID(s) of Target Chain 35	UniProt (SwissProt) Recommended Name of Target Chain 35	UniProt (SwissProt) Entry Name of Target Chain 35	UniProt (SwissProt) Primary ID of Target Chain 35	UniProt (SwissProt) Secondary ID(s) of Target Chain 35	UniProt (SwissProt) Alternative ID(s) of Target Chain 35	UniProt (TrEMBL) Submitted Name of Target Chain 35	UniProt (TrEMBL) Entry Name of Target Chain 35	UniProt (TrEMBL) Primary ID of Target Chain 35	UniProt (TrEMBL) Secondary ID(s) of Target Chain 35	UniProt (TrEMBL) Alternative ID(s) of Target Chain 35	BindingDB Target Chain Sequence 36	PDB ID(s) of Target Chain 36	UniProt (SwissProt) Recommended Name of Target Chain 36	UniProt (SwissProt) Entry Name of Target Chain 36	UniProt (SwissProt) Primary ID of Target Chain 36	UniProt (SwissProt) Secondary ID(s) of Target Chain 36	UniProt (SwissProt) Alternative ID(s) of Target Chain 36	UniProt (TrEMBL) Submitted Name of Target Chain 36	UniProt (TrEMBL) Entry Name of Target Chain 36	UniProt (TrEMBL) Primary ID of Target Chain 36	UniProt (TrEMBL) Secondary ID(s) of Target Chain 36	UniProt (TrEMBL) Alternative ID(s) of Target Chain 36	BindingDB Target Chain Sequence 37	PDB ID(s) of Target Chain 37	UniProt (SwissProt) Recommended Name of Target Chain 37	UniProt (SwissProt) Entry Name of Target Chain 37	UniProt (SwissProt) Primary ID of Target Chain 37	UniProt (SwissProt) Secondary ID(s) of Target Chain 37	UniProt (SwissProt) Alternative ID(s) of Target Chain 37	UniProt (TrEMBL) Submitted Name of Target Chain 37	UniProt (TrEMBL) Entry Name of Target Chain 37	UniProt (TrEMBL) Primary ID of Target Chain 37	UniProt (TrEMBL) Secondary ID(s) of Target Chain 37	UniProt (TrEMBL) Alternative ID(s) of Target Chain 37	BindingDB Target Chain Sequence 38	PDB ID(s) of Target Chain 38	UniProt (SwissProt) Recommended Name of Target Chain 38	UniProt (SwissProt) Entry Name of Target Chain 38	UniProt (SwissProt) Primary ID of Target Chain 38	UniProt (SwissProt) Secondary ID(s) of Target Chain 38	UniProt (SwissProt) Alternative ID(s) of Target Chain 38	UniProt (TrEMBL) Submitted Name of Target Chain 38	UniProt (TrEMBL) Entry Name of Target Chain 38	UniProt (TrEMBL) Primary ID of Target Chain 38	UniProt (TrEMBL) Secondary ID(s) of Target Chain 38	UniProt (TrEMBL) Alternative ID(s) of Target Chain 38	BindingDB Target Chain Sequence 39	PDB ID(s) of Target Chain 39	UniProt (SwissProt) Recommended Name of Target Chain 39	UniProt (SwissProt) Entry Name of Target Chain 39	UniProt (SwissProt) Primary ID of Target Chain 39	UniProt (SwissProt) Secondary ID(s) of Target Chain 39	UniProt (SwissProt) Alternative ID(s) of Target Chain 39	UniProt (TrEMBL) Submitted Name of Target Chain 39	UniProt (TrEMBL) Entry Name of Target Chain 39	UniProt (TrEMBL) Primary ID of Target Chain 39	UniProt (TrEMBL) Secondary ID(s) of Target Chain 39	UniProt (TrEMBL) Alternative ID(s) of Target Chain 39	BindingDB Target Chain Sequence 40	PDB ID(s) of Target Chain 40	UniProt (SwissProt) Recommended Name of Target Chain 40	UniProt (SwissProt) Entry Name of Target Chain 40	UniProt (SwissProt) Primary ID of Target Chain 40	UniProt (SwissProt) Secondary ID(s) of Target Chain 40	UniProt (SwissProt) Alternative ID(s) of Target Chain 40	UniProt (TrEMBL) Submitted Name of Target Chain 40	UniProt (TrEMBL) Entry Name of Target Chain 40	UniProt (TrEMBL) Primary ID of Target Chain 40	UniProt (TrEMBL) Secondary ID(s) of Target Chain 40	UniProt (TrEMBL) Alternative ID(s) of Target Chain 40	BindingDB Target Chain Sequence 41	PDB ID(s) of Target Chain 41	UniProt (SwissProt) Recommended Name of Target Chain 41	UniProt (SwissProt) Entry Name of Target Chain 41	UniProt (SwissProt) Primary ID of Target Chain 41	UniProt (SwissProt) Secondary ID(s) of Target Chain 41	UniProt (SwissProt) Alternative ID(s) of Target Chain 41	UniProt (TrEMBL) Submitted Name of Target Chain 41	UniProt (TrEMBL) Entry Name of Target Chain 41	UniProt (TrEMBL) Primary ID of Target Chain 41	UniProt (TrEMBL) Secondary ID(s) of Target Chain 41	UniProt (TrEMBL) Alternative ID(s) of Target Chain 41	BindingDB Target Chain Sequence 42	PDB ID(s) of Target Chain 42	UniProt (SwissProt) Recommended Name of Target Chain 42	UniProt (SwissProt) Entry Name of Target Chain 42	UniProt (SwissProt) Primary ID of Target Chain 42	UniProt (SwissProt) Secondary ID(s) of Target Chain 42	UniProt (SwissProt) Alternative ID(s) of Target Chain 42	UniProt (TrEMBL) Submitted Name of Target Chain 42	UniProt (TrEMBL) Entry Name of Target Chain 42	UniProt (TrEMBL) Primary ID of Target Chain 42	UniProt (TrEMBL) Secondary ID(s) of Target Chain 42	UniProt (TrEMBL) Alternative ID(s) of Target Chain 42	BindingDB Target Chain Sequence 43	PDB ID(s) of Target Chain 43	UniProt (SwissProt) Recommended Name of Target Chain 43	UniProt (SwissProt) Entry Name of Target Chain 43	UniProt (SwissProt) Primary ID of Target Chain 43	UniProt (SwissProt) Secondary ID(s) of Target Chain 43	UniProt (SwissProt) Alternative ID(s) of Target Chain 43	UniProt (TrEMBL) Submitted Name of Target Chain 43	UniProt (TrEMBL) Entry Name of Target Chain 43	UniProt (TrEMBL) Primary ID of Target Chain 43	UniProt (TrEMBL) Secondary ID(s) of Target Chain 43	UniProt (TrEMBL) Alternative ID(s) of Target Chain 43	BindingDB Target Chain Sequence 44	PDB ID(s) of Target Chain 44	UniProt (SwissProt) Recommended Name of Target Chain 44	UniProt (SwissProt) Entry Name of Target Chain 44	UniProt (SwissProt) Primary ID of Target Chain 44	UniProt (SwissProt) Secondary ID(s) of Target Chain 44	UniProt (SwissProt) Alternative ID(s) of Target Chain 44	UniProt (TrEMBL) Submitted Name of Target Chain 44	UniProt (TrEMBL) Entry Name of Target Chain 44	UniProt (TrEMBL) Primary ID of Target Chain 44	UniProt (TrEMBL) Secondary ID(s) of Target Chain 44	UniProt (TrEMBL) Alternative ID(s) of Target Chain 44	BindingDB Target Chain Sequence 45	PDB ID(s) of Target Chain 45	UniProt (SwissProt) Recommended Name of Target Chain 45	UniProt (SwissProt) Entry Name of Target Chain 45	UniProt (SwissProt) Primary ID of Target Chain 45	UniProt (SwissProt) Secondary ID(s) of Target Chain 45	UniProt (SwissProt) Alternative ID(s) of Target Chain 45	UniProt (TrEMBL) Submitted Name of Target Chain 45	UniProt (TrEMBL) Entry Name of Target Chain 45	UniProt (TrEMBL) Primary ID of Target Chain 45	UniProt (TrEMBL) Secondary ID(s) of Target Chain 45	UniProt (TrEMBL) Alternative ID(s) of Target Chain 45	BindingDB Target Chain Sequence 46	PDB ID(s) of Target Chain 46	UniProt (SwissProt) Recommended Name of Target Chain 46	UniProt (SwissProt) Entry Name of Target Chain 46	UniProt (SwissProt) Primary ID of Target Chain 46	UniProt (SwissProt) Secondary ID(s) of Target Chain 46	UniProt (SwissProt) Alternative ID(s) of Target Chain 46	UniProt (TrEMBL) Submitted Name of Target Chain 46	UniProt (TrEMBL) Entry Name of Target Chain 46	UniProt (TrEMBL) Primary ID of Target Chain 46	UniProt (TrEMBL) Secondary ID(s) of Target Chain 46	UniProt (TrEMBL) Alternative ID(s) of Target Chain 46	BindingDB Target Chain Sequence 47	PDB ID(s) of Target Chain 47	UniProt (SwissProt) Recommended Name of Target Chain 47	UniProt (SwissProt) Entry Name of Target Chain 47	UniProt (SwissProt) Primary ID of Target Chain 47	UniProt (SwissProt) Secondary ID(s) of Target Chain 47	UniProt (SwissProt) Alternative ID(s) of Target Chain 47	UniProt (TrEMBL) Submitted Name of Target Chain 47	UniProt (TrEMBL) Entry Name of Target Chain 47	UniProt (TrEMBL) Primary ID of Target Chain 47	UniProt (TrEMBL) Secondary ID(s) of Target Chain 47	UniProt (TrEMBL) Alternative ID(s) of Target Chain 47	BindingDB Target Chain Sequence 48	PDB ID(s) of Target Chain 48	UniProt (SwissProt) Recommended Name of Target Chain 48	UniProt (SwissProt) Entry Name of Target Chain 48	UniProt (SwissProt) Primary ID of Target Chain 48	UniProt (SwissProt) Secondary ID(s) of Target Chain 48	UniProt (SwissProt) Alternative ID(s) of Target Chain 48	UniProt (TrEMBL) Submitted Name of Target Chain 48	UniProt (TrEMBL) Entry Name of Target Chain 48	UniProt (TrEMBL) Primary ID of Target Chain 48	UniProt (TrEMBL) Secondary ID(s) of Target Chain 48	UniProt (TrEMBL) Alternative ID(s) of Target Chain 48	BindingDB Target Chain Sequence 49	PDB ID(s) of Target Chain 49	UniProt (SwissProt) Recommended Name of Target Chain 49	UniProt (SwissProt) Entry Name of Target Chain 49	UniProt (SwissProt) Primary ID of Target Chain 49	UniProt (SwissProt) Secondary ID(s) of Target Chain 49	UniProt (SwissProt) Alternative ID(s) of Target Chain 49	UniProt (TrEMBL) Submitted Name of Target Chain 49	UniProt (TrEMBL) Entry Name of Target Chain 49	UniProt (TrEMBL) Primary ID of Target Chain 49	UniProt (TrEMBL) Secondary ID(s) of Target Chain 49	UniProt (TrEMBL) Alternative ID(s) of Target Chain 49	BindingDB Target Chain Sequence 50	PDB ID(s) of Target Chain 50	UniProt (SwissProt) Recommended Name of Target Chain 50	UniProt (SwissProt) Entry Name of Target Chain 50	UniProt (SwissProt) Primary ID of Target Chain 50	UniProt (SwissProt) Secondary ID(s) of Target Chain 50	UniProt (SwissProt) Alternative ID(s) of Target Chain 50	UniProt (TrEMBL) Submitted Name of Target Chain 50	UniProt (TrEMBL) Entry Name of Target Chain 50	UniProt (TrEMBL) Primary ID of Target Chain 50	UniProt (TrEMBL) Secondary ID(s) of Target Chain 50	UniProt (TrEMBL) Alternative ID(s) of Target Chain 50
584403	COc1cc(cc2nnn(C)c12)C(CC(O)=O)c1ccc(C)c(CN2CCN(C)c3ccccc3S2(=O)=O)c1	InChI=1S/C28H31N5O5S/c1-18-9-10-19(22(16-27(34)35)20-14-23-28(25(15-20)38-4)32(3)30-29-23)13-21(18)17-33-12-11-31(2)24-7-5-6-8-26(24)39(33,36)37/h5-10,13-15,22H,11-12,16-17H2,1-4H3,(H,34,35)	IJHWQGAWCBWPSG-UHFFFAOYSA-N	304414	3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoic acid::US10144731, Example 1	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304414	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304414&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118188783	381753127							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584404	CN1CCN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc12	InChI=1S/C28H31N5O4S/c1-18-9-10-20(23(16-27(34)35)22-11-12-25-28(19(22)2)29-30-32(25)4)15-21(18)17-33-14-13-31(3)24-7-5-6-8-26(24)38(33,36)37/h5-12,15,23H,13-14,16-17H2,1-4H3,(H,34,35)	FGBWUXHBTBMVKE-UHFFFAOYSA-N	304443	3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoic acid::US10144731, Example 2	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304443	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304443&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170398	381753155							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584405	Cc1ccc(cc1CN1CCOc2ccccc2S1(=O)=O)C(CC(O)=O)c1ccc2n(C)nnc2c1C	InChI=1S/C27H28N4O5S/c1-17-8-9-19(22(15-26(32)33)21-10-11-23-27(18(21)2)28-29-30(23)3)14-20(17)16-31-12-13-36-24-6-4-5-7-25(24)37(31,34)35/h4-11,14,22H,12-13,15-16H2,1-3H3,(H,32,33)	NLWYXGJADHXGKC-UHFFFAOYSA-N	304719	3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-((1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)propanoic acid::US10144731, Example 3	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304719	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304719&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118169953	381753423							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584406	COc1cc(cc2nnn(C)c12)C(CC(O)=O)c1ccc(C)c(CN2C(C)COc3ccccc3S2(=O)=O)c1	InChI=1S/C28H30N4O6S/c1-17-9-10-19(22(14-27(33)34)20-12-23-28(25(13-20)37-4)31(3)30-29-23)11-21(17)15-32-18(2)16-38-24-7-5-6-8-26(24)39(32,35)36/h5-13,18,22H,14-16H2,1-4H3,(H,33,34)	OSZJZIMGVAMBKO-UHFFFAOYSA-N	304720	3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((3-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 4	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304720	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304720&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			122653376	381753424							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584407	COc1cc(cc2nnn(C)c12)C(CC(O)=O)c1ccc(C)c(CN2CC(C)Oc3ccccc3S2(=O)=O)c1	InChI=1S/C28H30N4O6S/c1-17-9-10-19(22(14-27(33)34)20-12-23-28(25(13-20)37-4)31(3)30-29-23)11-21(17)16-32-15-18(2)38-24-7-5-6-8-26(24)39(32,35)36/h5-13,18,22H,14-16H2,1-4H3,(H,33,34)	ZDNGJXBUEQNFBQ-UHFFFAOYSA-N	304721	3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 5	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304721	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304721&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			122653346	381753425							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584408	COc1cc(cc2nnn(C)c12)C(CC(O)=O)c1ccc(C)c(CN2CCOc3ncccc3S2(=O)=O)c1	InChI=1S/C26H27N5O6S/c1-16-6-7-17(11-19(16)15-31-9-10-37-26-23(38(31,34)35)5-4-8-27-26)20(14-24(32)33)18-12-21-25(22(13-18)36-3)30(2)29-28-21/h4-8,11-13,20H,9-10,14-15H2,1-3H3,(H,32,33)	IGSXVTNHKWFQHY-UHFFFAOYSA-N	304722	3-(3-((1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 6	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304722	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304722&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118169887	381753426							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584409	Cc1ccc(cc1CN1CCOc2ncccc2S1(=O)=O)C(CC(O)=O)c1ccc2n(C)nnc2c1C	InChI=1S/C26H27N5O5S/c1-16-6-7-18(21(14-24(32)33)20-8-9-22-25(17(20)2)28-29-30(22)3)13-19(16)15-31-11-12-36-26-23(37(31,34)35)5-4-10-27-26/h4-10,13,21H,11-12,14-15H2,1-3H3,(H,32,33)	TUUFGOFVAYQRAJ-UHFFFAOYSA-N	304723	3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-((1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)propanoic acid::US10144731, Example 8	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304723	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304723&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170159	381753427							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584410	CC1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc2O1	InChI=1S/C28H30N4O5S/c1-17-9-10-20(23(14-27(33)34)22-11-12-24-28(19(22)3)29-30-31(24)4)13-21(17)16-32-15-18(2)37-25-7-5-6-8-26(25)38(32,35)36/h5-13,18,23H,14-16H2,1-4H3,(H,33,34)	HKVJGRGOCHBUFK-UHFFFAOYSA-N	304724	3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 10	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304724	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304724&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170735	381753428							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584411	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C28H30N4O5S/c1-17-9-10-20(23(14-27(33)34)22-11-12-24-28(19(22)3)29-30-31(24)4)13-21(17)16-32-15-18(2)37-25-7-5-6-8-26(25)38(32,35)36/h5-13,18,23H,14-16H2,1-4H3,(H,33,34)	HKVJGRGOCHBUFK-UHFFFAOYSA-N	304725	3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 11	Nuclear factor erythroid 2-related factor 2	Human				 55					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304725	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304725&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			91810334	381753429							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584412	C[C@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C28H30N4O5S/c1-17-9-10-20(23(14-27(33)34)22-11-12-24-28(19(22)3)29-30-31(24)4)13-21(17)16-32-15-18(2)37-25-7-5-6-8-26(25)38(32,35)36/h5-13,18,23H,14-16H2,1-4H3,(H,33,34)	HKVJGRGOCHBUFK-UHFFFAOYSA-N	304726	3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((S)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 12	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304726	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304726&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118169972	381753430							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584413	COc1cc(cc2nnn(C)c12)C(CC(O)=O)c1ccc(C)c(CN2C[C@@H](C)Oc3ccccc3S2(=O)=O)c1 |r|	InChI=1S/C28H30N4O6S/c1-17-9-10-19(22(14-27(33)34)20-12-23-28(25(13-20)37-4)31(3)30-29-23)11-21(17)16-32-15-18(2)38-24-7-5-6-8-26(24)39(32,35)36/h5-13,18,22H,14-16H2,1-4H3,(H,33,34)	ZDNGJXBUEQNFBQ-UHFFFAOYSA-N	304727	3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 13	Nuclear factor erythroid 2-related factor 2	Human				 55					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304727	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304727&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170387	381753431							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584414	COc1cc(cc2nnn(C)c12)C(CC(O)=O)c1ccc(C)c(CN2C[C@H](C)Oc3ccccc3S2(=O)=O)c1 |r|	InChI=1S/C28H30N4O6S/c1-17-9-10-19(22(14-27(33)34)20-12-23-28(25(13-20)37-4)31(3)30-29-23)11-21(17)16-32-15-18(2)38-24-7-5-6-8-26(24)39(32,35)36/h5-13,18,22H,14-16H2,1-4H3,(H,33,34)	ZDNGJXBUEQNFBQ-UHFFFAOYSA-N	304728	3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((S)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 14	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304728	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304728&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170010	381753432							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584415	CCN1CCN(Cc2cc(ccc2C)C(CC(O)=O)c2cc(OC)c3n(C)nnc3c2)S(=O)(=O)c2ccccc12	InChI=1S/C29H33N5O5S/c1-5-33-12-13-34(40(37,38)27-9-7-6-8-25(27)33)18-22-14-20(11-10-19(22)2)23(17-28(35)36)21-15-24-29(26(16-21)39-4)32(3)31-30-24/h6-11,14-16,23H,5,12-13,17-18H2,1-4H3,(H,35,36)	ORCXIWDDBGRHOT-UHFFFAOYSA-N	304729	3-(3-((5-ethyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)-4-methylphenyl)-3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 15	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304729	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304729&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			122653399	381753433							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584416	CCN1CCN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc12	InChI=1S/C29H33N5O4S/c1-5-33-14-15-34(39(37,38)27-9-7-6-8-25(27)33)18-22-16-21(11-10-19(22)2)24(17-28(35)36)23-12-13-26-29(20(23)3)30-31-32(26)4/h6-13,16,24H,5,14-15,17-18H2,1-4H3,(H,35,36)	GRYNUYVNLFSDGO-UHFFFAOYSA-N	304730	3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-((5-ethyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)-4-methylphenyl)propanoic acid::US10144731, Example 16	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304730	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304730&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170188	381753434							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584417	COc1cc(cc2nnn(C)c12)C(CC(O)=O)c1ccc(C)c(CN2C[C@H](C)Oc3ncccc3S2(=O)=O)c1 |r|	InChI=1S/C27H29N5O6S/c1-16-7-8-18(21(13-25(33)34)19-11-22-26(23(12-19)37-4)31(3)30-29-22)10-20(16)15-32-14-17(2)38-27-24(39(32,35)36)6-5-9-28-27/h5-12,17,21H,13-15H2,1-4H3,(H,33,34)	CJTSGSQAUXSAER-UHFFFAOYSA-N	304731	3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((S)-4-methyl-1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 17	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304731	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304731&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170365	381753435							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584418	COc1cc(cc2nnn(C)c12)C(CC(O)=O)c1ccc(C)c(CN2C[C@@H](C)Oc3ncccc3S2(=O)=O)c1 |r|	InChI=1S/C27H29N5O6S/c1-16-7-8-18(21(13-25(33)34)19-11-22-26(23(12-19)37-4)31(3)30-29-22)10-20(16)15-32-14-17(2)38-27-24(39(32,35)36)6-5-9-28-27/h5-12,17,21H,13-15H2,1-4H3,(H,33,34)	CJTSGSQAUXSAER-UHFFFAOYSA-N	304732	3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 18	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304732	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304732&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170459	381753436							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584419	C[C@@H]1CN(Cc2cc(ccc2C)[C@H](CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C28H30N4O5S/c1-17-9-10-20(23(14-27(33)34)22-11-12-24-28(19(22)3)29-30-31(24)4)13-21(17)16-32-15-18(2)37-25-7-5-6-8-26(25)38(32,35)36/h5-13,18,23H,14-16H2,1-4H3,(H,33,34)	HKVJGRGOCHBUFK-UHFFFAOYSA-N	304733	(S)-3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 19	Nuclear factor erythroid 2-related factor 2	Human				 55					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304733	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304733&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170106	381753437							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584420	C[C@@H]1CN(Cc2cc(ccc2C)[C@@H](CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C28H30N4O5S/c1-17-9-10-20(23(14-27(33)34)22-11-12-24-28(19(22)3)29-30-31(24)4)13-21(17)16-32-15-18(2)37-25-7-5-6-8-26(25)38(32,35)36/h5-13,18,23H,14-16H2,1-4H3,(H,33,34)	HKVJGRGOCHBUFK-UHFFFAOYSA-N	304734	(R)-3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 20	Nuclear factor erythroid 2-related factor 2	Human				 55					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304734	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304734&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			122653584	381753438							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584421	CCC1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc2O1	InChI=1S/C29H32N4O5S/c1-5-22-17-33(39(36,37)27-9-7-6-8-26(27)38-22)16-21-14-20(11-10-18(21)2)24(15-28(34)35)23-12-13-25-29(19(23)3)30-31-32(25)4/h6-14,22,24H,5,15-17H2,1-4H3,(H,34,35)	PSAYWSGFKCURFC-UHFFFAOYSA-N	304735	3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-((4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)propanoic acid::US10144731, Example 21	Nuclear factor erythroid 2-related factor 2	Human				 55					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304735	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304735&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118169975	381753439							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584422	CCC1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2cccnc2O1	InChI=1S/C28H31N5O5S/c1-5-21-16-33(39(36,37)25-7-6-12-29-28(25)38-21)15-20-13-19(9-8-17(20)2)23(14-26(34)35)22-10-11-24-27(18(22)3)30-31-32(24)4/h6-13,21,23H,5,14-16H2,1-4H3,(H,34,35)	CYAWSFDLOYOCFO-UHFFFAOYSA-N	304736	3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-((4-ethyl-1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)propanoic acid::US10144731, Example 22	Nuclear factor erythroid 2-related factor 2	Human				 55					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304736	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304736&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170902	381753440							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584423	CCC1CN(Cc2cc(ccc2C)C(CC(O)=O)c2cc(OC)c3n(C)nnc3c2)S(=O)(=O)c2ccccc2O1	InChI=1S/C29H32N4O6S/c1-5-22-17-33(40(36,37)27-9-7-6-8-25(27)39-22)16-21-12-19(11-10-18(21)2)23(15-28(34)35)20-13-24-29(26(14-20)38-4)32(3)31-30-24/h6-14,22-23H,5,15-17H2,1-4H3,(H,34,35)	CGULIBNLQTVXJS-UHFFFAOYSA-N	304737	3-(3-((4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 23	Nuclear factor erythroid 2-related factor 2	Human				 55					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304737	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304737&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170304	381753441							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584424	CCC1CN(Cc2cc(ccc2C)C(CC(O)=O)c2cc(OC)c3n(C)nnc3c2)S(=O)(=O)c2cccnc2O1	InChI=1S/C28H31N5O6S/c1-5-21-16-33(40(36,37)25-7-6-10-29-28(25)39-21)15-20-11-18(9-8-17(20)2)22(14-26(34)35)19-12-23-27(24(13-19)38-4)32(3)31-30-23/h6-13,21-22H,5,14-16H2,1-4H3,(H,34,35)	JJZPWGQPPUTFLQ-UHFFFAOYSA-N	304738	3-(3-((4-ethyl-1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 24	Nuclear factor erythroid 2-related factor 2	Human				 55					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304738	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304738&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170830	381753442							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584425	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2cccnc2O1 |r|	InChI=1S/C27H29N5O5S/c1-16-7-8-19(22(13-25(33)34)21-9-10-23-26(18(21)3)29-30-31(23)4)12-20(16)15-32-14-17(2)37-27-24(38(32,35)36)6-5-11-28-27/h5-12,17,22H,13-15H2,1-4H3,(H,33,34)	DPUCGDIRADRVPW-UHFFFAOYSA-N	304739	3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 25	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304739	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304739&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170257	381753443							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584426	CCN1CCN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2cccnc12	InChI=1S/C28H32N6O4S/c1-5-33-13-14-34(39(37,38)25-7-6-12-29-28(25)33)17-21-15-20(9-8-18(21)2)23(16-26(35)36)22-10-11-24-27(19(22)3)30-31-32(24)4/h6-12,15,23H,5,13-14,16-17H2,1-4H3,(H,35,36)	IQURXROILDLSHX-UHFFFAOYSA-N	304740	3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-((5-ethyl-1,1-dioxido-4,5-dihydropyrido[2,3-f][1,2,5]thiadiazepin-2(3H)-yl)methyl)-4-methylphenyl)propanoic acid::US10144731, Example 26	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304740	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304740&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118169906	381753444							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584427	CCN1CCN(Cc2cc(ccc2C)C(CC(O)=O)c2cc(OC)c3n(C)nnc3c2)S(=O)(=O)c2cccnc12	InChI=1S/C28H32N6O5S/c1-5-33-11-12-34(40(37,38)25-7-6-10-29-28(25)33)17-21-13-19(9-8-18(21)2)22(16-26(35)36)20-14-23-27(24(15-20)39-4)32(3)31-30-23/h6-10,13-15,22H,5,11-12,16-17H2,1-4H3,(H,35,36)	JBXYFQNBDRELKW-UHFFFAOYSA-N	304741	3-(3-((5-ethyl-1,1-dioxido-4,5-dihydropyrido[2,3-f][1,2,5]thiadiazepin-2(3H)-yl)methyl)-4-methylphenyl)-3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 27	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304741	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304741&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170435	381753445							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584428	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2)S(=O)(=O)c2cccnc2O1 |r|	InChI=1S/C26H27N5O5S/c1-16-6-7-18(21(13-25(32)33)19-8-9-23-22(12-19)28-29-30(23)3)11-20(16)15-31-14-17(2)36-26-24(37(31,34)35)5-4-10-27-26/h4-12,17,21H,13-15H2,1-3H3,(H,32,33)	XEPNCVULOSCAJQ-UHFFFAOYSA-N	304742	3-(1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 28	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304742	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304742&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170876	381753446							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584429	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C27H28N4O5S/c1-17-8-9-19(22(14-27(32)33)20-10-11-24-23(13-20)28-29-30(24)3)12-21(17)16-31-15-18(2)36-25-6-4-5-7-26(25)37(31,34)35/h4-13,18,22H,14-16H2,1-3H3,(H,32,33)	YVVSLYWCORNKAO-UHFFFAOYSA-N	304743	US10144731, Example 29::3-(1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::BDBM304815	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304743	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304743&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170055	381753447							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584430	CCN1CCN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2)S(=O)(=O)c2ccccc12	InChI=1S/C28H31N5O4S/c1-4-32-13-14-33(38(36,37)27-8-6-5-7-26(27)32)18-22-15-20(10-9-19(22)2)23(17-28(34)35)21-11-12-25-24(16-21)29-30-31(25)3/h5-12,15-16,23H,4,13-14,17-18H2,1-3H3,(H,34,35)	PPNGGDOOVBFKCD-UHFFFAOYSA-N	304744	3-(3-((5-ethyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)-4-methylphenyl)-3-(1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 30	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304744	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304744&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118188766	381753448							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584431	CCC1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2)S(=O)(=O)c2cccnc2O1	InChI=1S/C27H29N5O5S/c1-4-21-16-32(38(35,36)25-6-5-11-28-27(25)37-21)15-20-12-18(8-7-17(20)2)22(14-26(33)34)19-9-10-24-23(13-19)29-30-31(24)3/h5-13,21-22H,4,14-16H2,1-3H3,(H,33,34)	VAANGWNZJXFEIA-UHFFFAOYSA-N	304745	3-(3-((4-ethyl-1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-3-(1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 31	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304745	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304745&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118169907	381753449							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584432	CCC1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2)S(=O)(=O)c2ccccc2O1	InChI=1S/C28H30N4O5S/c1-4-22-17-32(38(35,36)27-8-6-5-7-26(27)37-22)16-21-13-19(10-9-18(21)2)23(15-28(33)34)20-11-12-25-24(14-20)29-30-31(25)3/h5-14,22-23H,4,15-17H2,1-3H3,(H,33,34)	UHPAVJXNZSOPQI-UHFFFAOYSA-N	304746	3-(3-((4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-3-(1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 32	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304746	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304746&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170207	381753450							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584433	CCN1CCN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2)S(=O)(=O)c2cccnc12	InChI=1S/C27H30N6O4S/c1-4-32-12-13-33(38(36,37)25-6-5-11-28-27(25)32)17-21-14-19(8-7-18(21)2)22(16-26(34)35)20-9-10-24-23(15-20)29-30-31(24)3/h5-11,14-15,22H,4,12-13,16-17H2,1-3H3,(H,34,35)	WAXBHHQLKYBNQI-UHFFFAOYSA-N	304747	3-(3-((5-ethyl-1,1-dioxido-4,5-dihydropyrido[2,3-f][1,2,5]thiadiazepin-2(3H)-yl)methyl)-4-methylphenyl)-3-(1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 33	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304747	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304747&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			122653503	381753451							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584434	COc1cc(cc2nnn(C)c12)[C@H](CC(O)=O)c1ccc(C)c(CN2C[C@@H](C)Oc3ccccc3S2(=O)=O)c1 |r|	InChI=1S/C28H30N4O6S/c1-17-9-10-19(22(14-27(33)34)20-12-23-28(25(13-20)37-4)31(3)30-29-23)11-21(17)16-32-15-18(2)38-24-7-5-6-8-26(24)39(32,35)36/h5-13,18,22H,14-16H2,1-4H3,(H,33,34)	ZDNGJXBUEQNFBQ-UHFFFAOYSA-N	304748	US10144731, Example 34a::BDBM304749	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304748	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304748&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118169940	381753452							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584435	COc1cc(cc2nnn(C)c12)[C@H](CC(O)=O)c1ccc(C)c(CN2C[C@@H](C)Oc3ccccc3S2(=O)=O)c1 |r|	InChI=1S/C28H30N4O6S/c1-17-9-10-19(22(14-27(33)34)20-12-23-28(25(13-20)37-4)31(3)30-29-23)11-21(17)16-32-15-18(2)38-24-7-5-6-8-26(24)39(32,35)36/h5-13,18,22H,14-16H2,1-4H3,(H,33,34)	ZDNGJXBUEQNFBQ-UHFFFAOYSA-N	304748	US10144731, Example 34a::BDBM304749	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304748	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304748&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118169940	381753452							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584436	CCC1CN(C(C)c2cc(ccc2C)C(CC(O)=O)c2ccc3n(CC)nnc3c2C)S(=O)(=O)c2ccccc2O1	InChI=1S/C31H36N4O5S/c1-6-23-18-35(41(38,39)29-11-9-8-10-28(29)40-23)21(5)25-16-22(13-12-19(25)3)26(17-30(36)37)24-14-15-27-31(20(24)4)32-33-34(27)7-2/h8-16,21,23,26H,6-7,17-18H2,1-5H3,(H,36,37)	AKHCBMLHZMAGJM-UHFFFAOYSA-N	304750	3-(3-((4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-3-(1-ethyl-4-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 35	Nuclear factor erythroid 2-related factor 2	Human				 55					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304750	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304750&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			122660620	381753454							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584437	CCn1nnc2c(C)c(ccc12)C(CC(O)=O)c1ccc(C)c(CN2C[C@@H](C)Oc3ccccc3S2(=O)=O)c1 |r|	InChI=1S/C29H32N4O5S/c1-5-33-25-13-12-23(20(4)29(25)30-31-33)24(15-28(34)35)21-11-10-18(2)22(14-21)17-32-16-19(3)38-26-8-6-7-9-27(26)39(32,36)37/h6-14,19,24H,5,15-17H2,1-4H3,(H,34,35)	GSJYABPCKQDTOX-UHFFFAOYSA-N	304751	3-(1-ethyl-4-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 36	Nuclear factor erythroid 2-related factor 2	Human				 55					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304751	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304751&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170164	381753455							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584438	CCn1nnc2c(C)c(ccc12)C(CC(O)=O)c1ccc(C)c(CN2C[C@@H](C)Oc3ncccc3S2(=O)=O)c1 |r|	InChI=1S/C28H31N5O5S/c1-5-33-24-11-10-22(19(4)27(24)30-31-33)23(14-26(34)35)20-9-8-17(2)21(13-20)16-32-15-18(3)38-28-25(39(32,36)37)7-6-12-29-28/h6-13,18,23H,5,14-16H2,1-4H3,(H,34,35)	IOXXTPJNZJWFCO-UHFFFAOYSA-N	304752	3-(1-ethyl-4-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 37	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304752	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304752&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170686	381753456							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584439	CCC1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(CC)nnc3c2C)S(=O)(=O)c2cccnc2O1	InChI=1S/C29H33N5O5S/c1-5-22-17-33(40(37,38)26-8-7-13-30-29(26)39-22)16-21-14-20(10-9-18(21)3)24(15-27(35)36)23-11-12-25-28(19(23)4)31-32-34(25)6-2/h7-14,22,24H,5-6,15-17H2,1-4H3,(H,35,36)	FSVDYFNASNQHCE-UHFFFAOYSA-N	304753	3-(3-((4-ethyl-1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-3-(1-ethyl-4-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 38	Nuclear factor erythroid 2-related factor 2	Human				 55					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304753	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304753&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118169794	381753457							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584440	CCN1CCN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(CC)nnc3c2C)S(=O)(=O)c2cccnc12	InChI=1S/C29H34N6O4S/c1-5-33-14-15-34(40(38,39)26-8-7-13-30-29(26)33)18-22-16-21(10-9-19(22)3)24(17-27(36)37)23-11-12-25-28(20(23)4)31-32-35(25)6-2/h7-13,16,24H,5-6,14-15,17-18H2,1-4H3,(H,36,37)	FJBDTVHTQZMFJX-UHFFFAOYSA-N	304754	3-(3-((5-ethyl-1,1-dioxido-4,5-dihydropyrido[2,3-f][1,2,5]thiadiazepin-2(3H)-yl)methyl)-4-methylphenyl)-3-(1-ethyl-4-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 39	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304754	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304754&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118169897	381753458							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584441	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(CC)nnc3c2C)S(=O)(=O)c2cccnc2O1 |r|	InChI=1S/C29H33N5O5S/c1-5-22-17-33(40(37,38)26-8-7-13-30-29(26)39-22)16-21-14-20(10-9-18(21)3)24(15-27(35)36)23-11-12-25-28(19(23)4)31-32-34(25)6-2/h7-14,22,24H,5-6,15-17H2,1-4H3,(H,35,36)	FSVDYFNASNQHCE-UHFFFAOYSA-N	304755	US10144731, Example 40::BDBM304886::3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-3-(1-ethyl-4-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::BDBM304885::BDBM304838	Nuclear factor erythroid 2-related factor 2	Human				 55					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304755	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304755&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118169924	381753459							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584442	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2cccnc2O1 |r|	InChI=1S/C28H31N5O5S/c1-5-21-16-33(39(36,37)25-7-6-12-29-28(25)38-21)15-20-13-19(9-8-17(20)2)23(14-26(34)35)22-10-11-24-27(18(22)3)30-31-32(24)4/h6-13,21,23H,5,14-16H2,1-4H3,(H,34,35)	CYAWSFDLOYOCFO-UHFFFAOYSA-N	304756	3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)propanoic acid::US10144731, Example 41	Nuclear factor erythroid 2-related factor 2	Human				 55					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304756	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304756&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118169877	381753460							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584443	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(CC)nnc3c2C)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C30H34N4O5S/c1-5-23-18-33(40(37,38)28-10-8-7-9-27(28)39-23)17-22-15-21(12-11-19(22)3)25(16-29(35)36)24-13-14-26-30(20(24)4)31-32-34(26)6-2/h7-15,23,25H,5-6,16-18H2,1-4H3,(H,35,36)	VQHOXOKHXRHGJX-UHFFFAOYSA-N	304757	3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-3-(1-ethyl-4-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 42	Nuclear factor erythroid 2-related factor 2	Human				 55					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304757	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304757&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118169977	381753461							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584444	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C29H32N4O5S/c1-5-22-17-33(39(36,37)27-9-7-6-8-26(27)38-22)16-21-14-20(11-10-18(21)2)24(15-28(34)35)23-12-13-25-29(19(23)3)30-31-32(25)4/h6-14,22,24H,5,15-17H2,1-4H3,(H,34,35)	PSAYWSGFKCURFC-UHFFFAOYSA-N	304758	BDBM304884::BDBM304883::3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)propanoic acid::US10144731, Example 43	Nuclear factor erythroid 2-related factor 2	Human				 55					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304758	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304758&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170027	381753462							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584445	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2cc(OC)c3n(C)nnc3c2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C29H32N4O6S/c1-5-22-17-33(40(36,37)27-9-7-6-8-25(27)39-22)16-21-12-19(11-10-18(21)2)23(15-28(34)35)20-13-24-29(26(14-20)38-4)32(3)31-30-24/h6-14,22-23H,5,15-17H2,1-4H3,(H,34,35)	CGULIBNLQTVXJS-UHFFFAOYSA-N	304759	3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 44	Nuclear factor erythroid 2-related factor 2	Human				 55					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304759	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304759&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170220	381753463							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584446	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2cc(OC)c3n(C)nnc3c2)S(=O)(=O)c2cccnc2O1 |r|	InChI=1S/C28H31N5O6S/c1-5-21-16-33(40(36,37)25-7-6-10-29-28(25)39-21)15-20-11-18(9-8-17(20)2)22(14-26(34)35)19-12-23-27(24(13-19)38-4)32(3)31-30-23/h6-13,21-22H,5,14-16H2,1-4H3,(H,34,35)	JJZPWGQPPUTFLQ-UHFFFAOYSA-N	304760	3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 45	Nuclear factor erythroid 2-related factor 2	Human				 55					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304760	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304760&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170004	381753464							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584447	CC[C@@H]1CN(Cc2cc(ccc2CC)C(CC(O)=O)c2cccc(OC)c2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C29H33NO6S/c1-4-20-13-14-22(26(17-29(31)32)21-9-8-10-25(16-21)35-3)15-23(20)18-30-19-24(5-2)36-27-11-6-7-12-28(27)37(30,33)34/h6-16,24,26H,4-5,17-19H2,1-3H3,(H,31,32)	JBQFMPMORHDMHZ-UHFFFAOYSA-N	304761	3-(4-ethyl-3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)-3-(3-methoxyphenyl)propanoic acid::US10144731, Example 46	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304761	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304761&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170518	381753465							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584448	CN(Cc1cc(ccc1Cl)C(CC(O)=O)c1ccc2n(C)nnc2c1)S(=O)(=O)c1cccc(C)c1	InChI=1S/C25H25ClN4O4S/c1-16-5-4-6-20(11-16)35(33,34)29(2)15-19-12-17(7-9-22(19)26)21(14-25(31)32)18-8-10-24-23(13-18)27-28-30(24)3/h4-13,21H,14-15H2,1-3H3,(H,31,32)	LALJNFCDDXCGMH-UHFFFAOYSA-N	304762	3-(4-chloro-3-((N,3-dimethylphenylsulfonamido)methyl)phenyl)-3-(1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 48	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304762	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304762&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118169835	381753466							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584449	CN(Cc1cc(ccc1Cl)C(CC(O)=O)c1ccc2n(C)nnc2c1)S(=O)(=O)c1cccc(NC(C)=O)c1	InChI=1S/C26H26ClN5O5S/c1-16(33)28-20-5-4-6-21(13-20)38(36,37)31(2)15-19-11-17(7-9-23(19)27)22(14-26(34)35)18-8-10-25-24(12-18)29-30-32(25)3/h4-13,22H,14-15H2,1-3H3,(H,28,33)(H,34,35)	CCKFFZWASQCQFD-UHFFFAOYSA-N	304763	3-(3-((3-acetamido-N-methylphenylsulfonamido)methyl)-4-chlorophenyl)-3-(1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 50	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304763	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304763&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170465	381753467							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584450	CN(Cc1cc(ccc1Cl)C(CC(O)=O)c1ccc2n(C)nnc2c1)S(=O)(=O)c1ccc2OCCOc2c1	InChI=1S/C26H25ClN4O6S/c1-30(38(34,35)19-5-8-24-25(13-19)37-10-9-36-24)15-18-11-16(3-6-21(18)27)20(14-26(32)33)17-4-7-23-22(12-17)28-29-31(23)2/h3-8,11-13,20H,9-10,14-15H2,1-2H3,(H,32,33)	CPQNNJBTSHDTLZ-UHFFFAOYSA-N	304764	3-(4-chloro-3-((N-methyl-2,3-dihydrobenzo[b][1,4]dioxine-6-sulfonamido)methyl)phenyl)-3-(1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 52	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304764	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304764&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118169845	381753468							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584451	CN(Cc1cc(ccc1Cl)[C@@H](CC(O)=O)c1ccc2n(C)nnc2c1)S(=O)(=O)c1ccccc1 |r|	InChI=1S/C24H23ClN4O4S/c1-28(34(32,33)19-6-4-3-5-7-19)15-18-12-16(8-10-21(18)25)20(14-24(30)31)17-9-11-23-22(13-17)26-27-29(23)2/h3-13,20H,14-15H2,1-2H3,(H,30,31)	NICLDNFOUWEYPY-UHFFFAOYSA-N	304765	(3R)-3-{4-chloro-3-[(N-methylbenzenesulfonamido)methyl]phenyl}-3-(1-methyl-1H-1,2,3-benzotriazol-5-yl)propanoic acid::US10144731, Example 53	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304765	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304765&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170374	381753469							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584452	CN(Cc1cc(ccc1C)[C@@H](CC(O)=O)c1ccc2n(C)nnc2c1C)S(=O)(=O)c1ccccc1 |r|	InChI=1S/C26H28N4O4S/c1-17-10-11-19(14-20(17)16-29(3)35(33,34)21-8-6-5-7-9-21)23(15-25(31)32)22-12-13-24-26(18(22)2)27-28-30(24)4/h5-14,23H,15-16H2,1-4H3,(H,31,32)	RZDVYTYOVMEPBY-UHFFFAOYSA-N	304766	(3R)-3-(1,4-dimethyl-1H-1,2,3-benzotriazol-5-yl)-3-{4-methyl-3-[(N-methylbenzenesulfonamido)methyl]phenyl}propanoic acid::US10144731, Example 55	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304766	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304766&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170217	381753470							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584453	CN(Cc1cc(ccc1C)[C@H](CC(O)=O)c1ccc2n(C)nnc2c1C)S(=O)(=O)c1ccccc1 |r|	InChI=1S/C26H28N4O4S/c1-17-10-11-19(14-20(17)16-29(3)35(33,34)21-8-6-5-7-9-21)23(15-25(31)32)22-12-13-24-26(18(22)2)27-28-30(24)4/h5-14,23H,15-16H2,1-4H3,(H,31,32)	RZDVYTYOVMEPBY-UHFFFAOYSA-N	304767	(3S)-3-(1,4-dimethyl-1H-1,2,3-benzotriazol-5-yl)-3-{4-methyl-3-[(N-methylbenzenesulfonamido)methyl]phenyl}propanoic acid::US10144731, Example 56	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304767	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304767&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118169976	381753471							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584454	COc1cc(cc2nnn(C)c12)C(CC(O)=O)c1ccc(C)c(CN2CCOc3ccccc3S2(=O)=O)c1	InChI=1S/C27H28N4O6S/c1-17-8-9-18(12-20(17)16-31-10-11-37-23-6-4-5-7-25(23)38(31,34)35)21(15-26(32)33)19-13-22-27(24(14-19)36-3)30(2)29-28-22/h4-9,12-14,21H,10-11,15-16H2,1-3H3,(H,32,33)	RTGHTXKISWZXKJ-UHFFFAOYSA-N	304768	3-(3-((1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 57	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304768	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304768&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118169882	381753472							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584455	COc1cc(cc2nnn(C)c12)C(CC(O)=O)c1cccc(CN2C[C@@H](C)Oc3ncccc3S2(=O)=O)c1 |r|	InChI=1S/C26H27N5O6S/c1-16-14-31(38(34,35)23-8-5-9-27-26(23)37-16)15-17-6-4-7-18(10-17)20(13-24(32)33)19-11-21-25(22(12-19)36-3)30(2)29-28-21/h4-12,16,20H,13-15H2,1-3H3,(H,32,33)	WPLBGJOJRLUORQ-UHFFFAOYSA-N	304769	3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 61	Nuclear factor erythroid 2-related factor 2	Human				 55					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304769	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304769&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170333	381753473							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584456	COc1cc(cc2nnn(C)c12)C(CC(O)=O)c1cccc(CN2CC(C)Oc3ccccc3S2(=O)=O)c1	InChI=1S/C27H28N4O6S/c1-17-15-31(38(34,35)25-10-5-4-9-23(25)37-17)16-18-7-6-8-19(11-18)21(14-26(32)33)20-12-22-27(24(13-20)36-3)30(2)29-28-22/h4-13,17,21H,14-16H2,1-3H3,(H,32,33)	ZXWYNATUZLXLKZ-UHFFFAOYSA-N	304770	3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-((4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 62	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304770	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304770&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170433	381753474							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584457	COc1cc(cc2nnn(C)c12)C(CC(O)=O)c1cccc(CN2C[C@@H](C)Oc3ccccc3S2(=O)=O)c1 |r|	InChI=1S/C27H28N4O6S/c1-17-15-31(38(34,35)25-10-5-4-9-23(25)37-17)16-18-7-6-8-19(11-18)21(14-26(32)33)20-12-22-27(24(13-20)36-3)30(2)29-28-22/h4-13,17,21H,14-16H2,1-3H3,(H,32,33)	ZXWYNATUZLXLKZ-UHFFFAOYSA-N	304771	3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 63	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304771	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304771&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118169838	381753475							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584458	CCC1CN(Cc2cccc(c2)C(CC(O)=O)c2cc(OC)c3n(C)nnc3c2)S(=O)(=O)c2ccccc2O1	InChI=1S/C28H30N4O6S/c1-4-21-17-32(39(35,36)26-11-6-5-10-24(26)38-21)16-18-8-7-9-19(12-18)22(15-27(33)34)20-13-23-28(25(14-20)37-3)31(2)30-29-23/h5-14,21-22H,4,15-17H2,1-3H3,(H,33,34)	QSSUJNFHVOAPEV-UHFFFAOYSA-N	304772	3-(3-((4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)-3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 64	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304772	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304772&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170607	381753476							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584459	CCC1CN(Cc2cccc(c2)C(CC(O)=O)c2cc(OC)c3n(C)nnc3c2)S(=O)(=O)c2cccnc2O1	InChI=1S/C27H29N5O6S/c1-4-20-16-32(39(35,36)24-9-6-10-28-27(24)38-20)15-17-7-5-8-18(11-17)21(14-25(33)34)19-12-22-26(23(13-19)37-3)31(2)30-29-22/h5-13,20-21H,4,14-16H2,1-3H3,(H,33,34)	RMOOKCRRIXVINV-UHFFFAOYSA-N	304773	3-(3-((4-ethyl-1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)-3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 65	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304773	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304773&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170234	381753477							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584460	Cc1c(ccc2n(C)nnc12)C(CC(O)=O)c1ccc(F)c(CN2CCOc3ccccc3S2(=O)=O)c1	InChI=1S/C26H25FN4O5S/c1-16-19(8-10-22-26(16)28-29-30(22)2)20(14-25(32)33)17-7-9-21(27)18(13-17)15-31-11-12-36-23-5-3-4-6-24(23)37(31,34)35/h3-10,13,20H,11-12,14-15H2,1-2H3,(H,32,33)	DRSUZWSVWLQHEW-UHFFFAOYSA-N	304774	3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-((1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-fluorophenyl)propanoic acid::US10144731, Example 66	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304774	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304774&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170616	381753478							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584461	C[C@@H]1CN(Cc2cc(ccc2F)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C27H27FN4O5S/c1-16-14-32(38(35,36)25-7-5-4-6-24(25)37-16)15-19-12-18(8-10-22(19)28)21(13-26(33)34)20-9-11-23-27(17(20)2)29-30-31(23)3/h4-12,16,21H,13-15H2,1-3H3,(H,33,34)	CYYQUZIQAPCJLW-UHFFFAOYSA-N	304775	3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-fluoro-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 67	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304775	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304775&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170350	381753479							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584462	CCC1CN(Cc2cc(ccc2F)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc2O1	InChI=1S/C28H29FN4O5S/c1-4-20-16-33(39(36,37)26-8-6-5-7-25(26)38-20)15-19-13-18(9-11-23(19)29)22(14-27(34)35)21-10-12-24-28(17(21)2)30-31-32(24)3/h5-13,20,22H,4,14-16H2,1-3H3,(H,34,35)	FOUDITGFIOIXRN-UHFFFAOYSA-N	304776	3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-((4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-fluorophenyl)propanoic acid::US10144731, Example 68	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304776	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304776&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118169891	381753480							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584463	C[C@@H]1CN(Cc2cc(ccc2F)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2cccnc2O1 |r|	InChI=1S/C26H26FN5O5S/c1-15-13-32(38(35,36)23-5-4-10-28-26(23)37-15)14-18-11-17(6-8-21(18)27)20(12-24(33)34)19-7-9-22-25(16(19)2)29-30-31(22)3/h4-11,15,20H,12-14H2,1-3H3,(H,33,34)	SLZHPAVILAIJPT-UHFFFAOYSA-N	304777	3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-fluoro-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 69	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304777	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304777&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170503	381753481							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584464	C[C@@H]1CN(Cc2cc(ccc2Cl)C(CC(O)=O)c2ccc3n(C)nnc3c2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C26H25ClN4O5S/c1-16-14-31(37(34,35)25-6-4-3-5-24(25)36-16)15-19-11-17(7-9-21(19)27)20(13-26(32)33)18-8-10-23-22(12-18)28-29-30(23)2/h3-12,16,20H,13-15H2,1-2H3,(H,32,33)	XZYFMIIYOADPMK-UHFFFAOYSA-N	304778	3-(4-chloro-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)-3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 72	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304778	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304778&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170405	381753482							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584465	COc1cc(cc2nnn(C)c12)C(CC(O)=O)c1ccc(Cl)c(CN2C[C@@H](C)Oc3ccccc3S2(=O)=O)c1 |r|	InChI=1S/C27H27ClN4O6S/c1-16-14-32(39(35,36)25-7-5-4-6-23(25)38-16)15-19-10-17(8-9-21(19)28)20(13-26(33)34)18-11-22-27(24(12-18)37-3)31(2)30-29-22/h4-12,16,20H,13-15H2,1-3H3,(H,33,34)	CQYMHLFEMQKUBC-UHFFFAOYSA-N	304779	3-(4-chloro-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)-3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 73	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304779	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304779&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170618	381753483							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584466	COc1cccc(c1)C(CC(O)=O)c1ccc(C)c(CN2C[C@@H](C)Oc3ccccc3S2(=O)=O)c1 |r|	InChI=1S/C27H29NO6S/c1-18-11-12-21(24(15-27(29)30)20-7-6-8-23(14-20)33-3)13-22(18)17-28-16-19(2)34-25-9-4-5-10-26(25)35(28,31)32/h4-14,19,24H,15-17H2,1-3H3,(H,29,30)	LLMYBSXAZDMMIK-UHFFFAOYSA-N	304780	3-(3-methoxyphenyl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 74	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304780	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304780&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170664	381753484							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584467	Cn1nnc2cc(ccc12)C(CC(O)=O)c1ccc(Cl)c(CN2CCOc3ccccc3S2(=O)=O)c1	InChI=1S/C25H23ClN4O5S/c1-29-22-9-7-17(13-21(22)27-28-29)19(14-25(31)32)16-6-8-20(26)18(12-16)15-30-10-11-35-23-4-2-3-5-24(23)36(30,33)34/h2-9,12-13,19H,10-11,14-15H2,1H3,(H,31,32)	UYRDBYWOJSQQOH-UHFFFAOYSA-N	304781	3-(4-chloro-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)-3-(1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 75	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304781	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304781&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			122660623	381753485							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584468	COc1cccc(C(CC(O)=O)c2ccc(C)c(CN3C[C@@H](C)Oc4ccccc4S3(=O)=O)c2)c1C |r|	InChI=1S/C28H31NO6S/c1-18-12-13-21(24(15-28(30)31)23-8-7-10-25(34-4)20(23)3)14-22(18)17-29-16-19(2)35-26-9-5-6-11-27(26)36(29,32)33/h5-14,19,24H,15-17H2,1-4H3,(H,30,31)	UVNADZWWOXEWFH-UHFFFAOYSA-N	304782	3-(3-methoxy-2-methylphenyl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 76	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304782	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304782&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170544	381753486							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584469	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2cnc3n(C)nnc3c2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C26H27N5O5S/c1-16-8-9-18(21(12-25(32)33)19-11-22-26(27-13-19)30(3)29-28-22)10-20(16)15-31-14-17(2)36-23-6-4-5-7-24(23)37(31,34)35/h4-11,13,17,21H,12,14-15H2,1-3H3,(H,32,33)	MMIORKVIDQHGLK-UHFFFAOYSA-N	304783	3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)-3-(3-methyl-3H-[1,2,3]triazolo[4,5-b]pyridin-6-yl)propanoic acid::US10144731, Example 77	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304783	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304783&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170259	381753487							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584470	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccn(C)c(=O)c2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C26H28N2O6S/c1-17-8-9-19(22(14-26(30)31)20-10-11-27(3)25(29)13-20)12-21(17)16-28-15-18(2)34-23-6-4-5-7-24(23)35(28,32)33/h4-13,18,22H,14-16H2,1-3H3,(H,30,31)	WJSSYLMODFTVGW-UHFFFAOYSA-N	304784	3-(1-methyl-2-oxo-1,2-dihydropyridin-4-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 78	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304784	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304784&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			122653241	381753488							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584471	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2cnc3n(C)nnc3c2C)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C27H29N5O5S/c1-16-9-10-19(21(12-25(33)34)22-13-28-27-26(18(22)3)29-30-31(27)4)11-20(16)15-32-14-17(2)37-23-7-5-6-8-24(23)38(32,35)36/h5-11,13,17,21H,12,14-15H2,1-4H3,(H,33,34)	FUYXWABFTBBPPQ-UHFFFAOYSA-N	304785	3-(3,7-dimethyl-3H-[1,2,3]triazolo[4,5-b]pyridin-6-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 79	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304785	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304785&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170842	381753489							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584472	COc1cncc(c1)C(CC(O)=O)c1ccc(C)c(CN2C[C@@H](C)Oc3ccccc3S2(=O)=O)c1 |r|	InChI=1S/C26H28N2O6S/c1-17-8-9-19(23(12-26(29)30)20-11-22(33-3)14-27-13-20)10-21(17)16-28-15-18(2)34-24-6-4-5-7-25(24)35(28,31)32/h4-11,13-14,18,23H,12,15-16H2,1-3H3,(H,29,30)	RJGYBYWABYITLP-UHFFFAOYSA-N	304786	3-(5-methoxypyridin-3-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 81	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304786	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304786&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170726	381753490							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584473	CCC1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccn(C)c(=O)c2)S(=O)(=O)c2ccccc2O1	InChI=1S/C27H30N2O6S/c1-4-22-17-29(36(33,34)25-8-6-5-7-24(25)35-22)16-21-13-19(10-9-18(21)2)23(15-27(31)32)20-11-12-28(3)26(30)14-20/h5-14,22-23H,4,15-17H2,1-3H3,(H,31,32)	HMFIFAOORJCVCB-UHFFFAOYSA-N	304787	3-(3-((4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-3-(1-methyl-2-oxo-1,2-dihydropyridin-4-yl)propanoic acid::US10144731, Example 83	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304787	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304787&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170774	381753491							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584474	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccn(C)c(=O)c2)S(=O)(=O)c2cccnc2O1 |r|	InChI=1S/C25H27N3O6S/c1-16-6-7-18(21(13-24(30)31)19-8-10-27(3)23(29)12-19)11-20(16)15-28-14-17(2)34-25-22(35(28,32)33)5-4-9-26-25/h4-12,17,21H,13-15H2,1-3H3,(H,30,31)	XXWNAIROFABZMP-UHFFFAOYSA-N	304788	3-(1-methyl-2-oxo-1,2-dihydropyridin-4-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 84	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304788	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304788&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			122653429	381753492							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584475	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2cc(C)c3n(C)nnc3c2F)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C28H29FN4O5S/c1-16-9-10-19(21(13-25(34)35)22-11-17(2)28-27(26(22)29)30-31-32(28)4)12-20(16)15-33-14-18(3)38-23-7-5-6-8-24(23)39(33,36)37/h5-12,18,21H,13-15H2,1-4H3,(H,34,35)	IMPTVJDGGVRIHR-UHFFFAOYSA-N	304789	3-(4-fluoro-1,7-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 87	Nuclear factor erythroid 2-related factor 2	Human				 55					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304789	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304789&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170782	381753493							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584476	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2F)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C27H27FN4O5S/c1-16-8-9-18(21(13-25(33)34)20-10-11-22-27(26(20)28)29-30-31(22)3)12-19(16)15-32-14-17(2)37-23-6-4-5-7-24(23)38(32,35)36/h4-12,17,21H,13-15H2,1-3H3,(H,33,34)	ZHDBZJLNJLJQMN-UHFFFAOYSA-N	304790	3-(4-fluoro-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 88	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304790	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304790&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170198	381753494							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584477	COc1cc(C(CC(O)=O)c2ccc(C)c(CN(C)C(=O)OC3CCCC3)c2)c(C)c2nnn(C)c12	InChI=1S/C27H34N4O5/c1-16-10-11-18(12-19(16)15-30(3)27(34)36-20-8-6-7-9-20)22(14-24(32)33)21-13-23(35-5)26-25(17(21)2)28-29-31(26)4/h10-13,20,22H,6-9,14-15H2,1-5H3,(H,32,33)	FICRVLXLXMNVDH-UHFFFAOYSA-N	304791	3-(3-((((cyclopentyloxy)carbonyl)(methyl)amino)methyl)-4-methylphenyl)-3-(7-methoxy-1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 89	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304791	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304791&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170796	381753495							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584478	CN(Cc1cc(ccc1C)C(CC(O)=O)c1ccc2n(C)nnc2c1C)S(=O)(=O)C1CCCC1	InChI=1S/C25H32N4O4S/c1-16-9-10-18(13-19(16)15-28(3)34(32,33)20-7-5-6-8-20)22(14-24(30)31)21-11-12-23-25(17(21)2)26-27-29(23)4/h9-13,20,22H,5-8,14-15H2,1-4H3,(H,30,31)	TYEFYUBZAKPDAX-UHFFFAOYSA-N	304792	3-(1,4-Dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((N-methylcyclopentanesulfonamido)methyl)phenyl)propanoic acid::US10144731, Example 90	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304792	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304792&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170150	381753496							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584479	CN(C)C(=O)COC(=O)CC(c1ccc(C)c(CN2CCN(C)c3ccccc3S2(=O)=O)c1)c1ccc2n(C)nnc2c1C	InChI=1S/C32H38N6O5S/c1-21-11-12-23(17-24(21)19-38-16-15-36(5)27-9-7-8-10-29(27)44(38,41)42)26(18-31(40)43-20-30(39)35(3)4)25-13-14-28-32(22(25)2)33-34-37(28)6/h7-14,17,26H,15-16,18-20H2,1-6H3	MDSPUIITKWGXGF-UHFFFAOYSA-N	304793	2-(Dimethylamino)-2-oxoethyl 3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoate::US10144731, Example 91	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304793	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304793&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170105	381753497							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584480	CN1CCN(Cc2cc(ccc2C)C(CC(=O)OCc2oc(=O)oc2C)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc12	InChI=1S/C33H35N5O7S/c1-20-10-11-23(16-24(20)18-38-15-14-36(4)27-8-6-7-9-30(27)46(38,41)42)26(17-31(39)43-19-29-22(3)44-33(40)45-29)25-12-13-28-32(21(25)2)34-35-37(28)5/h6-13,16,26H,14-15,17-19H2,1-5H3	RZULNVGERYOKPS-UHFFFAOYSA-N	304794	(5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoate::US10144731, Example 92	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304794	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304794&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118169810	381753498							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584481	CN1CCN(Cc2cc(ccc2C)C(CC(=O)OCCO)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc12	InChI=1S/C30H35N5O5S/c1-20-9-10-22(17-23(20)19-35-14-13-33(3)26-7-5-6-8-28(26)41(35,38)39)25(18-29(37)40-16-15-36)24-11-12-27-30(21(24)2)31-32-34(27)4/h5-12,17,25,36H,13-16,18-19H2,1-4H3	XZTMQDGKWVWWGY-UHFFFAOYSA-N	304795	2-Hydroxyethyl 3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoate::US10144731, Example 93	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304795	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304795&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170672	381753499							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584482	CN(C)CCOC(=O)CC(c1ccc(C)c(CN2CCN(C)c3ccccc3S2(=O)=O)c1)c1ccc2n(C)nnc2c1C	InChI=1S/C32H40N6O4S/c1-22-11-12-24(19-25(22)21-38-16-15-36(5)28-9-7-8-10-30(28)43(38,40)41)27(20-31(39)42-18-17-35(3)4)26-13-14-29-32(23(26)2)33-34-37(29)6/h7-14,19,27H,15-18,20-21H2,1-6H3	KXTXQGKARMHJOC-UHFFFAOYSA-N	304796	2-(Dimethylamino)ethyl 3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoate::US10144731, Example 95	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304796	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304796&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170179	381753500							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584483	CN1CCN(Cc2cc(ccc2C)C(CC(=O)OCCN2CCOCC2)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc12	InChI=1S/C34H42N6O5S/c1-24-9-10-26(21-27(24)23-40-14-13-37(3)30-7-5-6-8-32(30)46(40,42)43)29(22-33(41)45-20-17-39-15-18-44-19-16-39)28-11-12-31-34(25(28)2)35-36-38(31)4/h5-12,21,29H,13-20,22-23H2,1-4H3	VKGHEMQKRSKYMO-UHFFFAOYSA-N	304797	2-Morpholinoethyl 3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoate::US10144731, Example 96	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304797	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304797&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170035	381753501							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584484	CN(C)CCCOC(=O)CC(c1ccc(C)c(CN2CCN(C)c3ccccc3S2(=O)=O)c1)c1ccc2n(C)nnc2c1C	InChI=1S/C33H42N6O4S/c1-23-12-13-25(20-26(23)22-39-18-17-37(5)29-10-7-8-11-31(29)44(39,41)42)28(21-32(40)43-19-9-16-36(3)4)27-14-15-30-33(24(27)2)34-35-38(30)6/h7-8,10-15,20,28H,9,16-19,21-22H2,1-6H3	WJQRKZLHDLFVLR-UHFFFAOYSA-N	304798	3-(Dimethylamino)propyl 3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoate::US10144731, Example 97	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304798	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304798&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118169861	381753502							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584485	CN1CCN(Cc2cc(ccc2C)C(CC(=O)OC2CCOC2=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc12	InChI=1S/C32H35N5O6S/c1-20-9-10-22(17-23(20)19-37-15-14-35(3)26-7-5-6-8-29(26)44(37,40)41)25(18-30(38)43-28-13-16-42-32(28)39)24-11-12-27-31(21(24)2)33-34-36(27)4/h5-12,17,25,28H,13-16,18-19H2,1-4H3	ACCKTIQSNBFAGE-UHFFFAOYSA-N	304799	2-Oxotetrahydrofuran-3-yl 3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoate::US10144731, Example 98	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304799	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304799&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170791	381753503							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584486	CN1CCN(Cc2cc(ccc2C)C(CC(=O)OCOC(=O)C(C)(C)C)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc12	InChI=1S/C34H41N5O6S/c1-22-12-13-24(18-25(22)20-39-17-16-37(6)28-10-8-9-11-30(28)46(39,42)43)27(19-31(40)44-21-45-33(41)34(3,4)5)26-14-15-29-32(23(26)2)35-36-38(29)7/h8-15,18,27H,16-17,19-21H2,1-7H3	QAHKYUWDTOFNKE-UHFFFAOYSA-N	304800	((3-(1,4-Dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoyl)oxy)methyl pivalate::US10144731, Example 99	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304800	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304800&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170658	381753504							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584487	CN1CCN(Cc2cc(ccc2C)C(CC(=O)OCCCN)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc12	InChI=1S/C31H38N6O4S/c1-21-10-11-23(18-24(21)20-37-16-15-35(3)27-8-5-6-9-29(27)42(37,39)40)26(19-30(38)41-17-7-14-32)25-12-13-28-31(22(25)2)33-34-36(28)4/h5-6,8-13,18,26H,7,14-17,19-20,32H2,1-4H3	GILCRRBNMVEERS-UHFFFAOYSA-N	304801	3-Aminopropyl 3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoate::US10144731, Example 100	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304801	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304801&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170625	381753505							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584488	CC(C)C(N)COC(=O)CC(c1ccc(C)c(CN2CCN(C)c3ccccc3S2(=O)=O)c1)c1ccc2n(C)nnc2c1C	InChI=1S/C33H42N6O4S/c1-21(2)28(34)20-43-32(40)18-27(26-13-14-30-33(23(26)4)35-36-38(30)6)24-12-11-22(3)25(17-24)19-39-16-15-37(5)29-9-7-8-10-31(29)44(39,41)42/h7-14,17,21,27-28H,15-16,18-20,34H2,1-6H3	PRDDRPQTESJCMJ-UHFFFAOYSA-N	304802	2-Amino-3-methylbutyl 3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoate::US10144731, Example 101	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304802	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304802&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170510	381753506							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584489	CN1CCN(Cc2cc(ccc2C)C(CC(=O)OCCn2ccnc2)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc12	InChI=1S/C33H37N7O4S/c1-23-9-10-25(19-26(23)21-40-16-15-37(3)29-7-5-6-8-31(29)45(40,42)43)28(20-32(41)44-18-17-39-14-13-34-22-39)27-11-12-30-33(24(27)2)35-36-38(30)4/h5-14,19,22,28H,15-18,20-21H2,1-4H3	FPLJRFMRUAYRHK-UHFFFAOYSA-N	304803	2-(1H-Imidazol-1-yl)ethyl 3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-34(5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoate::US10144731, Example 102	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304803	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304803&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118188787	381753507							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584490	CCN(CC)CCCOC(=O)CC(c1ccc(C)c(CN2CCN(C)c3ccccc3S2(=O)=O)c1)c1ccc2n(C)nnc2c1C	InChI=1S/C35H46N6O4S/c1-7-40(8-2)18-11-21-45-34(42)23-30(29-16-17-32-35(26(29)4)36-37-39(32)6)27-15-14-25(3)28(22-27)24-41-20-19-38(5)31-12-9-10-13-33(31)46(41,43)44/h9-10,12-17,22,30H,7-8,11,18-21,23-24H2,1-6H3	NSXJQKAKTZTGPQ-UHFFFAOYSA-N	304804	3-(Diethylamino)propyl 3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoate::US10144731, Example 103	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304804	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304804&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170172	381753508							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584491	CN(C)CCCCOC(=O)CC(c1ccc(C)c(CN2CCN(C)c3ccccc3S2(=O)=O)c1)c1ccc2n(C)nnc2c1C	InChI=1S/C34H44N6O4S/c1-24-13-14-26(21-27(24)23-40-19-18-38(5)30-11-7-8-12-32(30)45(40,42)43)29(22-33(41)44-20-10-9-17-37(3)4)28-15-16-31-34(25(28)2)35-36-39(31)6/h7-8,11-16,21,29H,9-10,17-20,22-23H2,1-6H3	UHZFHXHECXKUIN-UHFFFAOYSA-N	304805	4-(Di methylami no)butyl 3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoate::US10144731, Example 104	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304805	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304805&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118169783	381753509							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584492	CN(C)CC(C)(C)COC(=O)CC(c1ccc(C)c(CN2CCN(C)c3ccccc3S2(=O)=O)c1)c1ccc2n(C)nnc2c1C	InChI=1S/C35H46N6O4S/c1-24-13-14-26(19-27(24)21-41-18-17-39(7)30-11-9-10-12-32(30)46(41,43)44)29(20-33(42)45-23-35(3,4)22-38(5)6)28-15-16-31-34(25(28)2)36-37-40(31)8/h9-16,19,29H,17-18,20-23H2,1-8H3	VNXBBGNOTHOKLU-UHFFFAOYSA-N	304806	3-(Dimethylamino)-2,2-dimethylpropyl 3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoate::US10144731, Example 105	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304806	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304806&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118188857	381753510							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584493	CN1CCN(Cc2cc(ccc2C)C(CC(=O)OCCCN2CCCC2)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc12	InChI=1S/C35H44N6O4S/c1-25-12-13-27(22-28(25)24-41-20-19-38(3)31-10-5-6-11-33(31)46(41,43)44)30(23-34(42)45-21-9-18-40-16-7-8-17-40)29-14-15-32-35(26(29)2)36-37-39(32)4/h5-6,10-15,22,30H,7-9,16-21,23-24H2,1-4H3	RYATWPZKKNYZPW-UHFFFAOYSA-N	304807	3-(Pyrrolidin-1-yl)propyl 3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoate::US10144731, Example 106	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304807	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304807&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170197	381753511							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584494	CC(CN(C)C)OC(=O)CC(c1ccc(C)c(CN2CCN(C)c3ccccc3S2(=O)=O)c1)c1ccc2n(C)nnc2c1C	InChI=1S/C33H42N6O4S/c1-22-12-13-25(18-26(22)21-39-17-16-37(6)29-10-8-9-11-31(29)44(39,41)42)28(19-32(40)43-23(2)20-36(4)5)27-14-15-30-33(24(27)3)34-35-38(30)7/h8-15,18,23,28H,16-17,19-21H2,1-7H3	XGHQHSHDBJZAOQ-UHFFFAOYSA-N	304808	1-(Dimethylamino)propan-2-yl 3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoate::US10144731, Example 107	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304808	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304808&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170645	381753512							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584495	CN1CCN(Cc2cc(ccc2C)C(CC(=O)OCCCN2CCOCC2)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc12	InChI=1S/C35H44N6O5S/c1-25-10-11-27(22-28(25)24-41-16-15-38(3)31-8-5-6-9-33(31)47(41,43)44)30(29-12-13-32-35(26(29)2)36-37-39(32)4)23-34(42)46-19-7-14-40-17-20-45-21-18-40/h5-6,8-13,22,30H,7,14-21,23-24H2,1-4H3	QHHJBFGEOQGEIC-UHFFFAOYSA-N	304809	3-morpholinopropyl 3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoate::US10144731, Example 108	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304809	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304809&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170771	381753513							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584496	COC(=O)CC(c1ccc(C)c(CN2CCN(C)c3ccccc3S2(=O)=O)c1)c1ccc2n(C)nnc2c1C	InChI=1S/C29H33N5O4S/c1-19-10-11-21(24(17-28(35)38-5)23-12-13-26-29(20(23)2)30-31-33(26)4)16-22(19)18-34-15-14-32(3)25-8-6-7-9-27(25)39(34,36)37/h6-13,16,24H,14-15,17-18H2,1-5H3	UQZOVMSFIABCOG-UHFFFAOYSA-N	304810	Methyl 3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoate::US10144731, Example 109	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304810	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304810&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118188758	381753514							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584497	CN1CCCC(C1)OC(=O)CC(c1ccc(C)c(CN2CCN(C)c3ccccc3S2(=O)=O)c1)c1ccc2n(C)nnc2c1C	InChI=1S/C34H42N6O4S/c1-23-12-13-25(19-26(23)21-40-18-17-38(4)30-10-6-7-11-32(30)45(40,42)43)29(20-33(41)44-27-9-8-16-37(3)22-27)28-14-15-31-34(24(28)2)35-36-39(31)5/h6-7,10-15,19,27,29H,8-9,16-18,20-22H2,1-5H3	XHLFTXPROSAUAI-UHFFFAOYSA-N	304811	1-Methylpiperidin-3-yl 3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoate::US10144731, Example 111	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304811	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304811&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170677	381753515							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584498	CN1CCC[C@H]1COC(=O)CC(c1ccc(C)c(CN2CCN(C)c3ccccc3S2(=O)=O)c1)c1ccc2n(C)nnc2c1C |r|	InChI=1S/C34H42N6O4S/c1-23-12-13-25(19-26(23)21-40-18-17-38(4)30-10-6-7-11-32(30)45(40,42)43)29(20-33(41)44-22-27-9-8-16-37(27)3)28-14-15-31-34(24(28)2)35-36-39(31)5/h6-7,10-15,19,27,29H,8-9,16-18,20-22H2,1-5H3	PFCGOQHTVTVEGR-UHFFFAOYSA-N	304812	((S)-1-Methylpyrrolidin-2-yl)methyl 3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoate::US10144731, Example 112	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304812	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304812&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118188759	381753516							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584499	CN1CCN(Cc2cc(ccc2C)C(CC(=O)OCC2CCNC2)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc12	InChI=1S/C33H40N6O4S/c1-22-9-10-25(17-26(22)20-39-16-15-37(3)29-7-5-6-8-31(29)44(39,41)42)28(18-32(40)43-21-24-13-14-34-19-24)27-11-12-30-33(23(27)2)35-36-38(30)4/h5-12,17,24,28,34H,13-16,18-21H2,1-4H3	BGZLVEMQAMFUGJ-UHFFFAOYSA-N	304813	Pyrrolidin-3-ylmethyl 3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoate::US10144731, Example 113	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304813	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304813&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170493	381753517							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584500	CN1CCC(CC1)OC(=O)CC(c1ccc(C)c(CN2CCN(C)c3ccccc3S2(=O)=O)c1)c1ccc2n(C)nnc2c1C	InChI=1S/C34H42N6O4S/c1-23-10-11-25(20-26(23)22-40-19-18-38(4)30-8-6-7-9-32(30)45(40,42)43)29(21-33(41)44-27-14-16-37(3)17-15-27)28-12-13-31-34(24(28)2)35-36-39(31)5/h6-13,20,27,29H,14-19,21-22H2,1-5H3	SQYPJRMWUTXJDV-UHFFFAOYSA-N	304814	1-Methylpiperidin-4-yl 3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoate::US10144731, Example 114	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304814	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304814&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170629	381753518							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584501	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C27H28N4O5S/c1-17-8-9-19(22(14-27(32)33)20-10-11-24-23(13-20)28-29-30(24)3)12-21(17)16-31-15-18(2)36-25-6-4-5-7-26(25)37(31,34)35/h4-13,18,22H,14-16H2,1-3H3,(H,32,33)	YVVSLYWCORNKAO-UHFFFAOYSA-N	304743	US10144731, Example 29::3-(1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::BDBM304815	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304743	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304743&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170055	381753447							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584502	COc1cc(cc2nnn(C)c12)C(CC(O)=O)c1ccc(C)c(CN(C(C)C)S(=O)(=O)c2ccccc2)c1	InChI=1S/C28H32N4O5S/c1-18(2)32(38(35,36)23-9-7-6-8-10-23)17-22-13-20(12-11-19(22)3)24(16-27(33)34)21-14-25-28(26(15-21)37-5)31(4)30-29-25/h6-15,18,24H,16-17H2,1-5H3,(H,33,34)	GXKFLWFIKGXVFH-UHFFFAOYSA-N	304816	Ethyl 3-(3-((N-isopropylphenylsulfonamido)methyl)-4-methylphenyl)-3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoate::US10144731, Example 116	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304816	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304816&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118169943	381753520							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584503	C[C@@H]1CN(Cc2cc(ccc2C(F)(F)F)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C28H27F3N4O5S/c1-16-14-35(41(38,39)25-7-5-4-6-24(25)40-16)15-19-12-18(8-10-22(19)28(29,30)31)21(13-26(36)37)20-9-11-23-27(17(20)2)32-33-34(23)3/h4-12,16,21H,13-15H2,1-3H3,(H,36,37)	KJTROJDEHGPKAA-UHFFFAOYSA-N	304817	3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-(trifluoromethyl)phenyl)propanoic acid::US10144731, Example 117	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304817	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304817&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170742	381753521							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584504	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2Cl)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C27H27ClN4O5S/c1-16-8-9-18(21(13-25(33)34)20-10-11-22-27(26(20)28)29-30-31(22)3)12-19(16)15-32-14-17(2)37-23-6-4-5-7-24(23)38(32,35)36/h4-12,17,21H,13-15H2,1-3H3,(H,33,34)	KWYMBFUQBRMBQX-UHFFFAOYSA-N	304818	3-(4-Chloro-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 118	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304818	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304818&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170151	381753522							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584505	CC(C(c1ccc(C)c(CN(C)S(=O)(=O)c2ccccc2)c1)c1ccc2n(C)nnc2c1)C(O)=O	InChI=1S/C26H28N4O4S/c1-17-10-11-19(14-21(17)16-29(3)35(33,34)22-8-6-5-7-9-22)25(18(2)26(31)32)20-12-13-24-23(15-20)27-28-30(24)4/h5-15,18,25H,16H2,1-4H3,(H,31,32)	KZOPELYEZBBUIV-UHFFFAOYSA-N	304819	2-Methyl-3-(1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((N-methylphenylsulfonamido)methyl)phenyl)propanoic acid::US10144731, Example 119	Nuclear factor erythroid 2-related factor 2	Human				 55					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304819	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304819&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170409	381753523							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584506	CC(C(c1ccc(C)c(CN2CCN(C)c3ccccc3S2(=O)=O)c1)c1ccc2n(C)nnc2c1C)C(O)=O |w:3.2|	InChI=1S/C29H33N5O4S/c1-18-10-11-21(27(20(3)29(35)36)23-12-13-25-28(19(23)2)30-31-33(25)5)16-22(18)17-34-15-14-32(4)24-8-6-7-9-26(24)39(34,37)38/h6-13,16,20,27H,14-15,17H2,1-5H3,(H,35,36)	GFARMNLPSPHGIR-UHFFFAOYSA-N	304820	2-methyl-3-(1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((N-methylphenylsulfonamido)methyl)phenyl)propanoic acid::US10144731, Example 120	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304820	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304820&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170111	381753524							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584507	CC([C@@H](c1ccc(C)c(CN2CCN(C)c3ccccc3S2(=O)=O)c1)c1ccc2n(C)nnc2c1C)C(O)=O |r|	InChI=1S/C29H33N5O4S/c1-18-10-11-21(27(20(3)29(35)36)23-12-13-25-28(19(23)2)30-31-33(25)5)16-22(18)17-34-15-14-32(4)24-8-6-7-9-26(24)39(34,37)38/h6-13,16,20,27H,14-15,17H2,1-5H3,(H,35,36)	GFARMNLPSPHGIR-UHFFFAOYSA-N	304821	US10144731, Example 121	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304821	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304821&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			137554658	381753525							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584508	CC([C@H](c1ccc(C)c(CN2CCN(C)c3ccccc3S2(=O)=O)c1)c1ccc2n(C)nnc2c1C)C(O)=O |r|	InChI=1S/C29H33N5O4S/c1-18-10-11-21(27(20(3)29(35)36)23-12-13-25-28(19(23)2)30-31-33(25)5)16-22(18)17-34-15-14-32(4)24-8-6-7-9-26(24)39(34,37)38/h6-13,16,20,27H,14-15,17H2,1-5H3,(H,35,36)	GFARMNLPSPHGIR-UHFFFAOYSA-N	304822	US10144731, Example 122	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304822	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304822&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			137554659	381753526							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584509	C[C@@H]1CN(Cc2cc(ccc2C)C(CCc2c[nH]nn2)CC(O)=O)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C24H28N4O5S/c1-16-7-8-18(19(12-24(29)30)9-10-21-13-25-27-26-21)11-20(16)15-28-14-17(2)33-22-5-3-4-6-23(22)34(28,31)32/h3-8,11,13,17,19H,9-10,12,14-15H2,1-2H3,(H,29,30)(H,25,26,27)	CHDWDCOIXZPZNY-UHFFFAOYSA-N	304823	3-(4-Methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)-5-(1H-1,2,3-triazol-4-yl)pentanoic acid::US10144731, Example 123	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304823	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304823&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			137554660	381753527							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584510	C[C@@H]1CN(Cc2cc(ccc2C)C(CCc2cn(Cc3ccccc3)nn2)CC(O)=O)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C31H34N4O5S/c1-22-12-13-25(16-27(22)20-35-18-23(2)40-29-10-6-7-11-30(29)41(35,38)39)26(17-31(36)37)14-15-28-21-34(33-32-28)19-24-8-4-3-5-9-24/h3-13,16,21,23,26H,14-15,17-20H2,1-2H3,(H,36,37)	BOEKOLYWXVRUED-UHFFFAOYSA-N	304824	5-(1-Benzyl-1H-1,2,3-triazol-4-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)pentanoic acid::US10144731, Example 124	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304824	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304824&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118188761	381753528							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584511	C[C@@H]1CN(Cc2cc(ccc2C)C(CCc2cnn(C)n2)CC(O)=O)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C25H30N4O5S/c1-17-8-9-19(20(13-25(30)31)10-11-22-14-26-28(3)27-22)12-21(17)16-29-15-18(2)34-23-6-4-5-7-24(23)35(29,32)33/h4-9,12,14,18,20H,10-11,13,15-16H2,1-3H3,(H,30,31)	UEORTKJCUOEYPP-UHFFFAOYSA-N	304825	5-(2-Methyl-2H-1,2,3-triazol-4-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)pentanoic acid::US10144731, Example 125	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304825	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304825&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170725	381753529							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584512	C[C@@H]1CN(Cc2cc(ccc2C)C(CCc2cn(C)nn2)CC(O)=O)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C25H30N4O5S/c1-17-8-9-19(20(13-25(30)31)10-11-22-16-28(3)27-26-22)12-21(17)15-29-14-18(2)34-23-6-4-5-7-24(23)35(29,32)33/h4-9,12,16,18,20H,10-11,13-15H2,1-3H3,(H,30,31)	XKXXEUFAYDHYPN-UHFFFAOYSA-N	304826	5-(1-Methyl-1H-1,2,3-triazol-4-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)pentanoic acid::US10144731, Example 126	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304826	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304826&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170463	381753530							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584513	CCn1cc(CCC(CC(O)=O)c2ccc(C)c(CN3C[C@@H](C)Oc4ccccc4S3(=O)=O)c2)nn1 |r|	InChI=1S/C26H32N4O5S/c1-4-29-17-23(27-28-29)12-11-21(14-26(31)32)20-10-9-18(2)22(13-20)16-30-15-19(3)35-24-7-5-6-8-25(24)36(30,33)34/h5-10,13,17,19,21H,4,11-12,14-16H2,1-3H3,(H,31,32)	VPBZLUCAQZZNOB-UHFFFAOYSA-N	304827	5-(1-Ethyl-1H-1,2,3-triazol-4-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)pentanoic acid::US10144731, Example 127	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304827	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304827&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118188869	381753531							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584514	COc1cc(cc2nnn(C)c12)C(CC(O)=O)c1ccc(C)c(CN2C[C@@H](C)Oc3ccncc3S2(=O)=O)c1 |r|	InChI=1S/C27H29N5O6S/c1-16-5-6-18(21(12-26(33)34)19-10-22-27(24(11-19)37-4)31(3)30-29-22)9-20(16)15-32-14-17(2)38-23-7-8-28-13-25(23)39(32,35)36/h5-11,13,17,21H,12,14-15H2,1-4H3,(H,33,34)	HPTOTBDEYJWXMS-UHFFFAOYSA-N	304828	3-(7-Methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-pyrido[4,3-b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 128	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304828	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304828&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170652	381753532							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584515	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2cnccc2O1 |r|	InChI=1S/C27H29N5O5S/c1-16-5-6-19(22(12-26(33)34)21-7-8-23-27(18(21)3)29-30-31(23)4)11-20(16)15-32-14-17(2)37-24-9-10-28-13-25(24)38(32,35)36/h5-11,13,17,22H,12,14-15H2,1-4H3,(H,33,34)	BYWWNBFIESJIJW-UHFFFAOYSA-N	304829	3-(1,4-Dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-pyrido[4,3-b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 129	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304829	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304829&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170968	381753533							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584516	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2C(F)(F)F)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C28H27F3N4O5S/c1-16-8-9-18(12-19(16)15-35-14-17(2)40-23-6-4-5-7-24(23)41(35,38)39)21(13-25(36)37)20-10-11-22-27(32-33-34(22)3)26(20)28(29,30)31/h4-12,17,21H,13-15H2,1-3H3,(H,36,37)	UNBMJIHNTHTIKI-UHFFFAOYSA-N	304830	3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)-3-(1-methyl-4-(trifluoromethyl)-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 130	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304830	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304830&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170597	381753534							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584517	COc1cc(cc2nnn(C)c12)C(CC(O)=O)c1ccc(c(CN2C[C@@H](C)Oc3ccccc3S2(=O)=O)c1)C(F)(F)F |r|	InChI=1S/C28H27F3N4O6S/c1-16-14-35(42(38,39)25-7-5-4-6-23(25)41-16)15-19-10-17(8-9-21(19)28(29,30)31)20(13-26(36)37)18-11-22-27(24(12-18)40-3)34(2)33-32-22/h4-12,16,20H,13-15H2,1-3H3,(H,36,37)	MVHXCKOOPXKCMR-UHFFFAOYSA-N	304831	3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-(trifluoromethyl)phenyl)propanoic acid::US10144731, Example 131	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304831	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304831&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170706	381753535							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584518	COc1cc(C(CC(O)=O)c2ccc(C)c(CN3C[C@@H](C)Oc4ccccc4S3(=O)=O)c2)c(C)c2nnn(C)c12 |r|	InChI=1S/C29H32N4O6S/c1-17-10-11-20(12-21(17)16-33-15-18(2)39-24-8-6-7-9-26(24)40(33,36)37)23(14-27(34)35)22-13-25(38-5)29-28(19(22)3)30-31-32(29)4/h6-13,18,23H,14-16H2,1-5H3,(H,34,35)	QVAILDBNBWBUPT-UHFFFAOYSA-N	304832	3-(7-Methoxy-1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 132	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304832	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304832&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			122653343	381753536							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584519	CCn1ccc(cc1=O)C(CC(O)=O)c1ccc(C)c(CN2C[C@@H](C)Oc3ccccc3S2(=O)=O)c1 |r|	InChI=1S/C27H30N2O6S/c1-4-28-12-11-21(14-26(28)30)23(15-27(31)32)20-10-9-18(2)22(13-20)17-29-16-19(3)35-24-7-5-6-8-25(24)36(29,33)34/h5-14,19,23H,4,15-17H2,1-3H3,(H,31,32)	SZRUZELXIPIZEX-UHFFFAOYSA-N	304833	3-(1-Ethyl-2-oxo-1,2-dihydropyridin-4-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 133	Nuclear factor erythroid 2-related factor 2	Human				 55					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304833	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304833&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170093	381753537							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584520	CCCn1ccc(cc1=O)C(CC(O)=O)c1ccc(C)c(CN2C[C@@H](C)Oc3ccccc3S2(=O)=O)c1 |r|	InChI=1S/C28H32N2O6S/c1-4-12-29-13-11-22(15-27(29)31)24(16-28(32)33)21-10-9-19(2)23(14-21)18-30-17-20(3)36-25-7-5-6-8-26(25)37(30,34)35/h5-11,13-15,20,24H,4,12,16-18H2,1-3H3,(H,32,33)	IPCDQJRZKHHXLK-UHFFFAOYSA-N	304834	3-(4-Methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)-3-(2-oxo-1-propyl-1,2-dihydropyridin-4-yl)propanoic acid::US10144731, Example 134	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304834	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304834&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			122653283	381753538							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584521	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2cccc(=O)n2C)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C26H28N2O6S/c1-17-11-12-19(21(14-26(30)31)22-7-6-10-25(29)27(22)3)13-20(17)16-28-15-18(2)34-23-8-4-5-9-24(23)35(28,32)33/h4-13,18,21H,14-16H2,1-3H3,(H,30,31)	SMTWIJIRLUEPLY-UHFFFAOYSA-N	304835	3-(4-Methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)-3-(1-methyl-6-oxo-1,6-dihydropyridin-2-yl)propanoic acid::US10144731, Example 135	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304835	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304835&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170210	381753539							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584522	CN1CCN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2)S(=O)(=O)c2ccccc12	InChI=1S/C27H29N5O4S/c1-18-8-9-19(22(16-27(33)34)20-10-11-24-23(15-20)28-29-31(24)3)14-21(18)17-32-13-12-30(2)25-6-4-5-7-26(25)37(32,35)36/h4-11,14-15,22H,12-13,16-17H2,1-3H3,(H,33,34)	DCHYRWZYVQDJIJ-UHFFFAOYSA-N	304836	3-(1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoic acid::US10144731, Example 144	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304836	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304836&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170480	381753540							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584523	COc1cc(cc2nnn(C)c12)C(CC(O)=O)c1ccc(C)c(CN(C)S(=O)(=O)c2ccccc2)c1	InChI=1S/C26H28N4O5S/c1-17-10-11-18(12-20(17)16-29(2)36(33,34)21-8-6-5-7-9-21)22(15-25(31)32)19-13-23-26(24(14-19)35-4)30(3)28-27-23/h5-14,22H,15-16H2,1-4H3,(H,31,32)	VVWDXVKKAYFKNL-UHFFFAOYSA-N	304837	3-(7-methoxy-1-methyl-1H-1,2,3-benzotriazol-5-yl)-3-{4-methyl-3-[(N-methylbenzenesulfonamido)methyl]phenyl}propanoic acid::US10144731, Example 145	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304837	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304837&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170044	381753541							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584524	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(CC)nnc3c2C)S(=O)(=O)c2cccnc2O1 |r|	InChI=1S/C29H33N5O5S/c1-5-22-17-33(40(37,38)26-8-7-13-30-29(26)39-22)16-21-14-20(10-9-18(21)3)24(15-27(35)36)23-11-12-25-28(19(23)4)31-32-34(25)6-2/h7-14,22,24H,5-6,15-17H2,1-4H3,(H,35,36)	FSVDYFNASNQHCE-UHFFFAOYSA-N	304755	US10144731, Example 40::BDBM304886::3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-3-(1-ethyl-4-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::BDBM304885::BDBM304838	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304755	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304755&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118169924	381753459							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584525	CCn1nnc2c(C)c(ccc12)C(CC(O)=O)c1ccc(c(CN2C[C@@H](C)Oc3ccccc3S2(=O)=O)c1)C(F)(F)F |r|	InChI=1S/C29H29F3N4O5S/c1-4-36-24-12-10-21(18(3)28(24)33-34-36)22(14-27(37)38)19-9-11-23(29(30,31)32)20(13-19)16-35-15-17(2)41-25-7-5-6-8-26(25)42(35,39)40/h5-13,17,22H,4,14-16H2,1-3H3,(H,37,38)	UYHZTQMYFLSOSC-UHFFFAOYSA-N	304839	3-(1-Ethyl-4-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-(trifluoromethyl)phenyl)propanoic acid::US10144731, Example 147	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304839	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304839&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170392	381753543							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584526	C[C@@H]1CN(Cc2cc(ccc2C)C(Cc2nnn[nH]2)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C28H30N8O3S/c1-17-9-10-20(13-21(17)16-36-15-18(2)39-25-7-5-6-8-26(25)40(36,37)38)23(14-27-29-32-33-30-27)22-11-12-24-28(19(22)3)31-34-35(24)4/h5-13,18,23H,14-16H2,1-4H3,(H,29,30,32,33)	BQUWAECBQDXVJF-UHFFFAOYSA-N	304840	(4R)-2-(5-(1-(1,4-Dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-2-(1H-tetrazol-5-yl)ethyl)-2-methylbenzyl)-4-methyl-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepine 1,1-dioxide::US10144731, Example 148	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304840	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304840&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170685	381753544							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584527	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ncccc2O1 |r|	InChI=1S/C27H29N5O5S/c1-16-7-8-19(22(13-25(33)34)21-9-10-23-26(18(21)3)29-30-31(23)4)12-20(16)15-32-14-17(2)37-24-6-5-11-28-27(24)38(32,35)36/h5-12,17,22H,13-15H2,1-4H3,(H,33,34)	WASOKHKOUNQOSK-UHFFFAOYSA-N	304841	3-(1,4-Dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-pyrido[3,2-b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 149	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304841	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304841&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170661	381753545							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584528	CCn1cc(CCC(CC(O)=O)c2ccc(C)c(CN3C[C@@H](C)Oc4cccnc4S3(=O)=O)c2)nn1 |r|	InChI=1S/C25H31N5O5S/c1-4-29-16-22(27-28-29)10-9-20(13-24(31)32)19-8-7-17(2)21(12-19)15-30-14-18(3)35-23-6-5-11-26-25(23)36(30,33)34/h5-8,11-12,16,18,20H,4,9-10,13-15H2,1-3H3,(H,31,32)	PPMXGPZSQLHUHK-UHFFFAOYSA-N	304842	5-(1-Ethyl-1H-1,2,3-triazol-4-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-pyrido[3,2-b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)pentanoic acid::US10144731, Example 150	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304842	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304842&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170323	381753546							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584529	CCn1cc(CCC(CC(O)=O)c2ccc(C)c(CN3CC(C)Oc4ncccc4S3(=O)=O)c2)nn1 |w:21.21|	InChI=1S/C25H31N5O5S/c1-4-29-16-22(27-28-29)10-9-20(13-24(31)32)19-8-7-17(2)21(12-19)15-30-14-18(3)35-25-23(36(30,33)34)6-5-11-26-25/h5-8,11-12,16,18,20H,4,9-10,13-15H2,1-3H3,(H,31,32)	HRXPLCSOQNEFRZ-UHFFFAOYSA-N	304843	5-(1-Ethyl-1H-1,2,3-triazol-4-yl)-3-(4-methyl-3-((4-methyl-1,1-dioxido-4,5-dihydropyrido[2,34][1,2]thiazepin-2(3H)-yl)methyl)phenyl)pentanoic acid::US10144731, Example 151	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304843	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304843&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			122660638	381753547							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584530	CCn1cc(CCC(CC(O)=O)c2ccc(C)c(CN3CC(C)Cc4ccncc4S3(=O)=O)c2)nn1 |w:21.21|	InChI=1S/C26H33N5O4S/c1-4-30-17-24(28-29-30)8-7-21(13-26(32)33)20-6-5-19(3)23(12-20)16-31-15-18(2)11-22-9-10-27-14-25(22)36(31,34)35/h5-6,9-10,12,14,17-18,21H,4,7-8,11,13,15-16H2,1-3H3,(H,32,33)	NVMUELBMBSCZMG-UHFFFAOYSA-N	304844	5-(1-Ethyl-1H-1,2,3-triazol-4-yl)-3-(4-methyl-3-((4-methyl-1,1-dioxido-4,5-dihydropyrido[4,3-f][1,2]thiazepin-2(3H)-yl)methyl)phenyl)pentanoic acid::US10144731, Example 152	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304844	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304844&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170312	381753548							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584531	CCn1cc(CCC(CC(O)=O)c2ccc(C)c(CN3C[C@@H](C)Oc4cnccc4S3(=O)=O)c2)nn1 |r|	InChI=1S/C25H31N5O5S/c1-4-29-16-22(27-28-29)8-7-20(12-25(31)32)19-6-5-17(2)21(11-19)15-30-14-18(3)35-23-13-26-10-9-24(23)36(30,33)34/h5-6,9-11,13,16,18,20H,4,7-8,12,14-15H2,1-3H3,(H,31,32)	GANBXEQLAOHECS-UHFFFAOYSA-N	304845	5-(1-Ethyl-1H-1,2,3-triazol-4-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-pyrido[3,4-b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)pentanoic acid::US10144731, Example 153	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304845	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304845&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170599	381753549							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584532	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccncc2O1 |r|	InChI=1S/C27H29N5O5S/c1-16-5-6-19(22(12-26(33)34)21-7-8-23-27(18(21)3)29-30-31(23)4)11-20(16)15-32-14-17(2)37-24-13-28-10-9-25(24)38(32,35)36/h5-11,13,17,22H,12,14-15H2,1-4H3,(H,33,34)	XGXKKQDKTWYURX-UHFFFAOYSA-N	304846	3-(1,4-Dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-pyrido[3,4-b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 154	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304846	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304846&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170563	381753550							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584533	COc1cc(cc2nnn(C)c12)C(CC(O)=O)c1ccc(C)c(CN2CC(C)c3ccccc3S2(=O)=O)c1	InChI=1S/C28H30N4O5S/c1-17-9-10-19(11-21(17)16-32-15-18(2)22-7-5-6-8-26(22)38(32,35)36)23(14-27(33)34)20-12-24-28(25(13-20)37-4)31(3)30-29-24/h5-13,18,23H,14-16H2,1-4H3,(H,33,34)	CEYWUMVWUJLPTE-UHFFFAOYSA-N	304847	3-(7-Methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[e][1,2]thiazin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 155	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304847	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304847&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170315	381753551							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584534	CCC1CN(Cc2cc(ccc2C)C(CC(O)=O)c2cc(OC)c3n(C)nnc3c2)S(=O)(=O)c2ccccc12	InChI=1S/C29H32N4O5S/c1-5-19-16-33(39(36,37)27-9-7-6-8-23(19)27)17-22-12-20(11-10-18(22)2)24(15-28(34)35)21-13-25-29(26(14-21)38-4)32(3)31-30-25/h6-14,19,24H,5,15-17H2,1-4H3,(H,34,35)	IMVRDTIUXGSVRZ-UHFFFAOYSA-N	304848	3-(3-((4-Ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[e][1,2]thiazin-2-yl)methyl)-4-methylphenyl)-3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 156	Nuclear factor erythroid 2-related factor 2	Human				 55					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304848	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304848&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170823	381753552							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584535	C[C@H]1CN(Cc2cc(ccc2C)C(CCC(=O)N(C)Cc2ccccc2)CC(O)=O)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C31H36N2O6S/c1-22-13-14-25(26(18-31(35)36)15-16-30(34)32(3)20-24-9-5-4-6-10-24)17-27(22)21-33-19-23(2)39-28-11-7-8-12-29(28)40(33,37)38/h4-14,17,23,26H,15-16,18-21H2,1-3H3,(H,35,36)	VLUCKJQHVVDJRS-UHFFFAOYSA-N	304849	6-(Benzyl(methyl)amino)-3-(4-methyl-3-(((S)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)-6-oxohexanoic acid::US10144731, Example 157	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304849	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304849&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170050	381753553							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584536	CC1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc(F)cc2C)S(=O)(=O)c2ccc(CCCN(C)C)cc2C1	InChI=1S/C33H41FN2O4S/c1-22-15-27-17-25(7-6-14-35(4)5)9-13-32(27)41(39,40)36(20-22)21-28-18-26(10-8-23(28)2)31(19-33(37)38)30-12-11-29(34)16-24(30)3/h8-13,16-18,22,31H,6-7,14-15,19-21H2,1-5H3,(H,37,38)	BQKAFUSUOCKJSO-UHFFFAOYSA-N	304850	3-(3-((7-(3-(Dimethylamino)propyl)-4-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2]thiazepin-2(3H)-yl)methyl)-4-methylphenyl)-3-(4-fluoro-2-methylphenyl)propanoic acid::US10144731, Example 158	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304850	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304850&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170011	381753554							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584537	CNC(=O)CCC1CC(=O)O[C@H]2CN(Cc3cc1ccc3C)S(=O)(=O)c1ccccc1O2 |r|	InChI=1S/C23H26N2O6S/c1-15-7-8-16-11-18(15)13-25-14-23(30-19-5-3-4-6-20(19)32(25,28)29)31-22(27)12-17(16)9-10-21(26)24-2/h3-8,11,17,23H,9-10,12-14H2,1-2H3,(H,24,26)	CQOQRYVBFZKAPT-UHFFFAOYSA-N	304851	3-(4-Methyl-3-(((S)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)-6-(methylamino)-6-oxohexanoic acid::US10144731, Example 159	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304851	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304851&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118188811	381753555							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584538	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2c(C)cc(F)cc2CN(C)C)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C31H37FN2O5S/c1-6-26-19-34(40(37,38)29-10-8-7-9-28(29)39-26)18-23-14-22(12-11-20(23)2)27(16-30(35)36)31-21(3)13-25(32)15-24(31)17-33(4)5/h7-15,26-27H,6,16-19H2,1-5H3,(H,35,36)	JIZILTYHXGMOFC-UHFFFAOYSA-N	304852	3-(2-((Dimethylamino)methyl)-4-fluoro-6-methylphenyl)-3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)propanoic acid::US10144731, Example 160	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304852	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304852&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170381	381753556							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584539	COc1cnc(C)c(c1)C(CC(O)=O)c1ccc(C)c(CN2C[C@@H](C)Oc3ccccc3S2(=O)=O)c1 |r|	InChI=1S/C27H30N2O6S/c1-17-9-10-20(24(13-27(30)31)23-12-22(34-4)14-28-19(23)3)11-21(17)16-29-15-18(2)35-25-7-5-6-8-26(25)36(29,32)33/h5-12,14,18,24H,13,15-16H2,1-4H3,(H,30,31)	RRSZSRNHVNNEPA-UHFFFAOYSA-N	304853	3-(5-Methoxy-2-methylpyridin-3-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 161	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304853	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304853&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118169812	381753557							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584540	C[C@@H]1CN(Cc2cc(ccc2C)C(CCc2ccccc2C)CC(O)=O)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C29H33NO5S/c1-20-8-4-5-9-23(20)14-15-25(17-29(31)32)24-13-12-21(2)26(16-24)19-30-18-22(3)35-27-10-6-7-11-28(27)36(30,33)34/h4-13,16,22,25H,14-15,17-19H2,1-3H3,(H,31,32)	BBAQYZLFACJTEU-UHFFFAOYSA-N	304854	BDBM304862::3-(4-Methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)-5-(o-tolyl)pentanoic acid::US10144731, Example 162	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304854	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304854&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170697	381753558							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584541	CCn1cnc(c1)C(CC(O)=O)c1ccc(C)c(CN2C[C@@H](C)Oc3ccccc3S2(=O)=O)c1 |r|	InChI=1S/C25H29N3O5S/c1-4-27-15-22(26-16-27)21(12-25(29)30)19-10-9-17(2)20(11-19)14-28-13-18(3)33-23-7-5-6-8-24(23)34(28,31)32/h5-11,15-16,18,21H,4,12-14H2,1-3H3,(H,29,30)	JSTFODLCAFQDAZ-UHFFFAOYSA-N	304855	3-(1-Ethyl-1H-imidazol-4-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 163	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304855	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304855&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170556	381753559							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584542	CCn1cc(CCC(CC(O)=O)c2ccc(C)c(CN3C[C@@H](C)Oc4ccccc4S3(=O)=O)c2)cn1 |r|	InChI=1S/C27H33N3O5S/c1-4-29-17-21(15-28-29)10-12-23(14-27(31)32)22-11-9-19(2)24(13-22)18-30-16-20(3)35-25-7-5-6-8-26(25)36(30,33)34/h5-9,11,13,15,17,20,23H,4,10,12,14,16,18H2,1-3H3,(H,31,32)	KEWXNRYLPLVBKW-UHFFFAOYSA-N	304856	5-(1-Ethyl-1H-pyrazol-4-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)pentanoic acid::US10144731, Example 164	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304856	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304856&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170206	381753560							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584543	COCCCC(CC(O)=O)c1ccc(C)c(CN2C[C@@H](C)Oc3ccccc3S2(=O)=O)c1 |r|	InChI=1S/C24H31NO6S/c1-17-10-11-20(19(14-24(26)27)7-6-12-30-3)13-21(17)16-25-15-18(2)31-22-8-4-5-9-23(22)32(25,28)29/h4-5,8-11,13,18-19H,6-7,12,14-16H2,1-3H3,(H,26,27)	UGALCWYPMZIMJQ-UHFFFAOYSA-N	304857	6-Methoxy-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)hexanoic acid::US10144731, Example 165	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304857	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304857&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170410	381753561							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584544	CC1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2)S(=O)(=O)c2ccc(CCCNC(=O)OC(C)(C)C)cc2C1	InChI=1S/C36H45N5O6S/c1-23-16-28-17-25(8-7-15-37-35(44)47-36(3,4)5)10-14-33(28)48(45,46)41(21-23)22-29-18-26(11-9-24(29)2)30(20-34(42)43)27-12-13-32-31(19-27)38-39-40(32)6/h9-14,17-19,23,30H,7-8,15-16,20-22H2,1-6H3,(H,37,44)(H,42,43)	QVAJEJIFGDBUHQ-UHFFFAOYSA-N	304858	3-(3-((7-(3-((tert-Butoxycarbonyl)amino)propyl)-4-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2]thiazepin-2(3H)-yl)methyl)-4-methylphenyl)-3-(1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 166	Nuclear factor erythroid 2-related factor 2	Human				 55					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304858	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304858&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170543	381753562							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584545	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3CN(C)CCc3c2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C31H36N2O5S/c1-4-27-20-33(39(36,37)30-8-6-5-7-29(30)38-27)19-26-16-23(10-9-21(26)2)28(17-31(34)35)24-11-12-25-18-32(3)14-13-22(25)15-24/h5-12,15-16,27-28H,4,13-14,17-20H2,1-3H3,(H,34,35)	HTZLVFKYHDOFIL-UHFFFAOYSA-N	304859	3-(3-(((R)-4-Ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-3-(2-methyl-1,2,3,4-tetrahydroisoquinolin-6-yl)propanoic acid::US10144731, Example 167	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304859	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304859&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170632	381753563							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584546	CCn1cnc(CCC(CC(O)=O)c2ccc(C)c(CN3C[C@@H](C)Oc4ccccc4S3(=O)=O)c2)c1 |r|	InChI=1S/C27H33N3O5S/c1-4-29-17-24(28-18-29)12-11-22(14-27(31)32)21-10-9-19(2)23(13-21)16-30-15-20(3)35-25-7-5-6-8-26(25)36(30,33)34/h5-10,13,17-18,20,22H,4,11-12,14-16H2,1-3H3,(H,31,32)	NMVOOHUGPIZJBG-UHFFFAOYSA-N	304860	5-(1-Ethyl-1H-imidazol-4-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)pentanoic acid::US10144731, Example 168	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304860	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304860&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170528	381753564							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584547	C[C@@H]1CN(Cc2cc(ccc2C)C(CCc2cccnc2)CC(O)=O)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C27H30N2O5S/c1-19-9-11-22(23(15-27(30)31)12-10-21-6-5-13-28-16-21)14-24(19)18-29-17-20(2)34-25-7-3-4-8-26(25)35(29,32)33/h3-9,11,13-14,16,20,23H,10,12,15,17-18H2,1-2H3,(H,30,31)	GSFAKWDVAVVJHY-UHFFFAOYSA-N	304861	3-(4-Methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)-5-(pyridin-3-yl)pentanoic acid::US10144731, Example 169	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304861	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304861&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170785	381753565							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584548	C[C@@H]1CN(Cc2cc(ccc2C)C(CCc2ccccc2C)CC(O)=O)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C29H33NO5S/c1-20-8-4-5-9-23(20)14-15-25(17-29(31)32)24-13-12-21(2)26(16-24)19-30-18-22(3)35-27-10-6-7-11-28(27)36(30,33)34/h4-13,16,22,25H,14-15,17-19H2,1-3H3,(H,31,32)	BBAQYZLFACJTEU-UHFFFAOYSA-N	304854	BDBM304862::3-(4-Methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)-5-(o-tolyl)pentanoic acid::US10144731, Example 162	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304854	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304854&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170697	381753558							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584549	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2cc(CCN(C)C)c(F)cc2C)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C31H37FN2O5S/c1-20-10-11-23(27(17-31(35)36)26-16-24(12-13-33(4)5)28(32)14-21(26)2)15-25(20)19-34-18-22(3)39-29-8-6-7-9-30(29)40(34,37)38/h6-11,14-16,22,27H,12-13,17-19H2,1-5H3,(H,35,36)	WQULRZZFYDPKTH-UHFFFAOYSA-N	304863	3-(5-(2-(Dimethylamino)ethyl)-4-fluoro-2-methylphenyl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 171	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304863	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304863&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170310	381753567							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584550	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3CN(C)Cc3c2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C30H34N2O5S/c1-4-26-19-32(38(35,36)29-8-6-5-7-28(29)37-26)18-24-13-21(10-9-20(24)2)27(15-30(33)34)22-11-12-23-16-31(3)17-25(23)14-22/h5-14,26-27H,4,15-19H2,1-3H3,(H,33,34)	PRPJMTIHQARBAD-UHFFFAOYSA-N	304864	3-(3-(((R)-4-Ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-3-(2-methylisoindolin-5-yl)propanoic acid::US10144731, Example 172	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304864	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304864&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170067	381753568							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584551	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2cc(CCCN(C)C)c(F)cc2C)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C33H41FN2O5S/c1-6-27-21-36(42(39,40)32-12-8-7-11-31(32)41-27)20-26-17-24(14-13-22(26)2)29(19-33(37)38)28-18-25(10-9-15-35(4)5)30(34)16-23(28)3/h7-8,11-14,16-18,27,29H,6,9-10,15,19-21H2,1-5H3,(H,37,38)	IDWGQXZQNPNHGS-UHFFFAOYSA-N	304865	3-(5-(3-(Dimethylamino)propyl)-4-fluoro-2-methylphenyl)-3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)propanoic acid::US10144731, Example 173	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304865	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304865&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170780	381753569							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584552	CC(C)CCC(CC(O)=O)c1ccc(C)c(CN2C[C@@H](C)Oc3ccccc3S2(=O)=O)c1 |r|	InChI=1S/C25H33NO5S/c1-17(2)9-11-21(14-25(27)28)20-12-10-18(3)22(13-20)16-26-15-19(4)31-23-7-5-6-8-24(23)32(26,29)30/h5-8,10,12-13,17,19,21H,9,11,14-16H2,1-4H3,(H,27,28)	SINSEALUHHRXQF-UHFFFAOYSA-N	304866	6-Methyl-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)heptanoic acid::US10144731, Example 174	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304866	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304866&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170490	381753570							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584553	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2)S(=O)(=O)c2cc(Cl)ccc2O1 |r|	InChI=1S/C27H27ClN4O5S/c1-16-4-5-18(22(13-27(33)34)19-6-8-24-23(11-19)29-30-31(24)3)10-20(16)15-32-14-17(2)37-25-9-7-21(28)12-26(25)38(32,35)36/h4-12,17,22H,13-15H2,1-3H3,(H,33,34)	JSKSTRUXUJHPPP-UHFFFAOYSA-N	304867	3-(3-(((R)-8-Chloro-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-3-(1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 175	Nuclear factor erythroid 2-related factor 2	Human				 55					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304867	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304867&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170275	381753571							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584554	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2)S(=O)(=O)c2cc(ccc2O1)C#N |r|	InChI=1S/C28H27N5O5S/c1-17-4-6-20(23(13-28(34)35)21-7-8-25-24(12-21)30-31-32(25)3)11-22(17)16-33-15-18(2)38-26-9-5-19(14-29)10-27(26)39(33,36)37/h4-12,18,23H,13,15-16H2,1-3H3,(H,34,35)	WMOGSKRCIKIOJQ-UHFFFAOYSA-N	304868	3-(3-(((R)-8-Cyano-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-3-(1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 176	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304868	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304868&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118169819	381753572							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584555	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2)S(=O)(=O)c2cc(ccc2O1)C(N)=O |r|	InChI=1S/C28H29N5O6S/c1-16-4-5-18(22(13-27(34)35)19-6-8-24-23(11-19)30-31-32(24)3)10-21(16)15-33-14-17(2)39-25-9-7-20(28(29)36)12-26(25)40(33,37)38/h4-12,17,22H,13-15H2,1-3H3,(H2,29,36)(H,34,35)	LPMRCDNUPGZGDF-UHFFFAOYSA-N	304869	3-(3-(((R)-8-carbamoyl-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-3-(1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 177	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304869	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304869&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170194	381753573							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584556	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2cc(CN(C)C)c(F)cc2C)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C31H37FN2O5S/c1-6-25-19-34(40(37,38)30-10-8-7-9-29(30)39-25)18-23-14-22(12-11-20(23)2)27(16-31(35)36)26-15-24(17-33(4)5)28(32)13-21(26)3/h7-15,25,27H,6,16-19H2,1-5H3,(H,35,36)	SPZRBRCBCSIHAO-UHFFFAOYSA-N	304870	3-(5-((Dimethylamino)methyl)-4-fluoro-2-methylphenyl)-3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)propanoic acid::US10144731, Example 178	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304870	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304870&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118169787	381753574							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584557	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2cc(CCN(C)C)c(F)cc2C)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C32H39FN2O5S/c1-6-26-20-35(41(38,39)31-10-8-7-9-30(31)40-26)19-25-16-23(12-11-21(25)2)28(18-32(36)37)27-17-24(13-14-34(4)5)29(33)15-22(27)3/h7-12,15-17,26,28H,6,13-14,18-20H2,1-5H3,(H,36,37)	ZKSQTPIKIPUMJG-UHFFFAOYSA-N	304871	3-(5-(2-(Dimethylamino)ethyl)-4-fluoro-2-methylphenyl)-3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)propanoic acid::US10144731, Example 179	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304871	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304871&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170470	381753575							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584558	CC[C@@H]1CN(Cc2cc(ccc2C)C(C(N)C(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C29H33N5O5S/c1-5-21-16-34(40(37,38)25-9-7-6-8-24(25)39-21)15-20-14-19(11-10-17(20)2)26(27(30)29(35)36)22-12-13-23-28(18(22)3)31-32-33(23)4/h6-14,21,26-27H,5,15-16,30H2,1-4H3,(H,35,36)	YHTUWMPWCLKWCC-UHFFFAOYSA-N	304872	2-Amino-3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)propanoic acid::US10144731, Example 180	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304872	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304872&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170169	381753576							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584559	Cc1ccc(cc1CN1Cc2ccccc2CCS1(=O)=O)C(CC(O)=O)c1ccc2n(C)nnc2c1C	InChI=1S/C28H30N4O4S/c1-18-8-9-21(25(15-27(33)34)24-10-11-26-28(19(24)2)29-30-31(26)3)14-23(18)17-32-16-22-7-5-4-6-20(22)12-13-37(32,35)36/h4-11,14,25H,12-13,15-17H2,1-3H3,(H,33,34)	SEWYDCQSWUDUNQ-UHFFFAOYSA-N	304873	3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-((3,3-dioxido-4,5-dihydrobenzo[d][1,2]thiazepin-2(1H)-yl)methyl)-4-methylphenyl)propanoic acid::US10144731, Example 181	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304873	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304873&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170489	381753577							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584560	Cc1ccc(cc1CN1CC2CCCCC2CS1(=O)=O)C(CC(O)=O)c1ccc2n(C)nnc2c1C	InChI=1S/C27H34N4O4S/c1-17-8-9-19(12-22(17)15-31-14-20-6-4-5-7-21(20)16-36(31,34)35)24(13-26(32)33)23-10-11-25-27(18(23)2)28-29-30(25)3/h8-12,20-21,24H,4-7,13-16H2,1-3H3,(H,32,33)	RXICIKJEPOJGIF-UHFFFAOYSA-N	304874	3-(1,4-Dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-((2,2-dioxidohexahydro-1H-benzo[d][1,2]thiazin-3(4H)-yl)methyl)-4-methylphenyl)propanoic acid::US10144731, Example 182	Nuclear factor erythroid 2-related factor 2	Human				 55					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304874	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304874&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170723	381753578							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584561	Cc1ccc(cc1CN1Cc2ccccc2CS1(=O)=O)C(CC(O)=O)c1ccc2n(C)nnc2c1C	InChI=1S/C27H28N4O4S/c1-17-8-9-19(12-22(17)15-31-14-20-6-4-5-7-21(20)16-36(31,34)35)24(13-26(32)33)23-10-11-25-27(18(23)2)28-29-30(25)3/h4-12,24H,13-16H2,1-3H3,(H,32,33)	QRYZXQWLCHRQQQ-UHFFFAOYSA-N	304875	US10144731, Example 183::3-(1,4-Dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-((2,2-dioxido-1H-benzo[d][1,2]thiazin-3(4H)-yl)methyl)-4-methylphenyl)propanoic acid	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304875	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304875&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170119	381753579							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584562	Cc1ccc(cc1CN1CC2CCCCC2CCS1(=O)=O)C(CC(O)=O)c1ccc2n(C)nnc2c1C	InChI=1S/C28H36N4O4S/c1-18-8-9-21(25(15-27(33)34)24-10-11-26-28(19(24)2)29-30-31(26)3)14-23(18)17-32-16-22-7-5-4-6-20(22)12-13-37(32,35)36/h8-11,14,20,22,25H,4-7,12-13,15-17H2,1-3H3,(H,33,34)	GFQRQKUOFVNFKW-UHFFFAOYSA-N	304876	US10144731, Example 184::3-(1,4-Dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-((3,3-dioxidooctahydrobenzo[d][1,2]thiazepin-2(1H)-yl)methyl)-4-methylphenyl)propanoic acid	Nuclear factor erythroid 2-related factor 2	Human				 55					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304876	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304876&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170296	381753580							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584563	C[C@@H]1CN(Cc2cc(ccc2C)C(CCc2ccc(C)cc2)CC(O)=O)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C29H33NO5S/c1-20-8-11-23(12-9-20)13-15-25(17-29(31)32)24-14-10-21(2)26(16-24)19-30-18-22(3)35-27-6-4-5-7-28(27)36(30,33)34/h4-12,14,16,22,25H,13,15,17-19H2,1-3H3,(H,31,32)	BAPMTSPSGNUDMN-UHFFFAOYSA-N	304877	US10144731, Example 185::3-(4-Methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)-5-(p-tolyl)pentanoic acid	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304877	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304877&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170019	381753581							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584564	CC1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc(F)cc2F)S(=O)(=O)c2ccc(CCCN(C)C)cc2C1	InChI=1S/C32H38F2N2O4S/c1-21-14-25-15-23(6-5-13-35(3)4)8-12-31(25)41(39,40)36(19-21)20-26-16-24(9-7-22(26)2)29(18-32(37)38)28-11-10-27(33)17-30(28)34/h7-12,15-17,21,29H,5-6,13-14,18-20H2,1-4H3,(H,37,38)	WIHQYZMEMCQRKR-UHFFFAOYSA-N	304878	US10144731, Example 186::3-(2,4-Difluorophenyl)-3-(3-((7-(3-(dimethylamino)propyl)-4-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2]thiazepin-2(3H)-yl)methyl)-4-methylphenyl)propanoic acid	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304878	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304878&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170005	381753582							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584565	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3CCN(C)Cc3c2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C31H36N2O5S/c1-4-27-20-33(39(36,37)30-8-6-5-7-29(30)38-27)19-25-15-23(10-9-21(25)2)28(17-31(34)35)24-12-11-22-13-14-32(3)18-26(22)16-24/h5-12,15-16,27-28H,4,13-14,17-20H2,1-3H3,(H,34,35)	QLBKVJGMFUFAFO-UHFFFAOYSA-N	304879	US10144731, Example 187::3-(3-(((R)-4-Ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-3-(2-methyl-1,2,3,4-tetrahydroisoquinolin-7-yl)propanoic acid	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304879	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304879&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118169992	381753583							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584566	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)C2CC2c2cn(C)nn2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C26H30N4O5S/c1-16-8-9-18(20(12-26(31)32)21-11-22(21)23-15-29(3)28-27-23)10-19(16)14-30-13-17(2)35-24-6-4-5-7-25(24)36(30,33)34/h4-10,15,17,20-22H,11-14H2,1-3H3,(H,31,32)	TWSWLFZHICHMLD-UHFFFAOYSA-N	304880	US10144731, Example 188::3-(2-(1-Methyl-1H-1,2,3-triazol-4-yl)cyclopropyl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304880	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304880&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170278	381753584							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584567	CC(C(c1ccc(C)c(CN2CCN(C)c3ccccc3S2(=O)=O)c1)c1ccc2n(C)nnc2c1C)C(O)=O	InChI=1S/C29H33N5O4S/c1-18-10-11-21(27(20(3)29(35)36)23-12-13-25-28(19(23)2)30-31-33(25)5)16-22(18)17-34-15-14-32(4)24-8-6-7-9-26(24)39(34,37)38/h6-13,16,20,27H,14-15,17H2,1-5H3,(H,35,36)	GFARMNLPSPHGIR-UHFFFAOYSA-N	304881	US10144731, Example 189N1::US10144731, Example 189M1	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304881	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304881&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170111	381753585							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584568	CC(C(c1ccc(C)c(CN2CCN(C)c3ccccc3S2(=O)=O)c1)c1ccc2n(C)nnc2c1C)C(O)=O	InChI=1S/C29H33N5O4S/c1-18-10-11-21(27(20(3)29(35)36)23-12-13-25-28(19(23)2)30-31-33(25)5)16-22(18)17-34-15-14-32(4)24-8-6-7-9-26(24)39(34,37)38/h6-13,16,20,27H,14-15,17H2,1-5H3,(H,35,36)	GFARMNLPSPHGIR-UHFFFAOYSA-N	304881	US10144731, Example 189N1::US10144731, Example 189M1	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304881	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304881&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170111	381753585							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584569	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C29H32N4O5S/c1-5-22-17-33(39(36,37)27-9-7-6-8-26(27)38-22)16-21-14-20(11-10-18(21)2)24(15-28(34)35)23-12-13-25-29(19(23)3)30-31-32(25)4/h6-14,22,24H,5,15-17H2,1-4H3,(H,34,35)	PSAYWSGFKCURFC-UHFFFAOYSA-N	304758	BDBM304884::BDBM304883::3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)propanoic acid::US10144731, Example 43	Nuclear factor erythroid 2-related factor 2	Human				<10					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304758	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304758&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170027	381753462							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584570	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C29H32N4O5S/c1-5-22-17-33(39(36,37)27-9-7-6-8-26(27)38-22)16-21-14-20(11-10-18(21)2)24(15-28(34)35)23-12-13-25-29(19(23)3)30-31-32(25)4/h6-14,22,24H,5,15-17H2,1-4H3,(H,34,35)	PSAYWSGFKCURFC-UHFFFAOYSA-N	304758	BDBM304884::BDBM304883::3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)propanoic acid::US10144731, Example 43	Nuclear factor erythroid 2-related factor 2	Human				 55					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304758	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304758&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170027	381753462							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584571	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(CC)nnc3c2C)S(=O)(=O)c2cccnc2O1 |r|	InChI=1S/C29H33N5O5S/c1-5-22-17-33(40(37,38)26-8-7-13-30-29(26)39-22)16-21-14-20(10-9-18(21)3)24(15-27(35)36)23-11-12-25-28(19(23)4)31-32-34(25)6-2/h7-14,22,24H,5-6,15-17H2,1-4H3,(H,35,36)	FSVDYFNASNQHCE-UHFFFAOYSA-N	304755	US10144731, Example 40::BDBM304886::3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-3-(1-ethyl-4-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::BDBM304885::BDBM304838	Nuclear factor erythroid 2-related factor 2	Human				 55					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304755	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304755&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118169924	381753459							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584572	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(CC)nnc3c2C)S(=O)(=O)c2cccnc2O1 |r|	InChI=1S/C29H33N5O5S/c1-5-22-17-33(40(37,38)26-8-7-13-30-29(26)39-22)16-21-14-20(10-9-18(21)3)24(15-27(35)36)23-11-12-25-28(19(23)4)31-32-34(25)6-2/h7-14,22,24H,5-6,15-17H2,1-4H3,(H,35,36)	FSVDYFNASNQHCE-UHFFFAOYSA-N	304755	US10144731, Example 40::BDBM304886::3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-3-(1-ethyl-4-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::BDBM304885::BDBM304838	Nuclear factor erythroid 2-related factor 2	Human				 55					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304755	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304755&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118169924	381753459							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584573	CC[C@@H]1CN(Cc2cc(ccc2C)C(CCc2cn(CC)nn2)C(C)C(O)=O)S(=O)(=O)c2ccccc2O1 |r,w:14.14,23.25|	InChI=1S/C28H36N4O5S/c1-5-24-18-32(38(35,36)27-10-8-7-9-26(27)37-24)16-22-15-21(12-11-19(22)3)25(20(4)28(33)34)14-13-23-17-31(6-2)30-29-23/h7-12,15,17,20,24-25H,5-6,13-14,16,18H2,1-4H3,(H,33,34)	IDANVQJFZXIQGM-UHFFFAOYSA-N	304887	US10144731, Example 192::3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-5-(1-ethyl-1H-1,2,3-triazol-4-yl)-2-methylpentanoic acid	Nuclear factor erythroid 2-related factor 2	Human				<10					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304887	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304887&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170028	381753590							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584574	CC[C@@H]1CN(Cc2cc(ccc2C)C(CCc2cn(CC)nn2)C(C)C(O)=O)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C28H36N4O5S/c1-5-24-18-32(38(35,36)27-10-8-7-9-26(27)37-24)16-22-15-21(12-11-19(22)3)25(20(4)28(33)34)14-13-23-17-31(6-2)30-29-23/h7-12,15,17,20,24-25H,5-6,13-14,16,18H2,1-4H3,(H,33,34)	IDANVQJFZXIQGM-UHFFFAOYSA-N	304888	US10144731, Example 193::3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-5-(1-ethyl-1H-1,2,3-triazol-4-yl)-2-methylpentanoic acid	Nuclear factor erythroid 2-related factor 2	Human				<10					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304888	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304888&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170028	381753591							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584575	CC[C@@H]1CN(Cc2cc(ccc2C)C(CCc2cn(CC)nn2)CC(O)=O)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C27H34N4O5S/c1-4-24-18-31(37(34,35)26-9-7-6-8-25(26)36-24)16-22-14-20(11-10-19(22)3)21(15-27(32)33)12-13-23-17-30(5-2)29-28-23/h6-11,14,17,21,24H,4-5,12-13,15-16,18H2,1-3H3,(H,32,33)	OFFIZNQRXWXRFR-UHFFFAOYSA-N	304889	3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-5-(1-ethyl-1H-1,2,3-triazol-4-yl)pentanoic acid (isomer M1) and 3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-5-(1-ethyl-1H-1,2,3-triazol-4-yl)pentanoic acid (isomer N1)::BDBM304919::US10144731, Example 194	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304889	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304889&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170583	381753592							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584576	COCCC(CC(O)=O)c1ccc(C)c(CN2C[C@@H](C)Oc3ccccc3S2(=O)=O)c1 |r|	InChI=1S/C23H29NO6S/c1-16-8-9-18(19(10-11-29-3)13-23(25)26)12-20(16)15-24-14-17(2)30-21-6-4-5-7-22(21)31(24,27)28/h4-9,12,17,19H,10-11,13-15H2,1-3H3,(H,25,26)	MDMOGTPMLUHGBG-UHFFFAOYSA-N	304890	US10144731, Example 195::5-Methoxy-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)pentanoic acid	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304890	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304890&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170075	381753593							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584577	C[C@@H]1CN(Cc2cc(ccc2C)C(CCC2CCCC2)CC(O)=O)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C27H35NO5S/c1-19-11-13-22(23(16-27(29)30)14-12-21-7-3-4-8-21)15-24(19)18-28-17-20(2)33-25-9-5-6-10-26(25)34(28,31)32/h5-6,9-11,13,15,20-21,23H,3-4,7-8,12,14,16-18H2,1-2H3,(H,29,30)	JWCCGAXRMNTCEB-UHFFFAOYSA-N	304891	US10144731, Example 196::5-Cyclopentyl-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)pentanoic acid	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304891	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304891&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170092	381753594							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584578	CC[C@@H]1CN(Cc2cc(ccc2C(F)(F)F)C(CCc2cn(CC)nn2)CC(O)=O)S(=O)(=O)c2cnccc2O1 |r|	InChI=1S/C26H30F3N5O5S/c1-3-21-16-34(40(37,38)24-13-30-10-9-23(24)39-21)14-19-11-17(6-8-22(19)26(27,28)29)18(12-25(35)36)5-7-20-15-33(4-2)32-31-20/h6,8-11,13,15,18,21H,3-5,7,12,14,16H2,1-2H3,(H,35,36)	GNGJWPZEJKPGFY-UHFFFAOYSA-N	304892	US10144731, Example 197::3-(3-(((R)-4-Ethyl-1,1-dioxido-3,4-dihydro-2H-pyrido[4,3-b][1,4,5]oxathiazepin-2-yl)methyl)-4-(trifluoromethyl)phenyl)-5-(1-ethyl-1H-1,2,3-triazol-4-yl)pentanoic acid	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304892	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304892&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170712	381753595							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584579	CCn1cc(CCC(CC(O)=O)c2ccc(c(CN3CC(C)Cc4ccccc4S3(=O)=O)c2)C(F)(F)F)nn1	InChI=1S/C27H31F3N4O4S/c1-3-33-17-23(31-32-33)10-8-20(14-26(35)36)19-9-11-24(27(28,29)30)22(13-19)16-34-15-18(2)12-21-6-4-5-7-25(21)39(34,37)38/h4-7,9,11,13,17-18,20H,3,8,10,12,14-16H2,1-2H3,(H,35,36)	LJYJNPDCJALUPO-UHFFFAOYSA-N	304893	US10144731, Example 198::5-(1-Ethyl-1H-1,2,3-triazol-4-yl)-3-(3-((4-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2]thiazepin-2(3H)-yl)methyl)-4-(trifluoromethyl)phenyl)pentanoic acid	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304893	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304893&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170949	381753596							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584580	CC[C@@H]1CN(Cc2cc(ccc2C)C(CCc2cn(CC)nn2)CC(O)=O)S(=O)(=O)c2cnccc2C1 |r|	InChI=1S/C27H35N5O4S/c1-4-20-12-23-10-11-28-15-26(23)37(35,36)32(16-20)17-24-13-21(7-6-19(24)3)22(14-27(33)34)8-9-25-18-31(5-2)30-29-25/h6-7,10-11,13,15,18,20,22H,4-5,8-9,12,14,16-17H2,1-3H3,(H,33,34)	ZEXIQZWCZZOHLR-UHFFFAOYSA-N	304894	US10144731, Example 199::3-(3-(((R)-4-Ethyl-1,1-dioxido-3,4-dihydro-2H-pyrido[4,3-b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-5-(1-ethyl-1H-1,2,3-triazol-4-yl)pentanoic acid	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304894	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304894&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			122660642	381753597							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584581	CC[C@@H]1CN(Cc2cc(ccc2C(F)(F)F)C(CCc2cn(CC)nn2)CC(O)=O)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C27H31F3N4O5S/c1-3-22-17-34(40(37,38)25-8-6-5-7-24(25)39-22)15-20-13-18(10-12-23(20)27(28,29)30)19(14-26(35)36)9-11-21-16-33(4-2)32-31-21/h5-8,10,12-13,16,19,22H,3-4,9,11,14-15,17H2,1-2H3,(H,35,36)	GJIAQUPOXRGEOW-UHFFFAOYSA-N	304895	US10144731, Example 200::3-(3-(((R)-4-Ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-(trifluoromethyl)phenyl)-5-(1-ethyl-1H-1,2,3-triazol-4-yl)pentanoic acid	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304895	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304895&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170268	381753598							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584582	CCCn1cc(CCC(CC(O)=O)c2ccc(C)c(CN3C[C@@H](C)Oc4ccccc4S3(=O)=O)c2)nn1 |r|	InChI=1S/C27H34N4O5S/c1-4-13-30-18-24(28-29-30)12-11-22(15-27(32)33)21-10-9-19(2)23(14-21)17-31-16-20(3)36-25-7-5-6-8-26(25)37(31,34)35/h5-10,14,18,20,22H,4,11-13,15-17H2,1-3H3,(H,32,33)	DHXVRUGBGUAPNG-UHFFFAOYSA-N	304896	US10144731, Example 201::3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)-5-(1-propyl-1H-1,2,3-triazol-4-yl)pentanoic acid	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304896	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304896&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118169970	381753599							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584583	CCCn1cc(CCC(CC(O)=O)c2ccc(C)c(CN3C[C@@H](CC)Oc4ccccc4S3(=O)=O)c2)nn1 |r|	InChI=1S/C28H36N4O5S/c1-4-14-31-18-24(29-30-31)13-12-22(16-28(33)34)21-11-10-20(3)23(15-21)17-32-19-25(5-2)37-26-8-6-7-9-27(26)38(32,35)36/h6-11,15,18,22,25H,4-5,12-14,16-17,19H2,1-3H3,(H,33,34)	FGASSPDBSDOEPX-UHFFFAOYSA-N	304897	US10144731, Example 202::3-(3-(((R)-4-Ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-5-(1-propyl-1H-1,2,3-triazol-4-yl)pentanoic acid	Nuclear factor erythroid 2-related factor 2	Human				 55					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304897	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304897&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170142	381753600							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584584	CC(C)n1cc(CCC(CC(O)=O)c2ccc(C)c(CN3C[C@@H](C)Oc4ccccc4S3(=O)=O)c2)nn1 |r|	InChI=1S/C27H34N4O5S/c1-18(2)31-17-24(28-29-31)12-11-22(14-27(32)33)21-10-9-19(3)23(13-21)16-30-15-20(4)36-25-7-5-6-8-26(25)37(30,34)35/h5-10,13,17-18,20,22H,11-12,14-16H2,1-4H3,(H,32,33)	GNXFBTOJIPLCGB-UHFFFAOYSA-N	304898	US10144731, Example 203::5-(1-Isopropyl-1H-1,2,3-triazol-4-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)pentanoic acid	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304898	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304898&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170243	381753601							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584585	CC[C@@H]1CN(Cc2cc(ccc2C)C(CCc2cn(nn2)C(C)C)CC(O)=O)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C28H36N4O5S/c1-5-25-18-31(38(35,36)27-9-7-6-8-26(27)37-25)16-23-14-21(11-10-20(23)4)22(15-28(33)34)12-13-24-17-32(19(2)3)30-29-24/h6-11,14,17,19,22,25H,5,12-13,15-16,18H2,1-4H3,(H,33,34)	JBWZTQKHRVJEFM-UHFFFAOYSA-N	304899	3-(3-(((R)-4-Ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-5-(1-isopropyl-1H-1,2,3-triazol-4-yl)pentanoic acid::US10144731, Example 204	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304899	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304899&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170074	381753602							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584586	CCCn1cc(CCC(CC(O)=O)c2ccc(C)c(CN3C[C@@H](CC)Oc4ccncc4S3(=O)=O)c2)nn1 |r|	InChI=1S/C27H35N5O5S/c1-4-12-31-17-23(29-30-31)9-8-21(14-27(33)34)20-7-6-19(3)22(13-20)16-32-18-24(5-2)37-25-10-11-28-15-26(25)38(32,35)36/h6-7,10-11,13,15,17,21,24H,4-5,8-9,12,14,16,18H2,1-3H3,(H,33,34)	YHMSHUNSVHSTSR-UHFFFAOYSA-N	304900	3-(3-(((R)-4-Ethyl-1,1-dioxido-3,4-dihydro-2H-pyrido[4,3-b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-5-(1-propyl-1H-1,2,3-triazol-4-yl)pentanoic acid::US10144731, Example 205	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304900	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304900&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170571	381753603							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584587	CC[C@@H]1CN(Cc2cc(ccc2C)C(CCc2cn(nn2)C(C)C)CC(O)=O)S(=O)(=O)c2cnccc2O1 |r|	InChI=1S/C27H35N5O5S/c1-5-24-17-31(38(35,36)26-14-28-11-10-25(26)37-24)15-22-12-20(7-6-19(22)4)21(13-27(33)34)8-9-23-16-32(18(2)3)30-29-23/h6-7,10-12,14,16,18,21,24H,5,8-9,13,15,17H2,1-4H3,(H,33,34)	OCRPAIWDRJKOTN-UHFFFAOYSA-N	304901	3-(3-(((R)-4-Ethyl-1,1-dioxido-3,4-dihydro-2H-pyrido[4,3-b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-5-(1-isopropyl-1H-1,2,3-triazol-4-yl)pentanoic acid::US10144731, Example 206	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304901	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304901&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170617	381753604							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584588	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(C)c2cn(CC)nn2)CC(O)=O)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C28H36N4O5S/c1-5-24-17-32(38(35,36)27-10-8-7-9-26(27)37-24)16-23-14-21(12-11-19(23)3)22(15-28(33)34)13-20(4)25-18-31(6-2)30-29-25/h7-12,14,18,20,22,24H,5-6,13,15-17H2,1-4H3,(H,33,34)	BKKIQOWFHQPZEE-UHFFFAOYSA-N	304902	US10144731, Example 207::BDBM304903::3-(3-(((R)-4-Ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-5-(1-ethyl-1H-1,2,3-triazol-4-yl)hexanoic acid (peak 1)::BDBM304904	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304902	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304902&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118169840	381753605							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584589	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(C)c2cn(CC)nn2)CC(O)=O)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C28H36N4O5S/c1-5-24-17-32(38(35,36)27-10-8-7-9-26(27)37-24)16-23-14-21(12-11-19(23)3)22(15-28(33)34)13-20(4)25-18-31(6-2)30-29-25/h7-12,14,18,20,22,24H,5-6,13,15-17H2,1-4H3,(H,33,34)	BKKIQOWFHQPZEE-UHFFFAOYSA-N	304902	US10144731, Example 207::BDBM304903::3-(3-(((R)-4-Ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-5-(1-ethyl-1H-1,2,3-triazol-4-yl)hexanoic acid (peak 1)::BDBM304904	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304902	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304902&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118169840	381753605							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584590	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(C)c2cn(CC)nn2)CC(O)=O)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C28H36N4O5S/c1-5-24-17-32(38(35,36)27-10-8-7-9-26(27)37-24)16-23-14-21(12-11-19(23)3)22(15-28(33)34)13-20(4)25-18-31(6-2)30-29-25/h7-12,14,18,20,22,24H,5-6,13,15-17H2,1-4H3,(H,33,34)	BKKIQOWFHQPZEE-UHFFFAOYSA-N	304902	US10144731, Example 207::BDBM304903::3-(3-(((R)-4-Ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-5-(1-ethyl-1H-1,2,3-triazol-4-yl)hexanoic acid (peak 1)::BDBM304904	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304902	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304902&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118169840	381753605							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584591	Cc1ccc(cc1CN1CCCc2ccccc2S1(=O)=O)C(CC(O)=O)c1ccc2n(C)nnc2c1C	InChI=1S/C28H30N4O4S/c1-18-10-11-21(24(16-27(33)34)23-12-13-25-28(19(23)2)29-30-31(25)3)15-22(18)17-32-14-6-8-20-7-4-5-9-26(20)37(32,35)36/h4-5,7,9-13,15,24H,6,8,14,16-17H2,1-3H3,(H,33,34)	QWBZFCSPMMQPPO-UHFFFAOYSA-N	304905	3-(1,4-Dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-((1,1-dioxido-4,5-dihydrobenzo[f][1,2]thiazepin-2(3H)-yl)methyl)-4-methylphenyl)propanoic acid::US10144731, Example 209	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304905	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304905&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118169769	381753608							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584592	CC1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc2C1	InChI=1S/C29H32N4O4S/c1-18-13-22-7-5-6-8-27(22)38(36,37)33(16-18)17-23-14-21(10-9-19(23)2)25(15-28(34)35)24-11-12-26-29(20(24)3)30-31-32(26)4/h5-12,14,18,25H,13,15-17H2,1-4H3,(H,34,35)	BIHHECVWYUSKTL-UHFFFAOYSA-N	304906	3-(1,4-Dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((4-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2]thiazepin-2(3H)-yl)methyl)phenyl)propanoic acid::US10144731, Example 210	Nuclear factor erythroid 2-related factor 2	Human				 55					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304906	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304906&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170885	381753609							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584593	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2c(F)cccc2O1 |r|	InChI=1S/C28H29FN4O5S/c1-16-8-9-19(22(13-26(34)35)21-10-11-24-27(18(21)3)30-31-32(24)4)12-20(16)15-33-14-17(2)38-25-7-5-6-23(29)28(25)39(33,36)37/h5-12,17,22H,13-15H2,1-4H3,(H,34,35)	JKDFOYSIKNRLTR-UHFFFAOYSA-N	304907	3-(1,4-Dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-(((R)-9-fluoro-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)propanoic acid::US10144731, Example 211	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304907	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304907&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170032	381753610							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584594	COc1cc(cc2nnn(C)c12)[C@@H](CC(O)=O)c1ccc(C)c(CN2C[C@H](C)Cc3ccccc3S2(=O)=O)c1 |r|	InChI=1S/C29H32N4O5S/c1-18-11-21-7-5-6-8-27(21)39(36,37)33(16-18)17-23-12-20(10-9-19(23)2)24(15-28(34)35)22-13-25-29(26(14-22)38-4)32(3)31-30-25/h5-10,12-14,18,24H,11,15-17H2,1-4H3,(H,34,35)	HSPMCXSTLBKXFP-UHFFFAOYSA-N	304908	(S)-3-(7-Methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2]thiazepin-2(3H)-yl)methyl)phenyl)propanoic acid::US10144731, Example 212	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304908	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304908&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170319	381753611							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584595	COc1cc(cc2nnn(C)c12)[C@@H](CC(O)=O)c1ccc(C)c(CN2C[C@@H](C)Cc3ccccc3S2(=O)=O)c1 |r|	InChI=1S/C29H32N4O5S/c1-18-11-21-7-5-6-8-27(21)39(36,37)33(16-18)17-23-12-20(10-9-19(23)2)24(15-28(34)35)22-13-25-29(26(14-22)38-4)32(3)31-30-25/h5-10,12-14,18,24H,11,15-17H2,1-4H3,(H,34,35)	HSPMCXSTLBKXFP-UHFFFAOYSA-N	304909	(S)-3-(7-Methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((S)-4-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2]thiazepin-2(3H)-yl)methyl)phenyl)propanoic acid::US10144731, Example 213	Nuclear factor erythroid 2-related factor 2	Human				 55					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304909	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304909&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170404	381753612							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584596	CC1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc(cc2C)C#N)S(=O)(=O)c2ccccc2C1	InChI=1S/C29H30N2O4S/c1-19-12-24-6-4-5-7-28(24)36(34,35)31(17-19)18-25-14-23(10-8-20(25)2)27(15-29(32)33)26-11-9-22(16-30)13-21(26)3/h4-11,13-14,19,27H,12,15,17-18H2,1-3H3,(H,32,33)	QXXYHMOQLMDKMF-UHFFFAOYSA-N	304910	3-(4-Cyano-2-methylphenyl)-3-(4-methyl-3-((4-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2]thiazepin-2(3H)-yl)methyl)phenyl)propanoic acid::US10144731, Example 214	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304910	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304910&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170133	381753613							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584597	CC1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc(cc2C)C#N)S(=O)(=O)c2ccc(F)cc2C1	InChI=1S/C29H29FN2O4S/c1-18-10-23-13-25(30)7-9-28(23)37(35,36)32(16-18)17-24-12-22(6-4-19(24)2)27(14-29(33)34)26-8-5-21(15-31)11-20(26)3/h4-9,11-13,18,27H,10,14,16-17H2,1-3H3,(H,33,34)	HBNAUONLWDFYEA-UHFFFAOYSA-N	304911	3-(4-Cyano-2-methylphenyl)- 3-(3-((7-fluoro-4-methyl-1,1- dioxido-4,5-dihydrobenzo[f] [1,2]thiazepin-2(3H)-yl) methyl)-4-methylphenyl) propanoic acid::US10144731, Example 215	Nuclear factor erythroid 2-related factor 2	Human				 55					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304911	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304911&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170263	381753614							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584598	COc1ccc2c(CC(C)CN(Cc3cc(ccc3C)C(CC(O)=O)c3ccc(cc3C)C#N)S2(=O)=O)c1	InChI=1S/C30H32N2O5S/c1-19-11-24-14-26(37-4)8-10-29(24)38(35,36)32(17-19)18-25-13-23(7-5-20(25)2)28(15-30(33)34)27-9-6-22(16-31)12-21(27)3/h5-10,12-14,19,28H,11,15,17-18H2,1-4H3,(H,33,34)	GIPUEKGFFDJJJJ-UHFFFAOYSA-N	304912	3-(4-Cyano-2-methylphenyl)- 3-(3-((7-methoxy-4-methyl- 1,1-dioxido-4,5-dihydrobenzo [f][1,2]thiazepin-2(3H)-yl) methyl)-4-methylphenyl) propanoic acid::US10144731, Example 216	Nuclear factor erythroid 2-related factor 2	Human				 55					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304912	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304912&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			122653261	381753615							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584599	CC1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc(cc2C)C#N)S(=O)(=O)c2ccc(cc2C1)C(F)(F)F	InChI=1S/C30H29F3N2O4S/c1-18-10-23-13-25(30(31,32)33)7-9-28(23)40(38,39)35(16-18)17-24-12-22(6-4-19(24)2)27(14-29(36)37)26-8-5-21(15-34)11-20(26)3/h4-9,11-13,18,27H,10,14,16-17H2,1-3H3,(H,36,37)	IARGPHHSZQXOSH-UHFFFAOYSA-N	304913	3-(4-Cyano-2-methylphenyl)- 3-(4-methyl-3-((4-methyl-1,1- dioxido-7-(trifluoromethyl)- 4,5-dihydrobenzo[f][1,2] thiazepin-2(3H)-yl)methyl) phenyl)propanoic acid::US10144731, Example 217	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304913	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304913&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			122653400	381753616							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584600	CC1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc(cc2C)C#N)S(=O)(=O)c2ccc(OC(F)(F)F)cc2C1	InChI=1S/C30H29F3N2O5S/c1-18-10-23-13-25(40-30(31,32)33)7-9-28(23)41(38,39)35(16-18)17-24-12-22(6-4-19(24)2)27(14-29(36)37)26-8-5-21(15-34)11-20(26)3/h4-9,11-13,18,27H,10,14,16-17H2,1-3H3,(H,36,37)	YEJSAJHUMWAUBV-UHFFFAOYSA-N	304914	3-(4-Cyano-2-methylphenyl)- 3-(4-methyl-3-((4-methyl-1,1- dioxido-7-(trifluoromethoxy)- 4,5-dihydrobenzo[f][1,2] thiazepin-2(3H)-yl)methyl) phenyl)propanoic acid::US10144731, Example 218	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304914	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304914&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			122653290	381753617							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584601	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc(cc2OC)C#N)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C29H30N2O6S/c1-4-23-18-31(38(34,35)28-8-6-5-7-26(28)37-23)17-22-14-21(11-9-19(22)2)25(15-29(32)33)24-12-10-20(16-30)13-27(24)36-3/h5-14,23,25H,4,15,17-18H2,1-3H3,(H,32,33)	UANMOFVJIKFJJT-UHFFFAOYSA-N	304915	3-(4-Cyano-2-methoxyphenyl)-3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)propanoic acid::US10144731, Example 219	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304915	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304915&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170060	381753618							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584602	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc(C#N)c(OC)c2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C29H30N2O6S/c1-4-24-18-31(38(34,35)28-8-6-5-7-26(28)37-24)17-23-13-20(10-9-19(23)2)25(15-29(32)33)21-11-12-22(16-30)27(14-21)36-3/h5-14,24-25H,4,15,17-18H2,1-3H3,(H,32,33)	HZDUCHHJWUKSCD-UHFFFAOYSA-N	304916	3-(4-Cyano-3-methoxyphenyl)-3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)propanoic acid::US10144731, Example 220	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304916	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304916&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170248	381753619							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584603	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc(cc2F)C#N)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C28H27FN2O5S/c1-3-22-17-31(37(34,35)27-7-5-4-6-26(27)36-22)16-21-13-20(10-8-18(21)2)24(14-28(32)33)23-11-9-19(15-30)12-25(23)29/h4-13,22,24H,3,14,16-17H2,1-2H3,(H,32,33)	FVNHWMOCBZQTBI-UHFFFAOYSA-N	304917	3-(4-Cyano-2-fluorophenyl)-3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)propanoic acid::US10144731, Example 221	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304917	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304917&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170710	381753620							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584604	CCn1cc(CCC(CC(O)=O)c2ccc(C)c(CN3C[C@@H](C)Cc4ccccc4S3(=O)=O)c2)nn1 |r|	InChI=1S/C27H34N4O4S/c1-4-30-18-25(28-29-30)12-11-22(15-27(32)33)21-10-9-20(3)24(14-21)17-31-16-19(2)13-23-7-5-6-8-26(23)36(31,34)35/h5-10,14,18-19,22H,4,11-13,15-17H2,1-3H3,(H,32,33)	NZGGZISVMMEMJX-UHFFFAOYSA-N	304918	5-(1-Ethyl-1H-1,2,3-triazol-4-yl)-3-(4-methyl-3-(((S)-4-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2]thiazepin-2(3H)-yl)methyl)phenyl)pentanoic acid::US10144731, Example 222	Nuclear factor erythroid 2-related factor 2	Human				 55					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304918	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304918&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170380	381753621							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584605	CC[C@@H]1CN(Cc2cc(ccc2C)C(CCc2cn(CC)nn2)CC(O)=O)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C27H34N4O5S/c1-4-24-18-31(37(34,35)26-9-7-6-8-25(26)36-24)16-22-14-20(11-10-19(22)3)21(15-27(32)33)12-13-23-17-30(5-2)29-28-23/h6-11,14,17,21,24H,4-5,12-13,15-16,18H2,1-3H3,(H,32,33)	OFFIZNQRXWXRFR-UHFFFAOYSA-N	304889	3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-5-(1-ethyl-1H-1,2,3-triazol-4-yl)pentanoic acid (isomer M1) and 3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-5-(1-ethyl-1H-1,2,3-triazol-4-yl)pentanoic acid (isomer N1)::BDBM304919::US10144731, Example 194	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304889	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304889&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170583	381753592							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584606	CCn1cc(CCC(CC(O)=O)c2ccc(C)c(CN3CCCc4ccccc4S3(=O)=O)c2)nn1	InChI=1S/C26H32N4O4S/c1-3-29-18-24(27-28-29)13-12-22(16-26(31)32)21-11-10-19(2)23(15-21)17-30-14-6-8-20-7-4-5-9-25(20)35(30,33)34/h4-5,7,9-11,15,18,22H,3,6,8,12-14,16-17H2,1-2H3,(H,31,32)	FROVAICQVUYMQU-UHFFFAOYSA-N	304920	3-(3-((1,1-Dioxido-4,5-dihydrobenzo[f][1,2]thiazepin-2(3H)-yl)methyl)-4-methylphenyl)-5-(1-ethyl-1H-1,2,3-triazol-4-yl)pentanoic acid::US10144731, Example 224	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304920	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304920&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118188921	381753623							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584607	CC[C@@H]1CN(Cc2cc(ccc2C)C(CCc2cn(CC)nn2)CC(O)=O)S(=O)(=O)c2cccnc2O1 |r|	InChI=1S/C26H33N5O5S/c1-4-23-17-31(37(34,35)24-7-6-12-27-26(24)36-23)15-21-13-19(9-8-18(21)3)20(14-25(32)33)10-11-22-16-30(5-2)29-28-22/h6-9,12-13,16,20,23H,4-5,10-11,14-15,17H2,1-3H3,(H,32,33)	CAJHFKZCUUGUSQ-UHFFFAOYSA-N	304921	3-(3-(((R)-4-Ethyl-1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-5-(1-ethyl-1H-1,2,3-triazol-4-yl)pentanoic acid::US10144731, Example 225	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304921	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304921&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118188834	381753624							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584608	CCn1cc(CCC(CC(O)=O)c2ccc(C)c(CN3C[C@H](C)Cc4ccccc4S3(=O)=O)c2)nn1 |r|	InChI=1S/C27H34N4O4S/c1-4-30-18-25(28-29-30)12-11-22(15-27(32)33)21-10-9-20(3)24(14-21)17-31-16-19(2)13-23-7-5-6-8-26(23)36(31,34)35/h5-10,14,18-19,22H,4,11-13,15-17H2,1-3H3,(H,32,33)	NZGGZISVMMEMJX-UHFFFAOYSA-N	304922	5-(1-Ethyl-1H-1,2,3-triazol-4-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2]thiazepin-2(3H)-yl)methyl)phenyl)pentanoic acid::US10144731, Example 226	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304922	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304922&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170730	381753625							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584609	CCn1cc(CCC(CC(O)=O)c2ccc(C)c(CN3CC(C)Cc4ccc(F)cc4S3(=O)=O)c2)nn1	InChI=1S/C27H33FN4O4S/c1-4-31-17-25(29-30-31)10-8-21(13-27(33)34)20-6-5-19(3)23(12-20)16-32-15-18(2)11-22-7-9-24(28)14-26(22)37(32,35)36/h5-7,9,12,14,17-18,21H,4,8,10-11,13,15-16H2,1-3H3,(H,33,34)	KWDUEIBJQOEQJN-UHFFFAOYSA-N	304923	5-(1-Ethyl-1H-1,2,3-triazol-4-yl)-3-(3-((8-fluoro-4-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2]thiazepin-2(3H)-yl)methyl)-4-methylphenyl)pentanoic acid::US10144731, Example 227	Nuclear factor erythroid 2-related factor 2	Human				 55					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304923	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304923&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170581	381753626							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584610	CC1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2)S(=O)(=O)c2ccc(CCCN)cc2C1	InChI=1S/C31H37N5O4S/c1-20-13-25-14-22(5-4-12-32)7-11-30(25)41(39,40)36(18-20)19-26-15-23(8-6-21(26)2)27(17-31(37)38)24-9-10-29-28(16-24)33-34-35(29)3/h6-11,14-16,20,27H,4-5,12-13,17-19,32H2,1-3H3,(H,37,38)	HQLFULDUYCCJPE-UHFFFAOYSA-N	304924	3-(3-((7-(3-Aminopropyl)-4-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2]thiazepin-2(3H)-yl)methyl)-4-methylphenyl)-3-(1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid trifluoroacetic acid salt::US10144731, Example 228	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304924	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304924&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170512	381753627							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584611	CCC1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc(cc2C)C#N)S(=O)(=O)c2ccccc2O1	InChI=1S/C29H30N2O5S/c1-4-24-18-31(37(34,35)28-8-6-5-7-27(28)36-24)17-23-14-22(11-9-19(23)2)26(15-29(32)33)25-12-10-21(16-30)13-20(25)3/h5-14,24,26H,4,15,17-18H2,1-3H3,(H,32,33)	SFIXUCDVNKADGU-UHFFFAOYSA-N	304925	3-(4-Cyano-2-methylphenyl)-3-(3-((4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)propanoic acid::US10144731, Example 229	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304925	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304925&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170894	381753628							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584612	CCC1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc(cc2C)C#N)S(=O)(=O)c2cccnc2O1	InChI=1S/C28H29N3O5S/c1-4-23-17-31(37(34,35)26-6-5-11-30-28(26)36-23)16-22-13-21(9-7-18(22)2)25(14-27(32)33)24-10-8-20(15-29)12-19(24)3/h5-13,23,25H,4,14,16-17H2,1-3H3,(H,32,33)	ZSYJPILCQQZFGC-UHFFFAOYSA-N	304926	US10144731, Example 230::3-(4-Cyano-2-methylphenyl)-3-(3-((4-ethyl-1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)propanoic acid	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304926	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304926&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			122653388	381753629							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584613	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc(cc2C)C#N)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C28H28N2O5S/c1-18-8-10-22(25(14-28(31)32)24-11-9-21(15-29)12-19(24)2)13-23(18)17-30-16-20(3)35-26-6-4-5-7-27(26)36(30,33)34/h4-13,20,25H,14,16-17H2,1-3H3,(H,31,32)	WSAJFKZPNGAKAD-UHFFFAOYSA-N	304927	US10144731, Example 231::3-(4-Cyano-2-methylphenyl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304927	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304927&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118169745	381753630							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584614	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc(F)c(F)c2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C26H25F2NO5S/c1-16-7-8-18(21(13-26(30)31)19-9-10-22(27)23(28)12-19)11-20(16)15-29-14-17(2)34-24-5-3-4-6-25(24)35(29,32)33/h3-12,17,21H,13-15H2,1-2H3,(H,30,31)	MGIAJNGRXJICFA-UHFFFAOYSA-N	304928	US10144731, Example 232::3-(3,4-Difluorophenyl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304928	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304928&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170238	381753631							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584615	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2cc(F)c(F)c(F)c2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C26H24F3NO5S/c1-15-7-8-17(20(12-25(31)32)18-10-21(27)26(29)22(28)11-18)9-19(15)14-30-13-16(2)35-23-5-3-4-6-24(23)36(30,33)34/h3-11,16,20H,12-14H2,1-2H3,(H,31,32)	FRPGONVMQZYDCC-UHFFFAOYSA-N	304929	US10144731, Example 233::3-(4-Methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)-3-(3,4,5-trifluorophenyl)propanoic acid	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304929	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304929&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170539	381753632							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584616	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2cccc(F)c2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C26H26FNO5S/c1-17-10-11-20(23(14-26(29)30)19-6-5-7-22(27)13-19)12-21(17)16-28-15-18(2)33-24-8-3-4-9-25(24)34(28,31)32/h3-13,18,23H,14-16H2,1-2H3,(H,29,30)	OYZIJXYHWRIKIW-UHFFFAOYSA-N	304930	US10144731, Example 234::3-(3-Fluorophenyl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304930	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304930&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118169870	381753633							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584617	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccccc2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C26H27NO5S/c1-18-12-13-21(23(15-26(28)29)20-8-4-3-5-9-20)14-22(18)17-27-16-19(2)32-24-10-6-7-11-25(24)33(27,30)31/h3-14,19,23H,15-17H2,1-2H3,(H,28,29)	CUENPUOZILZXSI-UHFFFAOYSA-N	304931	US10144731, Example 235::3-(4-Methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)-3-phenylpropanoic acid	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304931	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304931&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			122653304	381753634							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584618	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccccc2C)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C27H29NO5S/c1-18-12-13-21(24(15-27(29)30)23-9-5-4-8-19(23)2)14-22(18)17-28-16-20(3)33-25-10-6-7-11-26(25)34(28,31)32/h4-14,20,24H,15-17H2,1-3H3,(H,29,30)	AKQXWJHIWSZQPZ-UHFFFAOYSA-N	304932	US10144731, Example 236::3-(4-Methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)-3-(o-tolyl)propanoic acid	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304932	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304932&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			122653333	381753635							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584619	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc(F)cc2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C26H26FNO5S/c1-17-7-8-20(23(14-26(29)30)19-9-11-22(27)12-10-19)13-21(17)16-28-15-18(2)33-24-5-3-4-6-25(24)34(28,31)32/h3-13,18,23H,14-16H2,1-2H3,(H,29,30)	PCWFDFLFSSELHV-UHFFFAOYSA-N	304933	US10144731, Example 237::3-(4-Fluorophenyl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304933	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304933&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170000	381753636							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584620	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc(F)cc2C)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C27H28FNO5S/c1-17-8-9-20(24(14-27(30)31)23-11-10-22(28)12-18(23)2)13-21(17)16-29-15-19(3)34-25-6-4-5-7-26(25)35(29,32)33/h4-13,19,24H,14-16H2,1-3H3,(H,30,31)	UAWAVHLCYBVILD-UHFFFAOYSA-N	304934	US10144731, Example 238::3-(4-Fluoro-2-methylphenyl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304934	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304934&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170335	381753637							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584621	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc(Cl)cc2C)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C27H28ClNO5S/c1-17-8-9-20(24(14-27(30)31)23-11-10-22(28)12-18(23)2)13-21(17)16-29-15-19(3)34-25-6-4-5-7-26(25)35(29,32)33/h4-13,19,24H,14-16H2,1-3H3,(H,30,31)	ROWJVYNPLUSZIZ-UHFFFAOYSA-N	304935	US10144731, Example 239::3-(4-Chloro-2-methylphenyl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304935	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304935&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			122653244	381753638							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584622	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc(Cl)cc2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C26H26ClNO5S/c1-17-7-8-20(23(14-26(29)30)19-9-11-22(27)12-10-19)13-21(17)16-28-15-18(2)33-24-5-3-4-6-25(24)34(28,31)32/h3-13,18,23H,14-16H2,1-2H3,(H,29,30)	JERKNUJOWYNDMT-UHFFFAOYSA-N	304936	US10144731, Example 240::3-(4-Chlorophenyl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304936	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304936&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170680	381753639							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584623	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc(NC=O)cc2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C28H30N2O6S/c1-3-24-17-30(37(34,35)27-7-5-4-6-26(27)36-24)16-22-14-21(9-8-19(22)2)25(15-28(32)33)20-10-12-23(13-11-20)29-18-31/h4-14,18,24-25H,3,15-17H2,1-2H3,(H,29,31)(H,32,33)	JHJVCRPWCAVTKW-UHFFFAOYSA-N	304937	US10144731, Example 241::3-(4-Carbamoyl-2-methylphenyl)-3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)propanoic acid	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304937	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304937&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			122660649	381753640					C06049		1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584624	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc(cc2)C(C)=O)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C28H29NO6S/c1-18-8-9-23(25(15-28(31)32)22-12-10-21(11-13-22)20(3)30)14-24(18)17-29-16-19(2)35-26-6-4-5-7-27(26)36(29,33)34/h4-14,19,25H,15-17H2,1-3H3,(H,31,32)	FUOCXMOMJRLFAS-UHFFFAOYSA-N	304938	US10144731, Example 242::3-(4-Acetylphenyl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304938	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304938&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170225	381753641							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584625	CCNC(=O)c1cc(ccc1C(O)=O)C(CC(O)=O)c1ccc(C)c(CN2C[C@@H](C)Oc3ccccc3S2(=O)=O)c1 |r|	InChI=1S/C30H32N2O8S/c1-4-31-29(35)25-14-21(11-12-23(25)30(36)37)24(15-28(33)34)20-10-9-18(2)22(13-20)17-32-16-19(3)40-26-7-5-6-8-27(26)41(32,38)39/h5-14,19,24H,4,15-17H2,1-3H3,(H,31,35)(H,33,34)(H,36,37)	MQSQNZXYSKOZIF-UHFFFAOYSA-N	304939	US10144731, Example 243::4-(2-Carboxy-1-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)ethyl)-2-(ethylcarbamoyl)benzoic acid; 5-(2-carboxy-1-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)ethyl)-2-(ethylcarbamoyl)benzoic acid (unknown ratio mixture)	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304939	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304939&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170347	381753642							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584626	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(CCNC(=O)OC(C)(C)C)nnc3c2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C33H39N5O7S/c1-21-10-11-23(16-25(21)20-37-19-22(2)44-29-8-6-7-9-30(29)46(37,42)43)26(18-31(39)40)24-12-13-28-27(17-24)35-36-38(28)15-14-34-32(41)45-33(3,4)5/h6-13,16-17,22,26H,14-15,18-20H2,1-5H3,(H,34,41)(H,39,40)	DXTPGWQAXLDDNL-UHFFFAOYSA-N	304940	US10144731, Example 244::3-(1-(2-((Tert-butoxycarbonyl)amino)ethyl)-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304940	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304940&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170224	381753643							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584627	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3CCC(=O)c3c2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C29H29NO6S/c1-18-7-8-21(24(15-29(32)33)22-10-9-20-11-12-26(31)25(20)14-22)13-23(18)17-30-16-19(2)36-27-5-3-4-6-28(27)37(30,34)35/h3-10,13-14,19,24H,11-12,15-17H2,1-2H3,(H,32,33)	UMAXIEJXCLMIAQ-UHFFFAOYSA-N	304941	US10144731, Example 245::3-(4-Methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)-3-(3-oxo-2,3-dihydro-1H-inden-5-yl)propanoic acid	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304941	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304941&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			122653291	381753644							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584628	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(CCCNC(=O)OC(C)(C)C)nnc3c2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C34H41N5O7S/c1-22-11-12-24(17-26(22)21-38-20-23(2)45-30-9-6-7-10-31(30)47(38,43)44)27(19-32(40)41)25-13-14-29-28(18-25)36-37-39(29)16-8-15-35-33(42)46-34(3,4)5/h6-7,9-14,17-18,23,27H,8,15-16,19-21H2,1-5H3,(H,35,42)(H,40,41)	YYIAYPKFORFCIY-UHFFFAOYSA-N	304942	US10144731, Example 246::3-(1-(3-((Tert-butoxycarbonyl)amino)propyl)-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304942	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304942&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170026	381753645							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584629	CSc1ccc(cc1)C(CC(O)=O)c1ccc(C)c(CN2C[C@@H](C)Oc3ccccc3S2(=O)=O)c1 |r|	InChI=1S/C27H29NO5S2/c1-18-8-9-21(24(15-27(29)30)20-10-12-23(34-3)13-11-20)14-22(18)17-28-16-19(2)33-25-6-4-5-7-26(25)35(28,31)32/h4-14,19,24H,15-17H2,1-3H3,(H,29,30)	QLPRJBMOBGFKTF-UHFFFAOYSA-N	304943	US10144731, Example 247::3-(4-Methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)-3-(4-(methylthio)phenyl)propanoic acid	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304943	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304943&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170951	381753646							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584630	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3C(=O)CCc3c2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C29H29NO6S/c1-18-7-8-21(25(15-29(32)33)22-9-11-24-20(13-22)10-12-26(24)31)14-23(18)17-30-16-19(2)36-27-5-3-4-6-28(27)37(30,34)35/h3-9,11,13-14,19,25H,10,12,15-17H2,1-2H3,(H,32,33)	UAQJDVHSQSTTOA-UHFFFAOYSA-N	304944	US10144731, Example 248::3-(4-Methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)-3-(1-oxo-2,3-dihydro-1H-inden-5-yl)propanoic acid	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304944	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304944&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170385	381753647							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584631	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc(F)cc2F)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C27H27F2NO5S/c1-3-21-16-30(36(33,34)26-7-5-4-6-25(26)35-21)15-19-12-18(9-8-17(19)2)23(14-27(31)32)22-11-10-20(28)13-24(22)29/h4-13,21,23H,3,14-16H2,1-2H3,(H,31,32)	MBIUESTWBZOSJW-UHFFFAOYSA-N	304945	US10144731, Example 249::3-(2,4-Difluorophenyl)-3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)propanoic acid	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304945	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304945&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118169939	381753648							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584632	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc(F)cc2F)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C26H25F2NO5S/c1-16-7-8-18(22(13-26(30)31)21-10-9-20(27)12-23(21)28)11-19(16)15-29-14-17(2)34-24-5-3-4-6-25(24)35(29,32)33/h3-12,17,22H,13-15H2,1-2H3,(H,30,31)	CYOBABBSHLGCGY-UHFFFAOYSA-N	304946	US10144731, Example 250::3-(2,4-Difluorophenyl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304946	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304946&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170719	381753649							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584633	COC(=O)CC(c1ccc(C)c(CN2C[C@@H](C)Oc3ccccc3S2(=O)=O)c1)c1ccc2n(C)nnc2c1 |r|	InChI=1S/C28H30N4O5S/c1-18-9-10-20(23(15-28(33)36-4)21-11-12-25-24(14-21)29-30-31(25)3)13-22(18)17-32-16-19(2)37-26-7-5-6-8-27(26)38(32,34)35/h5-14,19,23H,15-17H2,1-4H3	QZJNRQLKRKBRDX-UHFFFAOYSA-N	304947	US10144731, Example 251::Methyl 3-(1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoate	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304947	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304947&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			122653233	381753650							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584634	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc(cc2C)C(C)=O)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C29H31NO6S/c1-18-9-10-23(26(15-29(32)33)25-12-11-22(21(4)31)13-19(25)2)14-24(18)17-30-16-20(3)36-27-7-5-6-8-28(27)37(30,34)35/h5-14,20,26H,15-17H2,1-4H3,(H,32,33)	HSZYGMSIEGUWCB-UHFFFAOYSA-N	304948	US10144731, Example 252::3-(4-Acetyl-2-methylphenyl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304948	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304948&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118169978	381753651							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584635	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc(cc2C)C(C)=O)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C30H33NO6S/c1-5-25-18-31(38(35,36)29-9-7-6-8-28(29)37-25)17-24-15-23(11-10-19(24)2)27(16-30(33)34)26-13-12-22(21(4)32)14-20(26)3/h6-15,25,27H,5,16-18H2,1-4H3,(H,33,34)	FMVABZINBVIDQL-UHFFFAOYSA-N	304949	US10144731, Example 253::3-(4-Acetyl-2-methylphenyl)-3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)propanoic acid	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304949	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304949&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170038	381753652							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584636	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3C(=O)N(C)Cc3c2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C29H30N2O6S/c1-18-8-9-20(25(14-28(32)33)21-10-11-24-23(13-21)16-30(3)29(24)34)12-22(18)17-31-15-19(2)37-26-6-4-5-7-27(26)38(31,35)36/h4-13,19,25H,14-17H2,1-3H3,(H,32,33)	WWEHRWVLQHYSHD-UHFFFAOYSA-N	304950	US10144731, Example 254::3-(2-Methyl-1-oxoisoindolin-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304950	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304950&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170253	381753653							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584637	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3C(=O)C(C)(C)Cc3c2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C31H33NO6S/c1-19-9-10-21(26(15-29(33)34)22-11-12-25-23(13-22)16-31(3,4)30(25)35)14-24(19)18-32-17-20(2)38-27-7-5-6-8-28(27)39(32,36)37/h5-14,20,26H,15-18H2,1-4H3,(H,33,34)	FOIMBMUQCPZLMT-UHFFFAOYSA-N	304951	US10144731, Example 255::3-(2,2-Dimethyl-1-oxo-2,3-dihydro-1H-inden-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304951	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304951&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170295	381753654							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584638	CCN1C(=O)c2ccc(cc2C1=O)C(CC(O)=O)c1ccc(C)c(CN2C[C@@H](C)Oc3ccccc3S2(=O)=O)c1 |r|	InChI=1S/C30H30N2O7S/c1-4-32-29(35)23-12-11-21(14-25(23)30(32)36)24(15-28(33)34)20-10-9-18(2)22(13-20)17-31-16-19(3)39-26-7-5-6-8-27(26)40(31,37)38/h5-14,19,24H,4,15-17H2,1-3H3,(H,33,34)	UHGIIBFHIWYASA-UHFFFAOYSA-N	304952	US10144731, Example 256::3-(2-Ethyl-1,3-dioxoisoindolin-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304952	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304952&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170633	381753655							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584639	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3C(=O)N(CC)C(=O)c3c2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C31H32N2O7S/c1-4-23-18-32(41(38,39)28-9-7-6-8-27(28)40-23)17-22-14-20(11-10-19(22)3)25(16-29(34)35)21-12-13-24-26(15-21)31(37)33(5-2)30(24)36/h6-15,23,25H,4-5,16-18H2,1-3H3,(H,34,35)	CPMDCWKBUNBNCQ-UHFFFAOYSA-N	304953	US10144731, Example 257::3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-3-(2-ethyl-1,3-dioxoisoindolin-5-yl)propanoic acid	Nuclear factor erythroid 2-related factor 2	Human				 55					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304953	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304953&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170041	381753656							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584640	C[C@@H]1CN(C2CCc3ccc(cc23)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C29H30N4O5S/c1-17-16-33(39(36,37)27-7-5-4-6-26(27)38-17)24-12-10-19-8-9-20(14-23(19)24)22(15-28(34)35)21-11-13-25-29(18(21)2)30-31-32(25)3/h4-9,11,13-14,17,22,24H,10,12,15-16H2,1-3H3,(H,34,35)	CXZPRQFTYURHET-UHFFFAOYSA-N	304954	US10144731, Example 258::3-(1,4-Dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)-2,3-dihydro-1H-inden-5-yl)propanoic acid	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304954	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304954&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118169832	381753657							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584641	CC[C@@H]1CN(C2CCc3ccc(cc23)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C30H32N4O5S/c1-4-21-17-34(40(37,38)28-8-6-5-7-27(28)39-21)25-13-11-19-9-10-20(15-24(19)25)23(16-29(35)36)22-12-14-26-30(18(22)2)31-32-33(26)3/h5-10,12,14-15,21,23,25H,4,11,13,16-17H2,1-3H3,(H,35,36)	YFUKZAAYGLSBNI-UHFFFAOYSA-N	304955	US10144731, Example 259::3-(1,4-Dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)-2,3-dihydro-1H-inden-5-yl)propanoic acid	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304955	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304955&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170283	381753658							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584642	CC1CN(C2CCc3ccc(cc23)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc2C1	InChI=1S/C30H32N4O4S/c1-18-14-22-6-4-5-7-28(22)39(37,38)34(17-18)26-12-10-20-8-9-21(15-25(20)26)24(16-29(35)36)23-11-13-27-30(19(23)2)31-32-33(27)3/h4-9,11,13,15,18,24,26H,10,12,14,16-17H2,1-3H3,(H,35,36)	FGIULSJBSODLAD-UHFFFAOYSA-N	304956	US10144731, Example 260::3-(1,4-Dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-(4-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2]thiazepin-2(3H)-yl)-2,3-dihydro-1H-inden-5-yl)propanoic acid	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304956	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304956&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170167	381753659							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584643	CC1CN(C2CCc3ccc(cc23)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2cc(Br)ccc2C1	InChI=1S/C30H31BrN4O4S/c1-17-12-21-6-8-22(31)14-28(21)40(38,39)35(16-17)26-10-7-19-4-5-20(13-25(19)26)24(15-29(36)37)23-9-11-27-30(18(23)2)32-33-34(27)3/h4-6,8-9,11,13-14,17,24,26H,7,10,12,15-16H2,1-3H3,(H,36,37)	ZHMFLGKJTRLMKZ-UHFFFAOYSA-N	304957	3-(3-(8-Bromo-4-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2]thiazepin-2(3H)-yl)-2,3-dihydro-1H-inden-5-yl)-3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 262::US10144731, Example 261	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304957	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304957&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170640	381753660							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584644	CC1CN(C2CCc3ccc(cc23)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2cc(Br)ccc2C1	InChI=1S/C30H31BrN4O4S/c1-17-12-21-6-8-22(31)14-28(21)40(38,39)35(16-17)26-10-7-19-4-5-20(13-25(19)26)24(15-29(36)37)23-9-11-27-30(18(23)2)32-33-34(27)3/h4-6,8-9,11,13-14,17,24,26H,7,10,12,15-16H2,1-3H3,(H,36,37)	ZHMFLGKJTRLMKZ-UHFFFAOYSA-N	304957	3-(3-(8-Bromo-4-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2]thiazepin-2(3H)-yl)-2,3-dihydro-1H-inden-5-yl)-3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 262::US10144731, Example 261	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304957	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304957&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170640	381753660							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584645	Cc1c2ccc3n(CCCCCC4CN(C5CCc6ccc(cc56)C2CC(O)=O)S(=O)(=O)c2ccccc2O4)nnc13	InChI=1S/C32H34N4O5S/c1-20-24-13-15-28-32(20)33-34-35(28)16-6-2-3-7-23-19-36(42(39,40)30-9-5-4-8-29(30)41-23)27-14-12-21-10-11-22(17-26(21)27)25(24)18-31(37)38/h4-5,8-11,13,15,17,23,25,27H,2-3,6-7,12,14,16,18-19H2,1H3,(H,37,38)	VMBGZHLUBXWENN-UHFFFAOYSA-N	304959	2-{34-Methyl-3,3-dioxo-10-oxa-3&#955;6-thia-2,17,18,19-tetraazaheptacyclo[24.5.2.12,11.120,24.04,9.017,21.029,32]pentatriaconta-4(9),5,7,18,20(34),21,23,26(33),27,29(32)-decaen-25-yl}acetic acid::BDBM304960::US10144731, Example 263	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304959	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304959&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			122660654	381753661							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584646	Cc1c2ccc3n(CCCCCC4CN(C5CCc6ccc(cc56)C2CC(O)=O)S(=O)(=O)c2ccccc2O4)nnc13	InChI=1S/C32H34N4O5S/c1-20-24-13-15-28-32(20)33-34-35(28)16-6-2-3-7-23-19-36(42(39,40)30-9-5-4-8-29(30)41-23)27-14-12-21-10-11-22(17-26(21)27)25(24)18-31(37)38/h4-5,8-11,13,15,17,23,25,27H,2-3,6-7,12,14,16,18-19H2,1H3,(H,37,38)	VMBGZHLUBXWENN-UHFFFAOYSA-N	304959	2-{34-Methyl-3,3-dioxo-10-oxa-3&#955;6-thia-2,17,18,19-tetraazaheptacyclo[24.5.2.12,11.120,24.04,9.017,21.029,32]pentatriaconta-4(9),5,7,18,20(34),21,23,26(33),27,29(32)-decaen-25-yl}acetic acid::BDBM304960::US10144731, Example 263	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304959	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304959&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			122660654	381753661							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584647	Cc1ccc2cc1CN1CC(CCCCCn3nnc4c(C)c(ccc34)C2CC(O)=O)Oc2ccccc2S1(=O)=O	InChI=1S/C31H34N4O5S/c1-20-11-12-22-16-23(20)18-34-19-24(40-28-9-5-6-10-29(28)41(34,38)39)8-4-3-7-15-35-27-14-13-25(26(22)17-30(36)37)21(2)31(27)32-33-35/h5-6,9-14,16,24,26H,3-4,7-8,15,17-19H2,1-2H3,(H,36,37)	FEAUSMUUPSCPKO-UHFFFAOYSA-N	304961	US10144731, Example 265::2-{4,32-Dimethyl-30,30-dioxo-23-oxa-30&#955;6-thia-1,14,15,16-tetraazahexacyclo[20.8.1.13,7.19,13.012,16.024,29]tritriaconta-3,5,7(33),9,11,13(32),14,24(29),25,27-decaen-8-yl}acetic acid	Nuclear factor erythroid 2-related factor 2	Human				 550					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304961	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304961&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			122660656	381753663							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584648	Cc1ccc2cc1CN1CC(CCC=CCn3nnc4c(C)c(ccc34)C2CC(O)=O)Oc2ccccc2S1(=O)=O |w:13.13|	InChI=1S/C31H32N4O5S/c1-20-11-12-22-16-23(20)18-34-19-24(40-28-9-5-6-10-29(28)41(34,38)39)8-4-3-7-15-35-27-14-13-25(26(22)17-30(36)37)21(2)31(27)32-33-35/h3,5-7,9-14,16,24,26H,4,8,15,17-19H2,1-2H3,(H,36,37)	UOLHWQPOVKEGJH-UHFFFAOYSA-N	304962	US10144731, Example 266::2-{4,32-Dimethyl-30,30-dioxo-23-oxa-30&#955;6-thia-1,14,15,16-tetraazahexacyclo[20.8.1.13,7.19,13.012,16.024,29]tritriaconta-3,5,7(33),9,11,13(32),14,18,24(29),25,27-undecaen-8-yl}acetic acid	Nuclear factor erythroid 2-related factor 2	Human				 5500					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304962	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304962&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			137554661	381753664							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584649	Cc1c2ccc3n(CC=CCCC4CN(C5CCc6ccc(cc56)C2CC(O)=O)S(=O)(=O)c2ccccc2O4)nnc13 |w:9.9|	InChI=1S/C32H32N4O5S/c1-20-24-13-15-28-32(20)33-34-35(28)16-6-2-3-7-23-19-36(42(39,40)30-9-5-4-8-29(30)41-23)27-14-12-21-10-11-22(17-26(21)27)25(24)18-31(37)38/h2,4-6,8-11,13,15,17,23,25,27H,3,7,12,14,16,18-19H2,1H3,(H,37,38)	HHKMNRGIWAHEIR-UHFFFAOYSA-N	304963	US10144731, Example 267::2-{34-Methyl-3,3-dioxo-10-oxa-3&#955;6-thia-2,17,18,19-tetraazaheptacyclo[24.5.2.12,11.120,24.04,9.017,21.029,32]pentatriaconta-4(9), 5,7,14,18,20(34),21,23,26(33),27,29(32)-undecaen-25-yl}acetic acid	Nuclear factor erythroid 2-related factor 2	Human				 55000					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304963	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304963&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			137554662	381753665							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584650	CC[C@@H]1CN(Cc2cc(ccc2C)C(c2ccc3n(C)nnc3c2C)C(C)(C)C(O)=O)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C31H36N4O5S/c1-7-23-18-35(41(38,39)27-11-9-8-10-26(27)40-23)17-22-16-21(13-12-19(22)2)28(31(4,5)30(36)37)24-14-15-25-29(20(24)3)32-33-34(25)6/h8-16,23,28H,7,17-18H2,1-6H3,(H,36,37)	JXCOERQLGLXVIK-UHFFFAOYSA-N	304964	US10144731, Example 268::3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-2,2-dimethylpropanoic acid	Nuclear factor erythroid 2-related factor 2	Human				 55					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304964	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304964&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118169900	381753666							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584651	CC[C@@H]1CN(Cc2cc(ccc2C)[C@@H](c2ccc3n(C)nnc3c2C)C(C)(C)C(O)=O)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C31H36N4O5S/c1-7-23-18-35(41(38,39)27-11-9-8-10-26(27)40-23)17-22-16-21(13-12-19(22)2)28(31(4,5)30(36)37)24-14-15-25-29(20(24)3)32-33-34(25)6/h8-16,23,28H,7,17-18H2,1-6H3,(H,36,37)	JXCOERQLGLXVIK-UHFFFAOYSA-N	304965	US10144731, Example 269::(S)-3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-2,2-dimethylpropanoic acid	Nuclear factor erythroid 2-related factor 2	Human				 55					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304965	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304965&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170079	381753667							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584652	CC[C@@H]1CN(Cc2cc(ccc2C)[C@H](c2ccc3n(C)nnc3c2C)C(C)(C)C(O)=O)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C31H36N4O5S/c1-7-23-18-35(41(38,39)27-11-9-8-10-26(27)40-23)17-22-16-21(13-12-19(22)2)28(31(4,5)30(36)37)24-14-15-25-29(20(24)3)32-33-34(25)6/h8-16,23,28H,7,17-18H2,1-6H3,(H,36,37)	JXCOERQLGLXVIK-UHFFFAOYSA-N	304966	US10144731, Example 270::(R)-3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-2,2-dimethylpropanoic acid	Nuclear factor erythroid 2-related factor 2	Human				 55					US Patent		10.7270/Q25X2C17		aid1796184	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304966	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006637&target=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304966&enzyme=Nuclear+factor+erythroid+2-related+factor+2&column=ki&startPg=0&Increment=50&submit=Search			118170505	381753668							1	MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN	7X5F,7X5E,7O7B,2LZ1,3WN7,2DYH,4IFL,2FLU	Nuclear factor erythroid 2-related factor 2	NF2L2_HUMAN	Q16236	B2RBU2 B4E338 E9PGJ7 Q53RW6 Q59HH2 Q96F71																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584653	COc1cc(cc2nnn(C)c12)C(CC(O)=O)c1ccc(C)c(CN2CCN(C)c3ccccc3S2(=O)=O)c1	InChI=1S/C28H31N5O5S/c1-18-9-10-19(22(16-27(34)35)20-14-23-28(25(15-20)38-4)32(3)30-29-23)13-21(18)17-33-12-11-31(2)24-7-5-6-8-26(24)39(33,36)37/h5-10,13-15,22H,11-12,16-17H2,1-4H3,(H,34,35)	IJHWQGAWCBWPSG-UHFFFAOYSA-N	304414	3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoic acid::US10144731, Example 1	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304414	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304414&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118188783	381753127							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584654	CN1CCN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc12	InChI=1S/C28H31N5O4S/c1-18-9-10-20(23(16-27(34)35)22-11-12-25-28(19(22)2)29-30-32(25)4)15-21(18)17-33-14-13-31(3)24-7-5-6-8-26(24)38(33,36)37/h5-12,15,23H,13-14,16-17H2,1-4H3,(H,34,35)	FGBWUXHBTBMVKE-UHFFFAOYSA-N	304443	3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoic acid::US10144731, Example 2	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304443	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304443&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170398	381753155							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584655	Cc1ccc(cc1CN1CCOc2ccccc2S1(=O)=O)C(CC(O)=O)c1ccc2n(C)nnc2c1C	InChI=1S/C27H28N4O5S/c1-17-8-9-19(22(15-26(32)33)21-10-11-23-27(18(21)2)28-29-30(23)3)14-20(17)16-31-12-13-36-24-6-4-5-7-25(24)37(31,34)35/h4-11,14,22H,12-13,15-16H2,1-3H3,(H,32,33)	NLWYXGJADHXGKC-UHFFFAOYSA-N	304719	3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-((1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)propanoic acid::US10144731, Example 3	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304719	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304719&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118169953	381753423							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584656	COc1cc(cc2nnn(C)c12)C(CC(O)=O)c1ccc(C)c(CN2C(C)COc3ccccc3S2(=O)=O)c1	InChI=1S/C28H30N4O6S/c1-17-9-10-19(22(14-27(33)34)20-12-23-28(25(13-20)37-4)31(3)30-29-23)11-21(17)15-32-18(2)16-38-24-7-5-6-8-26(24)39(32,35)36/h5-13,18,22H,14-16H2,1-4H3,(H,33,34)	OSZJZIMGVAMBKO-UHFFFAOYSA-N	304720	3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((3-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 4	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304720	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304720&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			122653376	381753424							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584657	COc1cc(cc2nnn(C)c12)C(CC(O)=O)c1ccc(C)c(CN2CC(C)Oc3ccccc3S2(=O)=O)c1	InChI=1S/C28H30N4O6S/c1-17-9-10-19(22(14-27(33)34)20-12-23-28(25(13-20)37-4)31(3)30-29-23)11-21(17)16-32-15-18(2)38-24-7-5-6-8-26(24)39(32,35)36/h5-13,18,22H,14-16H2,1-4H3,(H,33,34)	ZDNGJXBUEQNFBQ-UHFFFAOYSA-N	304721	3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 5	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304721	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304721&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			122653346	381753425							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584658	COc1cc(cc2nnn(C)c12)C(CC(O)=O)c1ccc(C)c(CN2CCOc3ncccc3S2(=O)=O)c1	InChI=1S/C26H27N5O6S/c1-16-6-7-17(11-19(16)15-31-9-10-37-26-23(38(31,34)35)5-4-8-27-26)20(14-24(32)33)18-12-21-25(22(13-18)36-3)30(2)29-28-21/h4-8,11-13,20H,9-10,14-15H2,1-3H3,(H,32,33)	IGSXVTNHKWFQHY-UHFFFAOYSA-N	304722	3-(3-((1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 6	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304722	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304722&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118169887	381753426							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584659	COc1cc(cc2nnn(C)c12)C(CC(O)=O)c1ccc(C)c(CN(CCO)S(=O)(=O)c2cccnc2OC)c1	InChI=1S/C27H31N5O7S/c1-17-7-8-18(21(15-25(34)35)19-13-22-26(23(14-19)38-3)31(2)30-29-22)12-20(17)16-32(10-11-33)40(36,37)24-6-5-9-28-27(24)39-4/h5-9,12-14,21,33H,10-11,15-16H2,1-4H3,(H,34,35)	AEWQYTMJBRTVCM-UHFFFAOYSA-N	304967	US10144731, Example 7::3-(3-((N-(2-hydroxyethyl)-2-methoxypyridine-3-sulfonamido)methyl)-4-methylphenyl)-3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 5500							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304967	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304967&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170747	381753669							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584660	Cc1ccc(cc1CN1CCOc2ncccc2S1(=O)=O)C(CC(O)=O)c1ccc2n(C)nnc2c1C	InChI=1S/C26H27N5O5S/c1-16-6-7-18(21(14-24(32)33)20-8-9-22-25(17(20)2)28-29-30(22)3)13-19(16)15-31-11-12-36-26-23(37(31,34)35)5-4-10-27-26/h4-10,13,21H,11-12,14-15H2,1-3H3,(H,32,33)	TUUFGOFVAYQRAJ-UHFFFAOYSA-N	304723	3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-((1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)propanoic acid::US10144731, Example 8	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304723	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304723&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170159	381753427							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584661	COc1ncccc1S(=O)(=O)N(CCO)Cc1cc(ccc1C)C(CC(O)=O)c1ccc2n(C)nnc2c1C	InChI=1S/C27H31N5O6S/c1-17-7-8-19(22(15-25(34)35)21-9-10-23-26(18(21)2)29-30-31(23)3)14-20(17)16-32(12-13-33)39(36,37)24-6-5-11-28-27(24)38-4/h5-11,14,22,33H,12-13,15-16H2,1-4H3,(H,34,35)	SFUSXTAJJNOGFY-UHFFFAOYSA-N	304968	US10144731, Example 9::3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-((N-(2-hydroxyethyl)-2-methoxypyridine-3-sulfonamido)methyl)-4-methylphenyl)propanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 5500							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304968	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304968&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170033	381753670							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584662	CC1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc2O1	InChI=1S/C28H30N4O5S/c1-17-9-10-20(23(14-27(33)34)22-11-12-24-28(19(22)3)29-30-31(24)4)13-21(17)16-32-15-18(2)37-25-7-5-6-8-26(25)38(32,35)36/h5-13,18,23H,14-16H2,1-4H3,(H,33,34)	HKVJGRGOCHBUFK-UHFFFAOYSA-N	304724	3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 10	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304724	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304724&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170735	381753428							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584663	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C28H30N4O5S/c1-17-9-10-20(23(14-27(33)34)22-11-12-24-28(19(22)3)29-30-31(24)4)13-21(17)16-32-15-18(2)37-25-7-5-6-8-26(25)38(32,35)36/h5-13,18,23H,14-16H2,1-4H3,(H,33,34)	HKVJGRGOCHBUFK-UHFFFAOYSA-N	304725	3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 11	Kelch-like ECH-associated protein 1 [321-609]	Human		<10							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304725	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304725&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			91810334	381753429							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584664	C[C@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C28H30N4O5S/c1-17-9-10-20(23(14-27(33)34)22-11-12-24-28(19(22)3)29-30-31(24)4)13-21(17)16-32-15-18(2)37-25-7-5-6-8-26(25)38(32,35)36/h5-13,18,23H,14-16H2,1-4H3,(H,33,34)	HKVJGRGOCHBUFK-UHFFFAOYSA-N	304726	3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((S)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 12	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304726	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304726&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118169972	381753430							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584665	COc1cc(cc2nnn(C)c12)C(CC(O)=O)c1ccc(C)c(CN2C[C@@H](C)Oc3ccccc3S2(=O)=O)c1 |r|	InChI=1S/C28H30N4O6S/c1-17-9-10-19(22(14-27(33)34)20-12-23-28(25(13-20)37-4)31(3)30-29-23)11-21(17)16-32-15-18(2)38-24-7-5-6-8-26(24)39(32,35)36/h5-13,18,22H,14-16H2,1-4H3,(H,33,34)	ZDNGJXBUEQNFBQ-UHFFFAOYSA-N	304727	3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 13	Kelch-like ECH-associated protein 1 [321-609]	Human		<10							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304727	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304727&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170387	381753431							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584666	COc1cc(cc2nnn(C)c12)C(CC(O)=O)c1ccc(C)c(CN2C[C@H](C)Oc3ccccc3S2(=O)=O)c1 |r|	InChI=1S/C28H30N4O6S/c1-17-9-10-19(22(14-27(33)34)20-12-23-28(25(13-20)37-4)31(3)30-29-23)11-21(17)16-32-15-18(2)38-24-7-5-6-8-26(24)39(32,35)36/h5-13,18,22H,14-16H2,1-4H3,(H,33,34)	ZDNGJXBUEQNFBQ-UHFFFAOYSA-N	304728	3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((S)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 14	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304728	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304728&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170010	381753432							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584667	CCN1CCN(Cc2cc(ccc2C)C(CC(O)=O)c2cc(OC)c3n(C)nnc3c2)S(=O)(=O)c2ccccc12	InChI=1S/C29H33N5O5S/c1-5-33-12-13-34(40(37,38)27-9-7-6-8-25(27)33)18-22-14-20(11-10-19(22)2)23(17-28(35)36)21-15-24-29(26(16-21)39-4)32(3)31-30-24/h6-11,14-16,23H,5,12-13,17-18H2,1-4H3,(H,35,36)	ORCXIWDDBGRHOT-UHFFFAOYSA-N	304729	3-(3-((5-ethyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)-4-methylphenyl)-3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 15	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304729	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304729&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			122653399	381753433							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584668	CCN1CCN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc12	InChI=1S/C29H33N5O4S/c1-5-33-14-15-34(39(37,38)27-9-7-6-8-25(27)33)18-22-16-21(11-10-19(22)2)24(17-28(35)36)23-12-13-26-29(20(23)3)30-31-32(26)4/h6-13,16,24H,5,14-15,17-18H2,1-4H3,(H,35,36)	GRYNUYVNLFSDGO-UHFFFAOYSA-N	304730	3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-((5-ethyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)-4-methylphenyl)propanoic acid::US10144731, Example 16	Kelch-like ECH-associated protein 1 [321-609]	Human		<10							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304730	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304730&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170188	381753434							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584669	COc1cc(cc2nnn(C)c12)C(CC(O)=O)c1ccc(C)c(CN2C[C@H](C)Oc3ncccc3S2(=O)=O)c1 |r|	InChI=1S/C27H29N5O6S/c1-16-7-8-18(21(13-25(33)34)19-11-22-26(23(12-19)37-4)31(3)30-29-22)10-20(16)15-32-14-17(2)38-27-24(39(32,35)36)6-5-9-28-27/h5-12,17,21H,13-15H2,1-4H3,(H,33,34)	CJTSGSQAUXSAER-UHFFFAOYSA-N	304731	3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((S)-4-methyl-1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 17	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304731	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304731&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170365	381753435							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584670	COc1cc(cc2nnn(C)c12)C(CC(O)=O)c1ccc(C)c(CN2C[C@@H](C)Oc3ncccc3S2(=O)=O)c1 |r|	InChI=1S/C27H29N5O6S/c1-16-7-8-18(21(13-25(33)34)19-11-22-26(23(12-19)37-4)31(3)30-29-22)10-20(16)15-32-14-17(2)38-27-24(39(32,35)36)6-5-9-28-27/h5-12,17,21H,13-15H2,1-4H3,(H,33,34)	CJTSGSQAUXSAER-UHFFFAOYSA-N	304732	3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 18	Kelch-like ECH-associated protein 1 [321-609]	Human		<10							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304732	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304732&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170459	381753436							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584671	C[C@@H]1CN(Cc2cc(ccc2C)[C@H](CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C28H30N4O5S/c1-17-9-10-20(23(14-27(33)34)22-11-12-24-28(19(22)3)29-30-31(24)4)13-21(17)16-32-15-18(2)37-25-7-5-6-8-26(25)38(32,35)36/h5-13,18,23H,14-16H2,1-4H3,(H,33,34)	HKVJGRGOCHBUFK-UHFFFAOYSA-N	304733	(S)-3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 19	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304733	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304733&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170106	381753437							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584672	C[C@@H]1CN(Cc2cc(ccc2C)[C@@H](CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C28H30N4O5S/c1-17-9-10-20(23(14-27(33)34)22-11-12-24-28(19(22)3)29-30-31(24)4)13-21(17)16-32-15-18(2)37-25-7-5-6-8-26(25)38(32,35)36/h5-13,18,23H,14-16H2,1-4H3,(H,33,34)	HKVJGRGOCHBUFK-UHFFFAOYSA-N	304734	(R)-3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 20	Kelch-like ECH-associated protein 1 [321-609]	Human		<10							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304734	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304734&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			122653584	381753438							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584673	CCC1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc2O1	InChI=1S/C29H32N4O5S/c1-5-22-17-33(39(36,37)27-9-7-6-8-26(27)38-22)16-21-14-20(11-10-18(21)2)24(15-28(34)35)23-12-13-25-29(19(23)3)30-31-32(25)4/h6-14,22,24H,5,15-17H2,1-4H3,(H,34,35)	PSAYWSGFKCURFC-UHFFFAOYSA-N	304735	3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-((4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)propanoic acid::US10144731, Example 21	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304735	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304735&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118169975	381753439							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584674	CCC1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2cccnc2O1	InChI=1S/C28H31N5O5S/c1-5-21-16-33(39(36,37)25-7-6-12-29-28(25)38-21)15-20-13-19(9-8-17(20)2)23(14-26(34)35)22-10-11-24-27(18(22)3)30-31-32(24)4/h6-13,21,23H,5,14-16H2,1-4H3,(H,34,35)	CYAWSFDLOYOCFO-UHFFFAOYSA-N	304736	3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-((4-ethyl-1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)propanoic acid::US10144731, Example 22	Kelch-like ECH-associated protein 1 [321-609]	Human		<10							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304736	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304736&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170902	381753440							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584675	CCC1CN(Cc2cc(ccc2C)C(CC(O)=O)c2cc(OC)c3n(C)nnc3c2)S(=O)(=O)c2ccccc2O1	InChI=1S/C29H32N4O6S/c1-5-22-17-33(40(36,37)27-9-7-6-8-25(27)39-22)16-21-12-19(11-10-18(21)2)23(15-28(34)35)20-13-24-29(26(14-20)38-4)32(3)31-30-24/h6-14,22-23H,5,15-17H2,1-4H3,(H,34,35)	CGULIBNLQTVXJS-UHFFFAOYSA-N	304737	3-(3-((4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 23	Kelch-like ECH-associated protein 1 [321-609]	Human		<10							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304737	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304737&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170304	381753441							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584676	CCC1CN(Cc2cc(ccc2C)C(CC(O)=O)c2cc(OC)c3n(C)nnc3c2)S(=O)(=O)c2cccnc2O1	InChI=1S/C28H31N5O6S/c1-5-21-16-33(40(36,37)25-7-6-10-29-28(25)39-21)15-20-11-18(9-8-17(20)2)22(14-26(34)35)19-12-23-27(24(13-19)38-4)32(3)31-30-23/h6-13,21-22H,5,14-16H2,1-4H3,(H,34,35)	JJZPWGQPPUTFLQ-UHFFFAOYSA-N	304738	3-(3-((4-ethyl-1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 24	Kelch-like ECH-associated protein 1 [321-609]	Human		<10							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304738	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304738&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170830	381753442							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584677	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2cccnc2O1 |r|	InChI=1S/C27H29N5O5S/c1-16-7-8-19(22(13-25(33)34)21-9-10-23-26(18(21)3)29-30-31(23)4)12-20(16)15-32-14-17(2)37-27-24(38(32,35)36)6-5-11-28-27/h5-12,17,22H,13-15H2,1-4H3,(H,33,34)	DPUCGDIRADRVPW-UHFFFAOYSA-N	304739	3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 25	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304739	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304739&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170257	381753443							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584678	CCN1CCN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2cccnc12	InChI=1S/C28H32N6O4S/c1-5-33-13-14-34(39(37,38)25-7-6-12-29-28(25)33)17-21-15-20(9-8-18(21)2)23(16-26(35)36)22-10-11-24-27(19(22)3)30-31-32(24)4/h6-12,15,23H,5,13-14,16-17H2,1-4H3,(H,35,36)	IQURXROILDLSHX-UHFFFAOYSA-N	304740	3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-((5-ethyl-1,1-dioxido-4,5-dihydropyrido[2,3-f][1,2,5]thiadiazepin-2(3H)-yl)methyl)-4-methylphenyl)propanoic acid::US10144731, Example 26	Kelch-like ECH-associated protein 1 [321-609]	Human		<10							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304740	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304740&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118169906	381753444							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584679	CCN1CCN(Cc2cc(ccc2C)C(CC(O)=O)c2cc(OC)c3n(C)nnc3c2)S(=O)(=O)c2cccnc12	InChI=1S/C28H32N6O5S/c1-5-33-11-12-34(40(37,38)25-7-6-10-29-28(25)33)17-21-13-19(9-8-18(21)2)22(16-26(35)36)20-14-23-27(24(15-20)39-4)32(3)31-30-23/h6-10,13-15,22H,5,11-12,16-17H2,1-4H3,(H,35,36)	JBXYFQNBDRELKW-UHFFFAOYSA-N	304741	3-(3-((5-ethyl-1,1-dioxido-4,5-dihydropyrido[2,3-f][1,2,5]thiadiazepin-2(3H)-yl)methyl)-4-methylphenyl)-3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 27	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304741	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304741&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170435	381753445							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584680	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2)S(=O)(=O)c2cccnc2O1 |r|	InChI=1S/C26H27N5O5S/c1-16-6-7-18(21(13-25(32)33)19-8-9-23-22(12-19)28-29-30(23)3)11-20(16)15-31-14-17(2)36-26-24(37(31,34)35)5-4-10-27-26/h4-12,17,21H,13-15H2,1-3H3,(H,32,33)	XEPNCVULOSCAJQ-UHFFFAOYSA-N	304742	3-(1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 28	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304742	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304742&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170876	381753446							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584681	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C27H28N4O5S/c1-17-8-9-19(22(14-27(32)33)20-10-11-24-23(13-20)28-29-30(24)3)12-21(17)16-31-15-18(2)36-25-6-4-5-7-26(25)37(31,34)35/h4-13,18,22H,14-16H2,1-3H3,(H,32,33)	YVVSLYWCORNKAO-UHFFFAOYSA-N	304743	US10144731, Example 29::3-(1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::BDBM304815	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304743	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304743&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170055	381753447							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584682	CCN1CCN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2)S(=O)(=O)c2ccccc12	InChI=1S/C28H31N5O4S/c1-4-32-13-14-33(38(36,37)27-8-6-5-7-26(27)32)18-22-15-20(10-9-19(22)2)23(17-28(34)35)21-11-12-25-24(16-21)29-30-31(25)3/h5-12,15-16,23H,4,13-14,17-18H2,1-3H3,(H,34,35)	PPNGGDOOVBFKCD-UHFFFAOYSA-N	304744	3-(3-((5-ethyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)-4-methylphenyl)-3-(1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 30	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304744	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304744&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118188766	381753448							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584683	CCC1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2)S(=O)(=O)c2cccnc2O1	InChI=1S/C27H29N5O5S/c1-4-21-16-32(38(35,36)25-6-5-11-28-27(25)37-21)15-20-12-18(8-7-17(20)2)22(14-26(33)34)19-9-10-24-23(13-19)29-30-31(24)3/h5-13,21-22H,4,14-16H2,1-3H3,(H,33,34)	VAANGWNZJXFEIA-UHFFFAOYSA-N	304745	3-(3-((4-ethyl-1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-3-(1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 31	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304745	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304745&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118169907	381753449							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584684	CCC1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2)S(=O)(=O)c2ccccc2O1	InChI=1S/C28H30N4O5S/c1-4-22-17-32(38(35,36)27-8-6-5-7-26(27)37-22)16-21-13-19(10-9-18(21)2)23(15-28(33)34)20-11-12-25-24(14-20)29-30-31(25)3/h5-14,22-23H,4,15-17H2,1-3H3,(H,33,34)	UHPAVJXNZSOPQI-UHFFFAOYSA-N	304746	3-(3-((4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-3-(1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 32	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304746	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304746&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170207	381753450							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584685	CCN1CCN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2)S(=O)(=O)c2cccnc12	InChI=1S/C27H30N6O4S/c1-4-32-12-13-33(38(36,37)25-6-5-11-28-27(25)32)17-21-14-19(8-7-18(21)2)22(16-26(34)35)20-9-10-24-23(15-20)29-30-31(24)3/h5-11,14-15,22H,4,12-13,16-17H2,1-3H3,(H,34,35)	WAXBHHQLKYBNQI-UHFFFAOYSA-N	304747	3-(3-((5-ethyl-1,1-dioxido-4,5-dihydropyrido[2,3-f][1,2,5]thiadiazepin-2(3H)-yl)methyl)-4-methylphenyl)-3-(1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 33	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304747	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304747&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			122653503	381753451							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584686	COc1cc(cc2nnn(C)c12)[C@H](CC(O)=O)c1ccc(C)c(CN2C[C@@H](C)Oc3ccccc3S2(=O)=O)c1 |r|	InChI=1S/C28H30N4O6S/c1-17-9-10-19(22(14-27(33)34)20-12-23-28(25(13-20)37-4)31(3)30-29-23)11-21(17)16-32-15-18(2)38-24-7-5-6-8-26(24)39(32,35)36/h5-13,18,22H,14-16H2,1-4H3,(H,33,34)	ZDNGJXBUEQNFBQ-UHFFFAOYSA-N	304748	US10144731, Example 34a::BDBM304749	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304748	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304748&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118169940	381753452							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584687	COc1cc(cc2nnn(C)c12)[C@H](CC(O)=O)c1ccc(C)c(CN2C[C@@H](C)Oc3ccccc3S2(=O)=O)c1 |r|	InChI=1S/C28H30N4O6S/c1-17-9-10-19(22(14-27(33)34)20-12-23-28(25(13-20)37-4)31(3)30-29-23)11-21(17)16-32-15-18(2)38-24-7-5-6-8-26(24)39(32,35)36/h5-13,18,22H,14-16H2,1-4H3,(H,33,34)	ZDNGJXBUEQNFBQ-UHFFFAOYSA-N	304748	US10144731, Example 34a::BDBM304749	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304748	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304748&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118169940	381753452							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584688	CCC1CN(C(C)c2cc(ccc2C)C(CC(O)=O)c2ccc3n(CC)nnc3c2C)S(=O)(=O)c2ccccc2O1	InChI=1S/C31H36N4O5S/c1-6-23-18-35(41(38,39)29-11-9-8-10-28(29)40-23)21(5)25-16-22(13-12-19(25)3)26(17-30(36)37)24-14-15-27-31(20(24)4)32-33-34(27)7-2/h8-16,21,23,26H,6-7,17-18H2,1-5H3,(H,36,37)	AKHCBMLHZMAGJM-UHFFFAOYSA-N	304750	3-(3-((4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-3-(1-ethyl-4-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 35	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304750	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304750&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			122660620	381753454							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584689	CCn1nnc2c(C)c(ccc12)C(CC(O)=O)c1ccc(C)c(CN2C[C@@H](C)Oc3ccccc3S2(=O)=O)c1 |r|	InChI=1S/C29H32N4O5S/c1-5-33-25-13-12-23(20(4)29(25)30-31-33)24(15-28(34)35)21-11-10-18(2)22(14-21)17-32-16-19(3)38-26-8-6-7-9-27(26)39(32,36)37/h6-14,19,24H,5,15-17H2,1-4H3,(H,34,35)	GSJYABPCKQDTOX-UHFFFAOYSA-N	304751	3-(1-ethyl-4-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 36	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304751	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304751&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170164	381753455							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584690	CCn1nnc2c(C)c(ccc12)C(CC(O)=O)c1ccc(C)c(CN2C[C@@H](C)Oc3ncccc3S2(=O)=O)c1 |r|	InChI=1S/C28H31N5O5S/c1-5-33-24-11-10-22(19(4)27(24)30-31-33)23(14-26(34)35)20-9-8-17(2)21(13-20)16-32-15-18(3)38-28-25(39(32,36)37)7-6-12-29-28/h6-13,18,23H,5,14-16H2,1-4H3,(H,34,35)	IOXXTPJNZJWFCO-UHFFFAOYSA-N	304752	3-(1-ethyl-4-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 37	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304752	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304752&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170686	381753456							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584691	CCC1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(CC)nnc3c2C)S(=O)(=O)c2cccnc2O1	InChI=1S/C29H33N5O5S/c1-5-22-17-33(40(37,38)26-8-7-13-30-29(26)39-22)16-21-14-20(10-9-18(21)3)24(15-27(35)36)23-11-12-25-28(19(23)4)31-32-34(25)6-2/h7-14,22,24H,5-6,15-17H2,1-4H3,(H,35,36)	FSVDYFNASNQHCE-UHFFFAOYSA-N	304753	3-(3-((4-ethyl-1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-3-(1-ethyl-4-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 38	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304753	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304753&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118169794	381753457							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584692	CCN1CCN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(CC)nnc3c2C)S(=O)(=O)c2cccnc12	InChI=1S/C29H34N6O4S/c1-5-33-14-15-34(40(38,39)26-8-7-13-30-29(26)33)18-22-16-21(10-9-19(22)3)24(17-27(36)37)23-11-12-25-28(20(23)4)31-32-35(25)6-2/h7-13,16,24H,5-6,14-15,17-18H2,1-4H3,(H,36,37)	FJBDTVHTQZMFJX-UHFFFAOYSA-N	304754	3-(3-((5-ethyl-1,1-dioxido-4,5-dihydropyrido[2,3-f][1,2,5]thiadiazepin-2(3H)-yl)methyl)-4-methylphenyl)-3-(1-ethyl-4-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 39	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304754	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304754&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118169897	381753458							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584693	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(CC)nnc3c2C)S(=O)(=O)c2cccnc2O1 |r|	InChI=1S/C29H33N5O5S/c1-5-22-17-33(40(37,38)26-8-7-13-30-29(26)39-22)16-21-14-20(10-9-18(21)3)24(15-27(35)36)23-11-12-25-28(19(23)4)31-32-34(25)6-2/h7-14,22,24H,5-6,15-17H2,1-4H3,(H,35,36)	FSVDYFNASNQHCE-UHFFFAOYSA-N	304755	US10144731, Example 40::BDBM304886::3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-3-(1-ethyl-4-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::BDBM304885::BDBM304838	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304755	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304755&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118169924	381753459							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584694	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2cccnc2O1 |r|	InChI=1S/C28H31N5O5S/c1-5-21-16-33(39(36,37)25-7-6-12-29-28(25)38-21)15-20-13-19(9-8-17(20)2)23(14-26(34)35)22-10-11-24-27(18(22)3)30-31-32(24)4/h6-13,21,23H,5,14-16H2,1-4H3,(H,34,35)	CYAWSFDLOYOCFO-UHFFFAOYSA-N	304756	3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)propanoic acid::US10144731, Example 41	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304756	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304756&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118169877	381753460							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584695	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(CC)nnc3c2C)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C30H34N4O5S/c1-5-23-18-33(40(37,38)28-10-8-7-9-27(28)39-23)17-22-15-21(12-11-19(22)3)25(16-29(35)36)24-13-14-26-30(20(24)4)31-32-34(26)6-2/h7-15,23,25H,5-6,16-18H2,1-4H3,(H,35,36)	VQHOXOKHXRHGJX-UHFFFAOYSA-N	304757	3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-3-(1-ethyl-4-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 42	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304757	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304757&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118169977	381753461							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584696	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C29H32N4O5S/c1-5-22-17-33(39(36,37)27-9-7-6-8-26(27)38-22)16-21-14-20(11-10-18(21)2)24(15-28(34)35)23-12-13-25-29(19(23)3)30-31-32(25)4/h6-14,22,24H,5,15-17H2,1-4H3,(H,34,35)	PSAYWSGFKCURFC-UHFFFAOYSA-N	304758	BDBM304884::BDBM304883::3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)propanoic acid::US10144731, Example 43	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304758	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304758&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170027	381753462							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584697	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2cc(OC)c3n(C)nnc3c2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C29H32N4O6S/c1-5-22-17-33(40(36,37)27-9-7-6-8-25(27)39-22)16-21-12-19(11-10-18(21)2)23(15-28(34)35)20-13-24-29(26(14-20)38-4)32(3)31-30-24/h6-14,22-23H,5,15-17H2,1-4H3,(H,34,35)	CGULIBNLQTVXJS-UHFFFAOYSA-N	304759	3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 44	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304759	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304759&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170220	381753463							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584698	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2cc(OC)c3n(C)nnc3c2)S(=O)(=O)c2cccnc2O1 |r|	InChI=1S/C28H31N5O6S/c1-5-21-16-33(40(36,37)25-7-6-10-29-28(25)39-21)15-20-11-18(9-8-17(20)2)22(14-26(34)35)19-12-23-27(24(13-19)38-4)32(3)31-30-23/h6-13,21-22H,5,14-16H2,1-4H3,(H,34,35)	JJZPWGQPPUTFLQ-UHFFFAOYSA-N	304760	3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 45	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304760	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304760&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170004	381753464							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584699	CC[C@@H]1CN(Cc2cc(ccc2CC)C(CC(O)=O)c2cccc(OC)c2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C29H33NO6S/c1-4-20-13-14-22(26(17-29(31)32)21-9-8-10-25(16-21)35-3)15-23(20)18-30-19-24(5-2)36-27-11-6-7-12-28(27)37(30,33)34/h6-16,24,26H,4-5,17-19H2,1-3H3,(H,31,32)	JBQFMPMORHDMHZ-UHFFFAOYSA-N	304761	3-(4-ethyl-3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)-3-(3-methoxyphenyl)propanoic acid::US10144731, Example 46	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304761	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304761&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170518	381753465							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584700	CN(Cc1cc(ccc1Cl)C(CC(O)=O)c1ccc2n(C)nnc2c1)S(=O)(=O)c1ccc(C)cc1	InChI=1S/C25H25ClN4O4S/c1-16-4-8-20(9-5-16)35(33,34)29(2)15-19-12-17(6-10-22(19)26)21(14-25(31)32)18-7-11-24-23(13-18)27-28-30(24)3/h4-13,21H,14-15H2,1-3H3,(H,31,32)	FKGLABWENBSNRH-UHFFFAOYSA-N	304969	US10144731, Example 47::3-(4-chloro-3-((N,4-dimethylphenylsulfonamido)methyl)phenyl)-3-(1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304969	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304969&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170716	381753671							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584701	CN(Cc1cc(ccc1Cl)C(CC(O)=O)c1ccc2n(C)nnc2c1)S(=O)(=O)c1cccc(C)c1	InChI=1S/C25H25ClN4O4S/c1-16-5-4-6-20(11-16)35(33,34)29(2)15-19-12-17(7-9-22(19)26)21(14-25(31)32)18-8-10-24-23(13-18)27-28-30(24)3/h4-13,21H,14-15H2,1-3H3,(H,31,32)	LALJNFCDDXCGMH-UHFFFAOYSA-N	304762	3-(4-chloro-3-((N,3-dimethylphenylsulfonamido)methyl)phenyl)-3-(1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 48	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304762	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304762&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118169835	381753466							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584702	CN(Cc1cc(ccc1Cl)C(CC(O)=O)c1ccc2n(C)nnc2c1)S(=O)(=O)c1cccc(NC(C)=O)c1	InChI=1S/C26H26ClN5O5S/c1-16(33)28-20-5-4-6-21(13-20)38(36,37)31(2)15-19-11-17(7-9-23(19)27)22(14-26(34)35)18-8-10-25-24(12-18)29-30-32(25)3/h4-13,22H,14-15H2,1-3H3,(H,28,33)(H,34,35)	CCKFFZWASQCQFD-UHFFFAOYSA-N	304763	3-(3-((3-acetamido-N-methylphenylsulfonamido)methyl)-4-chlorophenyl)-3-(1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 50	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304763	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304763&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170465	381753467							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584703	CN(Cc1cc(ccc1Cl)C(CC(O)=O)c1ccc2n(C)nnc2c1)S(=O)(=O)C1CCCCC1	InChI=1S/C24H29ClN4O4S/c1-28(34(32,33)19-6-4-3-5-7-19)15-18-12-16(8-10-21(18)25)20(14-24(30)31)17-9-11-23-22(13-17)26-27-29(23)2/h8-13,19-20H,3-7,14-15H2,1-2H3,(H,30,31)	FFAANKRCKMNWSX-UHFFFAOYSA-N	304970	US10144731, Example 51::3-(4-chloro-3-((N-methylcyclohexanesulfonamido)methyl)phenyl)-3-(1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 5500							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304970	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304970&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170851	381753672							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584704	CN(Cc1cc(ccc1Cl)C(CC(O)=O)c1ccc2n(C)nnc2c1)S(=O)(=O)c1ccc2OCCOc2c1	InChI=1S/C26H25ClN4O6S/c1-30(38(34,35)19-5-8-24-25(13-19)37-10-9-36-24)15-18-11-16(3-6-21(18)27)20(14-26(32)33)17-4-7-23-22(12-17)28-29-31(23)2/h3-8,11-13,20H,9-10,14-15H2,1-2H3,(H,32,33)	CPQNNJBTSHDTLZ-UHFFFAOYSA-N	304764	3-(4-chloro-3-((N-methyl-2,3-dihydrobenzo[b][1,4]dioxine-6-sulfonamido)methyl)phenyl)-3-(1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 52	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304764	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304764&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118169845	381753468							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584705	CN(Cc1cc(ccc1Cl)[C@@H](CC(O)=O)c1ccc2n(C)nnc2c1)S(=O)(=O)c1ccccc1 |r|	InChI=1S/C24H23ClN4O4S/c1-28(34(32,33)19-6-4-3-5-7-19)15-18-12-16(8-10-21(18)25)20(14-24(30)31)17-9-11-23-22(13-17)26-27-29(23)2/h3-13,20H,14-15H2,1-2H3,(H,30,31)	NICLDNFOUWEYPY-UHFFFAOYSA-N	304765	(3R)-3-{4-chloro-3-[(N-methylbenzenesulfonamido)methyl]phenyl}-3-(1-methyl-1H-1,2,3-benzotriazol-5-yl)propanoic acid::US10144731, Example 53	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304765	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304765&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170374	381753469							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584706	Cn1c2ccc(cc2nn1)[C@@H](CC(=O)O)c3ccc(c(c3)CN(C)S(=O)(=O)c4ccccc4)Cl	InChI=1S/C24H23ClN4O4S/c1-28(34(32,33)19-6-4-3-5-7-19)15-18-12-16(8-10-21(18)25)20(14-24(30)31)17-9-11-23-22(13-17)26-27-29(23)2/h3-13,20H,14-15H2,1-2H3,(H,30,31)	NICLDNFOUWEYPY-UHFFFAOYSA-N	50180851	CHEMBL3818085::US10144731, Example 54	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50180851	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50180851&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	0PL	5FNT	118170891	346549844		CHEMBL3818085					1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584707	CN(Cc1cc(ccc1C)[C@@H](CC(O)=O)c1ccc2n(C)nnc2c1C)S(=O)(=O)c1ccccc1 |r|	InChI=1S/C26H28N4O4S/c1-17-10-11-19(14-20(17)16-29(3)35(33,34)21-8-6-5-7-9-21)23(15-25(31)32)22-12-13-24-26(18(22)2)27-28-30(24)4/h5-14,23H,15-16H2,1-4H3,(H,31,32)	RZDVYTYOVMEPBY-UHFFFAOYSA-N	304766	(3R)-3-(1,4-dimethyl-1H-1,2,3-benzotriazol-5-yl)-3-{4-methyl-3-[(N-methylbenzenesulfonamido)methyl]phenyl}propanoic acid::US10144731, Example 55	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304766	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304766&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170217	381753470							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584708	CN(Cc1cc(ccc1C)[C@H](CC(O)=O)c1ccc2n(C)nnc2c1C)S(=O)(=O)c1ccccc1 |r|	InChI=1S/C26H28N4O4S/c1-17-10-11-19(14-20(17)16-29(3)35(33,34)21-8-6-5-7-9-21)23(15-25(31)32)22-12-13-24-26(18(22)2)27-28-30(24)4/h5-14,23H,15-16H2,1-4H3,(H,31,32)	RZDVYTYOVMEPBY-UHFFFAOYSA-N	304767	(3S)-3-(1,4-dimethyl-1H-1,2,3-benzotriazol-5-yl)-3-{4-methyl-3-[(N-methylbenzenesulfonamido)methyl]phenyl}propanoic acid::US10144731, Example 56	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304767	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304767&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118169976	381753471							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584709	COc1cc(cc2nnn(C)c12)C(CC(O)=O)c1ccc(C)c(CN2CCOc3ccccc3S2(=O)=O)c1	InChI=1S/C27H28N4O6S/c1-17-8-9-18(12-20(17)16-31-10-11-37-23-6-4-5-7-25(23)38(31,34)35)21(15-26(32)33)19-13-22-27(24(14-19)36-3)30(2)29-28-22/h4-9,12-14,21H,10-11,15-16H2,1-3H3,(H,32,33)	RTGHTXKISWZXKJ-UHFFFAOYSA-N	304768	3-(3-((1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 57	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304768	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304768&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118169882	381753472							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584710	Cc1ccc(cc1CN1CCOc2ccccc2S1(=O)=O)C(CC(O)=O)c1ccn2nnnc2c1	InChI=1S/C24H23N5O5S/c1-16-6-7-17(20(14-24(30)31)18-8-9-29-23(13-18)25-26-27-29)12-19(16)15-28-10-11-34-21-4-2-3-5-22(21)35(28,32)33/h2-9,12-13,20H,10-11,14-15H2,1H3,(H,30,31)	SRMMWYRXUWFSNL-UHFFFAOYSA-N	304972	US10144731, Example 58::3-(3-((1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-3-(tetrazolo[1,5-a]pyridin-7-yl)propanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304972	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304972&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170439	381753674							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584711	COc1cc(cc2nnn(C)c12)C(CC(O)=O)c1ccc(C)c(CN2CCOCCS2(=O)=O)c1	InChI=1S/C23H28N4O6S/c1-15-4-5-16(10-18(15)14-27-6-7-33-8-9-34(27,30)31)19(13-22(28)29)17-11-20-23(21(12-17)32-3)26(2)25-24-20/h4-5,10-12,19H,6-9,13-14H2,1-3H3,(H,28,29)	DLUHYYWDKTVUNT-UHFFFAOYSA-N	304973	US10144731, Example 59::3-(3-((4,4-dioxido-1,4,5-oxathiazepan-5-yl)methyl)-4-methylphenyl)-3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304973	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304973&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170107	381753675							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584712	COc1cc(cc2nnn(C)c12)C(CC(O)=O)c1cccc(CN2C[C@@H](C)Oc3ncccc3S2(=O)=O)c1 |r|	InChI=1S/C26H27N5O6S/c1-16-14-31(38(34,35)23-8-5-9-27-26(23)37-16)15-17-6-4-7-18(10-17)20(13-24(32)33)19-11-21-25(22(12-19)36-3)30(2)29-28-21/h4-12,16,20H,13-15H2,1-3H3,(H,32,33)	WPLBGJOJRLUORQ-UHFFFAOYSA-N	304769	3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 61	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304769	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304769&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170333	381753473							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584713	COc1cc(cc2nnn(C)c12)C(CC(O)=O)c1cccc(CN2CC(C)Oc3ccccc3S2(=O)=O)c1	InChI=1S/C27H28N4O6S/c1-17-15-31(38(34,35)25-10-5-4-9-23(25)37-17)16-18-7-6-8-19(11-18)21(14-26(32)33)20-12-22-27(24(13-20)36-3)30(2)29-28-22/h4-13,17,21H,14-16H2,1-3H3,(H,32,33)	ZXWYNATUZLXLKZ-UHFFFAOYSA-N	304770	3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-((4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 62	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304770	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304770&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170433	381753474							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584714	COc1cc(cc2nnn(C)c12)C(CC(O)=O)c1cccc(CN2C[C@@H](C)Oc3ccccc3S2(=O)=O)c1 |r|	InChI=1S/C27H28N4O6S/c1-17-15-31(38(34,35)25-10-5-4-9-23(25)37-17)16-18-7-6-8-19(11-18)21(14-26(32)33)20-12-22-27(24(13-20)36-3)30(2)29-28-22/h4-13,17,21H,14-16H2,1-3H3,(H,32,33)	ZXWYNATUZLXLKZ-UHFFFAOYSA-N	304771	3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 63	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304771	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304771&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118169838	381753475							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584715	CCC1CN(Cc2cccc(c2)C(CC(O)=O)c2cc(OC)c3n(C)nnc3c2)S(=O)(=O)c2ccccc2O1	InChI=1S/C28H30N4O6S/c1-4-21-17-32(39(35,36)26-11-6-5-10-24(26)38-21)16-18-8-7-9-19(12-18)22(15-27(33)34)20-13-23-28(25(14-20)37-3)31(2)30-29-23/h5-14,21-22H,4,15-17H2,1-3H3,(H,33,34)	QSSUJNFHVOAPEV-UHFFFAOYSA-N	304772	3-(3-((4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)-3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 64	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304772	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304772&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170607	381753476							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584716	CCC1CN(Cc2cccc(c2)C(CC(O)=O)c2cc(OC)c3n(C)nnc3c2)S(=O)(=O)c2cccnc2O1	InChI=1S/C27H29N5O6S/c1-4-20-16-32(39(35,36)24-9-6-10-28-27(24)38-20)15-17-7-5-8-18(11-17)21(14-25(33)34)19-12-22-26(23(13-19)37-3)31(2)30-29-22/h5-13,20-21H,4,14-16H2,1-3H3,(H,33,34)	RMOOKCRRIXVINV-UHFFFAOYSA-N	304773	3-(3-((4-ethyl-1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)-3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 65	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304773	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304773&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170234	381753477							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584717	Cc1c(ccc2n(C)nnc12)C(CC(O)=O)c1ccc(F)c(CN2CCOc3ccccc3S2(=O)=O)c1	InChI=1S/C26H25FN4O5S/c1-16-19(8-10-22-26(16)28-29-30(22)2)20(14-25(32)33)17-7-9-21(27)18(13-17)15-31-11-12-36-23-5-3-4-6-24(23)37(31,34)35/h3-10,13,20H,11-12,14-15H2,1-2H3,(H,32,33)	DRSUZWSVWLQHEW-UHFFFAOYSA-N	304774	3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-((1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-fluorophenyl)propanoic acid::US10144731, Example 66	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304774	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304774&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170616	381753478							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584718	C[C@@H]1CN(Cc2cc(ccc2F)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C27H27FN4O5S/c1-16-14-32(38(35,36)25-7-5-4-6-24(25)37-16)15-19-12-18(8-10-22(19)28)21(13-26(33)34)20-9-11-23-27(17(20)2)29-30-31(23)3/h4-12,16,21H,13-15H2,1-3H3,(H,33,34)	CYYQUZIQAPCJLW-UHFFFAOYSA-N	304775	3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-fluoro-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 67	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304775	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304775&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170350	381753479							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584719	CCC1CN(Cc2cc(ccc2F)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc2O1	InChI=1S/C28H29FN4O5S/c1-4-20-16-33(39(36,37)26-8-6-5-7-25(26)38-20)15-19-13-18(9-11-23(19)29)22(14-27(34)35)21-10-12-24-28(17(21)2)30-31-32(24)3/h5-13,20,22H,4,14-16H2,1-3H3,(H,34,35)	FOUDITGFIOIXRN-UHFFFAOYSA-N	304776	3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-((4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-fluorophenyl)propanoic acid::US10144731, Example 68	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304776	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304776&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118169891	381753480							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584720	C[C@@H]1CN(Cc2cc(ccc2F)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2cccnc2O1 |r|	InChI=1S/C26H26FN5O5S/c1-15-13-32(38(35,36)23-5-4-10-28-26(23)37-15)14-18-11-17(6-8-21(18)27)20(12-24(33)34)19-7-9-22-25(16(19)2)29-30-31(22)3/h4-11,15,20H,12-14H2,1-3H3,(H,33,34)	SLZHPAVILAIJPT-UHFFFAOYSA-N	304777	3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-fluoro-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 69	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304777	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304777&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170503	381753481							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584721	Cc1ccc(cc1CN1CCOc2ccncc2S1(=O)=O)C(CC(O)=O)c1ccc2n(C)nnc2c1C	InChI=1S/C26H27N5O5S/c1-16-4-5-18(21(13-25(32)33)20-6-7-22-26(17(20)2)28-29-30(22)3)12-19(16)15-31-10-11-36-23-8-9-27-14-24(23)37(31,34)35/h4-9,12,14,21H,10-11,13,15H2,1-3H3,(H,32,33)	KHKRJIKQDOFQIX-UHFFFAOYSA-N	304974	US10144731, Example 70::3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-((1,1-dioxido-3,4-dihydro-2H-pyrido[4,3-b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)propanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304974	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304974&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170326	381753676							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584722	CN1CCN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2cnccc12	InChI=1S/C27H30N6O4S/c1-17-5-6-19(22(14-26(34)35)21-7-8-24-27(18(21)2)29-30-32(24)4)13-20(17)16-33-12-11-31(3)23-9-10-28-15-25(23)38(33,36)37/h5-10,13,15,22H,11-12,14,16H2,1-4H3,(H,34,35)	OLHWMXBKPFRTNX-UHFFFAOYSA-N	304975	US10144731, Example 71::3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((5-methyl-1,1-dioxido-4,5-dihydropyrido[4,3-f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304975	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304975&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170120	381753677							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584723	C[C@@H]1CN(Cc2cc(ccc2Cl)C(CC(O)=O)c2ccc3n(C)nnc3c2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C26H25ClN4O5S/c1-16-14-31(37(34,35)25-6-4-3-5-24(25)36-16)15-19-11-17(7-9-21(19)27)20(13-26(32)33)18-8-10-23-22(12-18)28-29-30(23)2/h3-12,16,20H,13-15H2,1-2H3,(H,32,33)	XZYFMIIYOADPMK-UHFFFAOYSA-N	304778	3-(4-chloro-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)-3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 72	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304778	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304778&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170405	381753482							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584724	COc1cc(cc2nnn(C)c12)C(CC(O)=O)c1ccc(Cl)c(CN2C[C@@H](C)Oc3ccccc3S2(=O)=O)c1 |r|	InChI=1S/C27H27ClN4O6S/c1-16-14-32(39(35,36)25-7-5-4-6-23(25)38-16)15-19-10-17(8-9-21(19)28)20(13-26(33)34)18-11-22-27(24(12-18)37-3)31(2)30-29-22/h4-12,16,20H,13-15H2,1-3H3,(H,33,34)	CQYMHLFEMQKUBC-UHFFFAOYSA-N	304779	3-(4-chloro-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)-3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 73	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304779	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304779&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170618	381753483							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584725	COc1cccc(c1)C(CC(O)=O)c1ccc(C)c(CN2C[C@@H](C)Oc3ccccc3S2(=O)=O)c1 |r|	InChI=1S/C27H29NO6S/c1-18-11-12-21(24(15-27(29)30)20-7-6-8-23(14-20)33-3)13-22(18)17-28-16-19(2)34-25-9-4-5-10-26(25)35(28,31)32/h4-14,19,24H,15-17H2,1-3H3,(H,29,30)	LLMYBSXAZDMMIK-UHFFFAOYSA-N	304780	3-(3-methoxyphenyl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 74	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304780	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304780&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170664	381753484							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584726	Cn1nnc2cc(ccc12)C(CC(O)=O)c1ccc(Cl)c(CN2CCOc3ccccc3S2(=O)=O)c1	InChI=1S/C25H23ClN4O5S/c1-29-22-9-7-17(13-21(22)27-28-29)19(14-25(31)32)16-6-8-20(26)18(12-16)15-30-10-11-35-23-4-2-3-5-24(23)36(30,33)34/h2-9,12-13,19H,10-11,14-15H2,1H3,(H,31,32)	UYRDBYWOJSQQOH-UHFFFAOYSA-N	304781	3-(4-chloro-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)-3-(1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 75	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304781	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304781&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			122660623	381753485							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584727	COc1cccc(C(CC(O)=O)c2ccc(C)c(CN3C[C@@H](C)Oc4ccccc4S3(=O)=O)c2)c1C |r|	InChI=1S/C28H31NO6S/c1-18-12-13-21(24(15-28(30)31)23-8-7-10-25(34-4)20(23)3)14-22(18)17-29-16-19(2)35-26-9-5-6-11-27(26)36(29,32)33/h5-14,19,24H,15-17H2,1-4H3,(H,30,31)	UVNADZWWOXEWFH-UHFFFAOYSA-N	304782	3-(3-methoxy-2-methylphenyl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 76	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304782	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304782&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170544	381753486							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584728	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2cnc3n(C)nnc3c2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C26H27N5O5S/c1-16-8-9-18(21(12-25(32)33)19-11-22-26(27-13-19)30(3)29-28-22)10-20(16)15-31-14-17(2)36-23-6-4-5-7-24(23)37(31,34)35/h4-11,13,17,21H,12,14-15H2,1-3H3,(H,32,33)	MMIORKVIDQHGLK-UHFFFAOYSA-N	304783	3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)-3-(3-methyl-3H-[1,2,3]triazolo[4,5-b]pyridin-6-yl)propanoic acid::US10144731, Example 77	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304783	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304783&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170259	381753487							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584729	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccn(C)c(=O)c2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C26H28N2O6S/c1-17-8-9-19(22(14-26(30)31)20-10-11-27(3)25(29)13-20)12-21(17)16-28-15-18(2)34-23-6-4-5-7-24(23)35(28,32)33/h4-13,18,22H,14-16H2,1-3H3,(H,30,31)	WJSSYLMODFTVGW-UHFFFAOYSA-N	304784	3-(1-methyl-2-oxo-1,2-dihydropyridin-4-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 78	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304784	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304784&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			122653241	381753488							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584730	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2cnc3n(C)nnc3c2C)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C27H29N5O5S/c1-16-9-10-19(21(12-25(33)34)22-13-28-27-26(18(22)3)29-30-31(27)4)11-20(16)15-32-14-17(2)37-23-7-5-6-8-24(23)38(32,35)36/h5-11,13,17,21H,12,14-15H2,1-4H3,(H,33,34)	FUYXWABFTBBPPQ-UHFFFAOYSA-N	304785	3-(3,7-dimethyl-3H-[1,2,3]triazolo[4,5-b]pyridin-6-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 79	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304785	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304785&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170842	381753489							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584731	COc1cc(OC)cc(c1)C(CC(O)=O)c1ccc(C)c(CN2C[C@@H](C)Oc3ccccc3S2(=O)=O)c1 |r|	InChI=1S/C28H31NO7S/c1-18-9-10-20(25(15-28(30)31)21-12-23(34-3)14-24(13-21)35-4)11-22(18)17-29-16-19(2)36-26-7-5-6-8-27(26)37(29,32)33/h5-14,19,25H,15-17H2,1-4H3,(H,30,31)	OCGMVPCBHCZPCM-UHFFFAOYSA-N	304976	US10144731, Example 80::3-(3,5-dimethoxyphenyl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 5500							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304976	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304976&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170805	381753678							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584732	COc1cncc(c1)C(CC(O)=O)c1ccc(C)c(CN2C[C@@H](C)Oc3ccccc3S2(=O)=O)c1 |r|	InChI=1S/C26H28N2O6S/c1-17-8-9-19(23(12-26(29)30)20-11-22(33-3)14-27-13-20)10-21(17)16-28-15-18(2)34-24-6-4-5-7-25(24)35(28,31)32/h4-11,13-14,18,23H,12,15-16H2,1-3H3,(H,29,30)	RJGYBYWABYITLP-UHFFFAOYSA-N	304786	3-(5-methoxypyridin-3-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 81	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304786	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304786&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170726	381753490							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584733	COc1cc(OC(F)(F)F)cc(c1)C(CC(O)=O)c1ccc(C)c(CN2C[C@@H](C)Oc3ccccc3S2(=O)=O)c1 |r|	InChI=1S/C28H28F3NO7S/c1-17-8-9-19(24(14-27(33)34)20-11-22(37-3)13-23(12-20)39-28(29,30)31)10-21(17)16-32-15-18(2)38-25-6-4-5-7-26(25)40(32,35)36/h4-13,18,24H,14-16H2,1-3H3,(H,33,34)	QYFOHDFHKGTAAT-UHFFFAOYSA-N	304977	US10144731, Example 82::3-(3-methoxy-5-(trifluoromethoxy)phenyl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 5500							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304977	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304977&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170468	381753679							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584734	CCC1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccn(C)c(=O)c2)S(=O)(=O)c2ccccc2O1	InChI=1S/C27H30N2O6S/c1-4-22-17-29(36(33,34)25-8-6-5-7-24(25)35-22)16-21-13-19(10-9-18(21)2)23(15-27(31)32)20-11-12-28(3)26(30)14-20/h5-14,22-23H,4,15-17H2,1-3H3,(H,31,32)	HMFIFAOORJCVCB-UHFFFAOYSA-N	304787	3-(3-((4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-3-(1-methyl-2-oxo-1,2-dihydropyridin-4-yl)propanoic acid::US10144731, Example 83	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304787	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304787&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170774	381753491							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584735	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccn(C)c(=O)c2)S(=O)(=O)c2cccnc2O1 |r|	InChI=1S/C25H27N3O6S/c1-16-6-7-18(21(13-24(30)31)19-8-10-27(3)23(29)12-19)11-20(16)15-28-14-17(2)34-25-22(35(28,32)33)5-4-9-26-25/h4-12,17,21H,13-15H2,1-3H3,(H,30,31)	XXWNAIROFABZMP-UHFFFAOYSA-N	304788	3-(1-methyl-2-oxo-1,2-dihydropyridin-4-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 84	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304788	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304788&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			122653429	381753492							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584736	C[C@@H]1CN(Cc2cc(ccc2Cl)C(CC(O)=O)c2ccn(C)c(=O)c2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C25H25ClN2O6S/c1-16-14-28(35(32,33)23-6-4-3-5-22(23)34-16)15-19-11-17(7-8-21(19)26)20(13-25(30)31)18-9-10-27(2)24(29)12-18/h3-12,16,20H,13-15H2,1-2H3,(H,30,31)	YZJHIJHDIPVFFH-UHFFFAOYSA-N	304978	US10144731, Example 85::3-(4-chloro-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)-3-(1-methyl-2-oxo-1,2-dihydropyridin-4-yl)propanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304978	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304978&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170221	381753680							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584737	CN1CCN(Cc2cc(ccc2C)C(CC(O)=O)c2ccn(C)c(=O)c2)S(=O)(=O)c2ccccc12	InChI=1S/C26H29N3O5S/c1-18-8-9-19(22(16-26(31)32)20-10-11-28(3)25(30)15-20)14-21(18)17-29-13-12-27(2)23-6-4-5-7-24(23)35(29,33)34/h4-11,14-15,22H,12-13,16-17H2,1-3H3,(H,31,32)	BTPDPSLUOKOLFC-UHFFFAOYSA-N	304979	US10144731, Example 86::3-(1-methyl-2-oxo-1,2-dihydropyridin-4-yl)-3-(4-methyl-3-((5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304979	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304979&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170619	381753681							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584738	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2cc(C)c3n(C)nnc3c2F)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C28H29FN4O5S/c1-16-9-10-19(21(13-25(34)35)22-11-17(2)28-27(26(22)29)30-31-32(28)4)12-20(16)15-33-14-18(3)38-23-7-5-6-8-24(23)39(33,36)37/h5-12,18,21H,13-15H2,1-4H3,(H,34,35)	IMPTVJDGGVRIHR-UHFFFAOYSA-N	304789	3-(4-fluoro-1,7-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 87	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304789	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304789&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170782	381753493							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584739	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2F)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C27H27FN4O5S/c1-16-8-9-18(21(13-25(33)34)20-10-11-22-27(26(20)28)29-30-31(22)3)12-19(16)15-32-14-17(2)37-23-6-4-5-7-24(23)38(32,35)36/h4-12,17,21H,13-15H2,1-3H3,(H,33,34)	ZHDBZJLNJLJQMN-UHFFFAOYSA-N	304790	3-(4-fluoro-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 88	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304790	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304790&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170198	381753494							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584740	COc1cc(C(CC(O)=O)c2ccc(C)c(CN(C)C(=O)OC3CCCC3)c2)c(C)c2nnn(C)c12	InChI=1S/C27H34N4O5/c1-16-10-11-18(12-19(16)15-30(3)27(34)36-20-8-6-7-9-20)22(14-24(32)33)21-13-23(35-5)26-25(17(21)2)28-29-31(26)4/h10-13,20,22H,6-9,14-15H2,1-5H3,(H,32,33)	FICRVLXLXMNVDH-UHFFFAOYSA-N	304791	3-(3-((((cyclopentyloxy)carbonyl)(methyl)amino)methyl)-4-methylphenyl)-3-(7-methoxy-1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 89	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304791	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304791&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170796	381753495							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584741	CN(Cc1cc(ccc1C)C(CC(O)=O)c1ccc2n(C)nnc2c1C)S(=O)(=O)C1CCCC1	InChI=1S/C25H32N4O4S/c1-16-9-10-18(13-19(16)15-28(3)34(32,33)20-7-5-6-8-20)22(14-24(30)31)21-11-12-23-25(17(21)2)26-27-29(23)4/h9-13,20,22H,5-8,14-15H2,1-4H3,(H,30,31)	TYEFYUBZAKPDAX-UHFFFAOYSA-N	304792	3-(1,4-Dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((N-methylcyclopentanesulfonamido)methyl)phenyl)propanoic acid::US10144731, Example 90	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304792	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304792&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170150	381753496							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584742	CN(C)C(=O)COC(=O)CC(c1ccc(C)c(CN2CCN(C)c3ccccc3S2(=O)=O)c1)c1ccc2n(C)nnc2c1C	InChI=1S/C32H38N6O5S/c1-21-11-12-23(17-24(21)19-38-16-15-36(5)27-9-7-8-10-29(27)44(38,41)42)26(18-31(40)43-20-30(39)35(3)4)25-13-14-28-32(22(25)2)33-34-37(28)6/h7-14,17,26H,15-16,18-20H2,1-6H3	MDSPUIITKWGXGF-UHFFFAOYSA-N	304793	2-(Dimethylamino)-2-oxoethyl 3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoate::US10144731, Example 91	Kelch-like ECH-associated protein 1 [321-609]	Human		 55000							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304793	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304793&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170105	381753497							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584743	CN1CCN(Cc2cc(ccc2C)C(CC(=O)OCc2oc(=O)oc2C)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc12	InChI=1S/C33H35N5O7S/c1-20-10-11-23(16-24(20)18-38-15-14-36(4)27-8-6-7-9-30(27)46(38,41)42)26(17-31(39)43-19-29-22(3)44-33(40)45-29)25-12-13-28-32(21(25)2)34-35-37(28)5/h6-13,16,26H,14-15,17-19H2,1-5H3	RZULNVGERYOKPS-UHFFFAOYSA-N	304794	(5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoate::US10144731, Example 92	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304794	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304794&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118169810	381753498							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584744	CN1CCN(Cc2cc(ccc2C)C(CC(=O)OCCO)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc12	InChI=1S/C30H35N5O5S/c1-20-9-10-22(17-23(20)19-35-14-13-33(3)26-7-5-6-8-28(26)41(35,38)39)25(18-29(37)40-16-15-36)24-11-12-27-30(21(24)2)31-32-34(27)4/h5-12,17,25,36H,13-16,18-19H2,1-4H3	XZTMQDGKWVWWGY-UHFFFAOYSA-N	304795	2-Hydroxyethyl 3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoate::US10144731, Example 93	Kelch-like ECH-associated protein 1 [321-609]	Human		 5500							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304795	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304795&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170672	381753499							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584745	CN(C)CCOC(=O)CC(c1ccc(C)c(CN2CCN(C)c3ccccc3S2(=O)=O)c1)c1ccc2n(C)nnc2c1C	InChI=1S/C32H40N6O4S/c1-22-11-12-24(19-25(22)21-38-16-15-36(5)28-9-7-8-10-30(28)43(38,40)41)27(20-31(39)42-18-17-35(3)4)26-13-14-29-32(23(26)2)33-34-37(29)6/h7-14,19,27H,15-18,20-21H2,1-6H3	KXTXQGKARMHJOC-UHFFFAOYSA-N	304796	2-(Dimethylamino)ethyl 3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoate::US10144731, Example 95	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304796	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304796&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170179	381753500							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584746	CN1CCN(Cc2cc(ccc2C)C(CC(=O)OCCN2CCOCC2)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc12	InChI=1S/C34H42N6O5S/c1-24-9-10-26(21-27(24)23-40-14-13-37(3)30-7-5-6-8-32(30)46(40,42)43)29(22-33(41)45-20-17-39-15-18-44-19-16-39)28-11-12-31-34(25(28)2)35-36-38(31)4/h5-12,21,29H,13-20,22-23H2,1-4H3	VKGHEMQKRSKYMO-UHFFFAOYSA-N	304797	2-Morpholinoethyl 3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoate::US10144731, Example 96	Kelch-like ECH-associated protein 1 [321-609]	Human		 5500							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304797	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304797&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170035	381753501							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584747	CN(C)CCCOC(=O)CC(c1ccc(C)c(CN2CCN(C)c3ccccc3S2(=O)=O)c1)c1ccc2n(C)nnc2c1C	InChI=1S/C33H42N6O4S/c1-23-12-13-25(20-26(23)22-39-18-17-37(5)29-10-7-8-11-31(29)44(39,41)42)28(21-32(40)43-19-9-16-36(3)4)27-14-15-30-33(24(27)2)34-35-38(30)6/h7-8,10-15,20,28H,9,16-19,21-22H2,1-6H3	WJQRKZLHDLFVLR-UHFFFAOYSA-N	304798	3-(Dimethylamino)propyl 3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoate::US10144731, Example 97	Kelch-like ECH-associated protein 1 [321-609]	Human		 5500							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304798	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304798&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118169861	381753502							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584748	CN1CCN(Cc2cc(ccc2C)C(CC(=O)OC2CCOC2=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc12	InChI=1S/C32H35N5O6S/c1-20-9-10-22(17-23(20)19-37-15-14-35(3)26-7-5-6-8-29(26)44(37,40)41)25(18-30(38)43-28-13-16-42-32(28)39)24-11-12-27-31(21(24)2)33-34-36(27)4/h5-12,17,25,28H,13-16,18-19H2,1-4H3	ACCKTIQSNBFAGE-UHFFFAOYSA-N	304799	2-Oxotetrahydrofuran-3-yl 3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoate::US10144731, Example 98	Kelch-like ECH-associated protein 1 [321-609]	Human		 5500							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304799	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304799&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170791	381753503							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584749	CN1CCN(Cc2cc(ccc2C)C(CC(=O)OCOC(=O)C(C)(C)C)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc12	InChI=1S/C34H41N5O6S/c1-22-12-13-24(18-25(22)20-39-17-16-37(6)28-10-8-9-11-30(28)46(39,42)43)27(19-31(40)44-21-45-33(41)34(3,4)5)26-14-15-29-32(23(26)2)35-36-38(29)7/h8-15,18,27H,16-17,19-21H2,1-7H3	QAHKYUWDTOFNKE-UHFFFAOYSA-N	304800	((3-(1,4-Dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoyl)oxy)methyl pivalate::US10144731, Example 99	Kelch-like ECH-associated protein 1 [321-609]	Human		 55000							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304800	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304800&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170658	381753504							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584750	CN1CCN(Cc2cc(ccc2C)C(CC(=O)OCCCN)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc12	InChI=1S/C31H38N6O4S/c1-21-10-11-23(18-24(21)20-37-16-15-35(3)27-8-5-6-9-29(27)42(37,39)40)26(19-30(38)41-17-7-14-32)25-12-13-28-31(22(25)2)33-34-36(28)4/h5-6,8-13,18,26H,7,14-17,19-20,32H2,1-4H3	GILCRRBNMVEERS-UHFFFAOYSA-N	304801	3-Aminopropyl 3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoate::US10144731, Example 100	Kelch-like ECH-associated protein 1 [321-609]	Human		 5500							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304801	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304801&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170625	381753505							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584751	CC(C)C(N)COC(=O)CC(c1ccc(C)c(CN2CCN(C)c3ccccc3S2(=O)=O)c1)c1ccc2n(C)nnc2c1C	InChI=1S/C33H42N6O4S/c1-21(2)28(34)20-43-32(40)18-27(26-13-14-30-33(23(26)4)35-36-38(30)6)24-12-11-22(3)25(17-24)19-39-16-15-37(5)29-9-7-8-10-31(29)44(39,41)42/h7-14,17,21,27-28H,15-16,18-20,34H2,1-6H3	PRDDRPQTESJCMJ-UHFFFAOYSA-N	304802	2-Amino-3-methylbutyl 3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoate::US10144731, Example 101	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304802	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304802&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170510	381753506							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584752	CN1CCN(Cc2cc(ccc2C)C(CC(=O)OCCn2ccnc2)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc12	InChI=1S/C33H37N7O4S/c1-23-9-10-25(19-26(23)21-40-16-15-37(3)29-7-5-6-8-31(29)45(40,42)43)28(20-32(41)44-18-17-39-14-13-34-22-39)27-11-12-30-33(24(27)2)35-36-38(30)4/h5-14,19,22,28H,15-18,20-21H2,1-4H3	FPLJRFMRUAYRHK-UHFFFAOYSA-N	304803	2-(1H-Imidazol-1-yl)ethyl 3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-34(5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoate::US10144731, Example 102	Kelch-like ECH-associated protein 1 [321-609]	Human		 5500							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304803	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304803&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118188787	381753507							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584753	CCN(CC)CCCOC(=O)CC(c1ccc(C)c(CN2CCN(C)c3ccccc3S2(=O)=O)c1)c1ccc2n(C)nnc2c1C	InChI=1S/C35H46N6O4S/c1-7-40(8-2)18-11-21-45-34(42)23-30(29-16-17-32-35(26(29)4)36-37-39(32)6)27-15-14-25(3)28(22-27)24-41-20-19-38(5)31-12-9-10-13-33(31)46(41,43)44/h9-10,12-17,22,30H,7-8,11,18-21,23-24H2,1-6H3	NSXJQKAKTZTGPQ-UHFFFAOYSA-N	304804	3-(Diethylamino)propyl 3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoate::US10144731, Example 103	Kelch-like ECH-associated protein 1 [321-609]	Human		 5500							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304804	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304804&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170172	381753508							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584754	CN(C)CCCCOC(=O)CC(c1ccc(C)c(CN2CCN(C)c3ccccc3S2(=O)=O)c1)c1ccc2n(C)nnc2c1C	InChI=1S/C34H44N6O4S/c1-24-13-14-26(21-27(24)23-40-19-18-38(5)30-11-7-8-12-32(30)45(40,42)43)29(22-33(41)44-20-10-9-17-37(3)4)28-15-16-31-34(25(28)2)35-36-39(31)6/h7-8,11-16,21,29H,9-10,17-20,22-23H2,1-6H3	UHZFHXHECXKUIN-UHFFFAOYSA-N	304805	4-(Di methylami no)butyl 3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoate::US10144731, Example 104	Kelch-like ECH-associated protein 1 [321-609]	Human		 55000							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304805	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304805&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118169783	381753509							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584755	CN(C)CC(C)(C)COC(=O)CC(c1ccc(C)c(CN2CCN(C)c3ccccc3S2(=O)=O)c1)c1ccc2n(C)nnc2c1C	InChI=1S/C35H46N6O4S/c1-24-13-14-26(19-27(24)21-41-18-17-39(7)30-11-9-10-12-32(30)46(41,43)44)29(20-33(42)45-23-35(3,4)22-38(5)6)28-15-16-31-34(25(28)2)36-37-40(31)8/h9-16,19,29H,17-18,20-23H2,1-8H3	VNXBBGNOTHOKLU-UHFFFAOYSA-N	304806	3-(Dimethylamino)-2,2-dimethylpropyl 3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoate::US10144731, Example 105	Kelch-like ECH-associated protein 1 [321-609]	Human		 5500							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304806	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304806&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118188857	381753510							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584756	CN1CCN(Cc2cc(ccc2C)C(CC(=O)OCCCN2CCCC2)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc12	InChI=1S/C35H44N6O4S/c1-25-12-13-27(22-28(25)24-41-20-19-38(3)31-10-5-6-11-33(31)46(41,43)44)30(23-34(42)45-21-9-18-40-16-7-8-17-40)29-14-15-32-35(26(29)2)36-37-39(32)4/h5-6,10-15,22,30H,7-9,16-21,23-24H2,1-4H3	RYATWPZKKNYZPW-UHFFFAOYSA-N	304807	3-(Pyrrolidin-1-yl)propyl 3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoate::US10144731, Example 106	Kelch-like ECH-associated protein 1 [321-609]	Human		 5500							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304807	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304807&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170197	381753511							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584757	CC(CN(C)C)OC(=O)CC(c1ccc(C)c(CN2CCN(C)c3ccccc3S2(=O)=O)c1)c1ccc2n(C)nnc2c1C	InChI=1S/C33H42N6O4S/c1-22-12-13-25(18-26(22)21-39-17-16-37(6)29-10-8-9-11-31(29)44(39,41)42)28(19-32(40)43-23(2)20-36(4)5)27-14-15-30-33(24(27)3)34-35-38(30)7/h8-15,18,23,28H,16-17,19-21H2,1-7H3	XGHQHSHDBJZAOQ-UHFFFAOYSA-N	304808	1-(Dimethylamino)propan-2-yl 3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoate::US10144731, Example 107	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304808	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304808&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170645	381753512							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584758	CN1CCN(Cc2cc(ccc2C)C(CC(=O)OCCCN2CCOCC2)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc12	InChI=1S/C35H44N6O5S/c1-25-10-11-27(22-28(25)24-41-16-15-38(3)31-8-5-6-9-33(31)47(41,43)44)30(29-12-13-32-35(26(29)2)36-37-39(32)4)23-34(42)46-19-7-14-40-17-20-45-21-18-40/h5-6,8-13,22,30H,7,14-21,23-24H2,1-4H3	QHHJBFGEOQGEIC-UHFFFAOYSA-N	304809	3-morpholinopropyl 3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoate::US10144731, Example 108	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304809	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304809&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170771	381753513							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584759	COC(=O)CC(c1ccc(C)c(CN2CCN(C)c3ccccc3S2(=O)=O)c1)c1ccc2n(C)nnc2c1C	InChI=1S/C29H33N5O4S/c1-19-10-11-21(24(17-28(35)38-5)23-12-13-26-29(20(23)2)30-31-33(26)4)16-22(19)18-34-15-14-32(3)25-8-6-7-9-27(25)39(34,36)37/h6-13,16,24H,14-15,17-18H2,1-5H3	UQZOVMSFIABCOG-UHFFFAOYSA-N	304810	Methyl 3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoate::US10144731, Example 109	Kelch-like ECH-associated protein 1 [321-609]	Human		 5500							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304810	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304810&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118188758	381753514							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584760	CN1CCCC(C1)OC(=O)CC(c1ccc(C)c(CN2CCN(C)c3ccccc3S2(=O)=O)c1)c1ccc2n(C)nnc2c1C	InChI=1S/C34H42N6O4S/c1-23-12-13-25(19-26(23)21-40-18-17-38(4)30-10-6-7-11-32(30)45(40,42)43)29(20-33(41)44-27-9-8-16-37(3)22-27)28-14-15-31-34(24(28)2)35-36-39(31)5/h6-7,10-15,19,27,29H,8-9,16-18,20-22H2,1-5H3	XHLFTXPROSAUAI-UHFFFAOYSA-N	304811	1-Methylpiperidin-3-yl 3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoate::US10144731, Example 111	Kelch-like ECH-associated protein 1 [321-609]	Human		 5500							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304811	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304811&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170677	381753515							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584761	CN1CCC[C@H]1COC(=O)CC(c1ccc(C)c(CN2CCN(C)c3ccccc3S2(=O)=O)c1)c1ccc2n(C)nnc2c1C |r|	InChI=1S/C34H42N6O4S/c1-23-12-13-25(19-26(23)21-40-18-17-38(4)30-10-6-7-11-32(30)45(40,42)43)29(20-33(41)44-22-27-9-8-16-37(27)3)28-14-15-31-34(24(28)2)35-36-39(31)5/h6-7,10-15,19,27,29H,8-9,16-18,20-22H2,1-5H3	PFCGOQHTVTVEGR-UHFFFAOYSA-N	304812	((S)-1-Methylpyrrolidin-2-yl)methyl 3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoate::US10144731, Example 112	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304812	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304812&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118188759	381753516							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584762	CN1CCN(Cc2cc(ccc2C)C(CC(=O)OCC2CCNC2)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc12	InChI=1S/C33H40N6O4S/c1-22-9-10-25(17-26(22)20-39-16-15-37(3)29-7-5-6-8-31(29)44(39,41)42)28(18-32(40)43-21-24-13-14-34-19-24)27-11-12-30-33(23(27)2)35-36-38(30)4/h5-12,17,24,28,34H,13-16,18-21H2,1-4H3	BGZLVEMQAMFUGJ-UHFFFAOYSA-N	304813	Pyrrolidin-3-ylmethyl 3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoate::US10144731, Example 113	Kelch-like ECH-associated protein 1 [321-609]	Human		 5500							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304813	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304813&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170493	381753517							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584763	CN1CCC(CC1)OC(=O)CC(c1ccc(C)c(CN2CCN(C)c3ccccc3S2(=O)=O)c1)c1ccc2n(C)nnc2c1C	InChI=1S/C34H42N6O4S/c1-23-10-11-25(20-26(23)22-40-19-18-38(4)30-8-6-7-9-32(30)45(40,42)43)29(21-33(41)44-27-14-16-37(3)17-15-27)28-12-13-31-34(24(28)2)35-36-39(31)5/h6-13,20,27,29H,14-19,21-22H2,1-5H3	SQYPJRMWUTXJDV-UHFFFAOYSA-N	304814	1-Methylpiperidin-4-yl 3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)propanoate::US10144731, Example 114	Kelch-like ECH-associated protein 1 [321-609]	Human		 5500							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304814	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304814&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170629	381753518							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584764	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C27H28N4O5S/c1-17-8-9-19(22(14-27(32)33)20-10-11-24-23(13-20)28-29-30(24)3)12-21(17)16-31-15-18(2)36-25-6-4-5-7-26(25)37(31,34)35/h4-13,18,22H,14-16H2,1-3H3,(H,32,33)	YVVSLYWCORNKAO-UHFFFAOYSA-N	304743	US10144731, Example 29::3-(1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::BDBM304815	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304743	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304743&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170055	381753447							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584765	COc1cc(cc2nnn(C)c12)C(CC(O)=O)c1ccc(C)c(CN(C(C)C)S(=O)(=O)c2ccccc2)c1	InChI=1S/C28H32N4O5S/c1-18(2)32(38(35,36)23-9-7-6-8-10-23)17-22-13-20(12-11-19(22)3)24(16-27(33)34)21-14-25-28(26(15-21)37-5)31(4)30-29-25/h6-15,18,24H,16-17H2,1-5H3,(H,33,34)	GXKFLWFIKGXVFH-UHFFFAOYSA-N	304816	Ethyl 3-(3-((N-isopropylphenylsulfonamido)methyl)-4-methylphenyl)-3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoate::US10144731, Example 116	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304816	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304816&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118169943	381753520							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584766	C[C@@H]1CN(Cc2cc(ccc2C(F)(F)F)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C28H27F3N4O5S/c1-16-14-35(41(38,39)25-7-5-4-6-24(25)40-16)15-19-12-18(8-10-22(19)28(29,30)31)21(13-26(36)37)20-9-11-23-27(17(20)2)32-33-34(23)3/h4-12,16,21H,13-15H2,1-3H3,(H,36,37)	KJTROJDEHGPKAA-UHFFFAOYSA-N	304817	3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-(trifluoromethyl)phenyl)propanoic acid::US10144731, Example 117	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304817	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304817&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170742	381753521							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584767	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2Cl)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C27H27ClN4O5S/c1-16-8-9-18(21(13-25(33)34)20-10-11-22-27(26(20)28)29-30-31(22)3)12-19(16)15-32-14-17(2)37-23-6-4-5-7-24(23)38(32,35)36/h4-12,17,21H,13-15H2,1-3H3,(H,33,34)	KWYMBFUQBRMBQX-UHFFFAOYSA-N	304818	3-(4-Chloro-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 118	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304818	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304818&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170151	381753522							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584768	CC(C(c1ccc(C)c(CN(C)S(=O)(=O)c2ccccc2)c1)c1ccc2n(C)nnc2c1)C(O)=O	InChI=1S/C26H28N4O4S/c1-17-10-11-19(14-21(17)16-29(3)35(33,34)22-8-6-5-7-9-22)25(18(2)26(31)32)20-12-13-24-23(15-20)27-28-30(24)4/h5-15,18,25H,16H2,1-4H3,(H,31,32)	KZOPELYEZBBUIV-UHFFFAOYSA-N	304819	2-Methyl-3-(1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((N-methylphenylsulfonamido)methyl)phenyl)propanoic acid::US10144731, Example 119	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304819	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304819&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170409	381753523							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584769	CC(C(c1ccc(C)c(CN2CCN(C)c3ccccc3S2(=O)=O)c1)c1ccc2n(C)nnc2c1C)C(O)=O |w:3.2|	InChI=1S/C29H33N5O4S/c1-18-10-11-21(27(20(3)29(35)36)23-12-13-25-28(19(23)2)30-31-33(25)5)16-22(18)17-34-15-14-32(4)24-8-6-7-9-26(24)39(34,37)38/h6-13,16,20,27H,14-15,17H2,1-5H3,(H,35,36)	GFARMNLPSPHGIR-UHFFFAOYSA-N	304820	2-methyl-3-(1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((N-methylphenylsulfonamido)methyl)phenyl)propanoic acid::US10144731, Example 120	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304820	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304820&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170111	381753524							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584770	CC([C@@H](c1ccc(C)c(CN2CCN(C)c3ccccc3S2(=O)=O)c1)c1ccc2n(C)nnc2c1C)C(O)=O |r|	InChI=1S/C29H33N5O4S/c1-18-10-11-21(27(20(3)29(35)36)23-12-13-25-28(19(23)2)30-31-33(25)5)16-22(18)17-34-15-14-32(4)24-8-6-7-9-26(24)39(34,37)38/h6-13,16,20,27H,14-15,17H2,1-5H3,(H,35,36)	GFARMNLPSPHGIR-UHFFFAOYSA-N	304821	US10144731, Example 121	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304821	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304821&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			137554658	381753525							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584771	CC([C@H](c1ccc(C)c(CN2CCN(C)c3ccccc3S2(=O)=O)c1)c1ccc2n(C)nnc2c1C)C(O)=O |r|	InChI=1S/C29H33N5O4S/c1-18-10-11-21(27(20(3)29(35)36)23-12-13-25-28(19(23)2)30-31-33(25)5)16-22(18)17-34-15-14-32(4)24-8-6-7-9-26(24)39(34,37)38/h6-13,16,20,27H,14-15,17H2,1-5H3,(H,35,36)	GFARMNLPSPHGIR-UHFFFAOYSA-N	304822	US10144731, Example 122	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304822	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304822&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			137554659	381753526							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584772	C[C@@H]1CN(Cc2cc(ccc2C)C(CCc2c[nH]nn2)CC(O)=O)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C24H28N4O5S/c1-16-7-8-18(19(12-24(29)30)9-10-21-13-25-27-26-21)11-20(16)15-28-14-17(2)33-22-5-3-4-6-23(22)34(28,31)32/h3-8,11,13,17,19H,9-10,12,14-15H2,1-2H3,(H,29,30)(H,25,26,27)	CHDWDCOIXZPZNY-UHFFFAOYSA-N	304823	3-(4-Methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)-5-(1H-1,2,3-triazol-4-yl)pentanoic acid::US10144731, Example 123	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304823	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304823&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			137554660	381753527							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584773	C[C@@H]1CN(Cc2cc(ccc2C)C(CCc2cn(Cc3ccccc3)nn2)CC(O)=O)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C31H34N4O5S/c1-22-12-13-25(16-27(22)20-35-18-23(2)40-29-10-6-7-11-30(29)41(35,38)39)26(17-31(36)37)14-15-28-21-34(33-32-28)19-24-8-4-3-5-9-24/h3-13,16,21,23,26H,14-15,17-20H2,1-2H3,(H,36,37)	BOEKOLYWXVRUED-UHFFFAOYSA-N	304824	5-(1-Benzyl-1H-1,2,3-triazol-4-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)pentanoic acid::US10144731, Example 124	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304824	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304824&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118188761	381753528							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584774	C[C@@H]1CN(Cc2cc(ccc2C)C(CCc2cnn(C)n2)CC(O)=O)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C25H30N4O5S/c1-17-8-9-19(20(13-25(30)31)10-11-22-14-26-28(3)27-22)12-21(17)16-29-15-18(2)34-23-6-4-5-7-24(23)35(29,32)33/h4-9,12,14,18,20H,10-11,13,15-16H2,1-3H3,(H,30,31)	UEORTKJCUOEYPP-UHFFFAOYSA-N	304825	5-(2-Methyl-2H-1,2,3-triazol-4-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)pentanoic acid::US10144731, Example 125	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304825	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304825&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170725	381753529							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584775	C[C@@H]1CN(Cc2cc(ccc2C)C(CCc2cn(C)nn2)CC(O)=O)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C25H30N4O5S/c1-17-8-9-19(20(13-25(30)31)10-11-22-16-28(3)27-26-22)12-21(17)15-29-14-18(2)34-23-6-4-5-7-24(23)35(29,32)33/h4-9,12,16,18,20H,10-11,13-15H2,1-3H3,(H,30,31)	XKXXEUFAYDHYPN-UHFFFAOYSA-N	304826	5-(1-Methyl-1H-1,2,3-triazol-4-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)pentanoic acid::US10144731, Example 126	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304826	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304826&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170463	381753530							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584776	CCn1cc(CCC(CC(O)=O)c2ccc(C)c(CN3C[C@@H](C)Oc4ccccc4S3(=O)=O)c2)nn1 |r|	InChI=1S/C26H32N4O5S/c1-4-29-17-23(27-28-29)12-11-21(14-26(31)32)20-10-9-18(2)22(13-20)16-30-15-19(3)35-24-7-5-6-8-25(24)36(30,33)34/h5-10,13,17,19,21H,4,11-12,14-16H2,1-3H3,(H,31,32)	VPBZLUCAQZZNOB-UHFFFAOYSA-N	304827	5-(1-Ethyl-1H-1,2,3-triazol-4-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)pentanoic acid::US10144731, Example 127	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304827	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304827&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118188869	381753531							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584777	COc1cc(cc2nnn(C)c12)C(CC(O)=O)c1ccc(C)c(CN2C[C@@H](C)Oc3ccncc3S2(=O)=O)c1 |r|	InChI=1S/C27H29N5O6S/c1-16-5-6-18(21(12-26(33)34)19-10-22-27(24(11-19)37-4)31(3)30-29-22)9-20(16)15-32-14-17(2)38-23-7-8-28-13-25(23)39(32,35)36/h5-11,13,17,21H,12,14-15H2,1-4H3,(H,33,34)	HPTOTBDEYJWXMS-UHFFFAOYSA-N	304828	3-(7-Methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-pyrido[4,3-b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 128	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304828	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304828&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170652	381753532							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584778	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2cnccc2O1 |r|	InChI=1S/C27H29N5O5S/c1-16-5-6-19(22(12-26(33)34)21-7-8-23-27(18(21)3)29-30-31(23)4)11-20(16)15-32-14-17(2)37-24-9-10-28-13-25(24)38(32,35)36/h5-11,13,17,22H,12,14-15H2,1-4H3,(H,33,34)	BYWWNBFIESJIJW-UHFFFAOYSA-N	304829	3-(1,4-Dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-pyrido[4,3-b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 129	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304829	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304829&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170968	381753533							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584779	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2C(F)(F)F)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C28H27F3N4O5S/c1-16-8-9-18(12-19(16)15-35-14-17(2)40-23-6-4-5-7-24(23)41(35,38)39)21(13-25(36)37)20-10-11-22-27(32-33-34(22)3)26(20)28(29,30)31/h4-12,17,21H,13-15H2,1-3H3,(H,36,37)	UNBMJIHNTHTIKI-UHFFFAOYSA-N	304830	3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)-3-(1-methyl-4-(trifluoromethyl)-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 130	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304830	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304830&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170597	381753534							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584780	COc1cc(cc2nnn(C)c12)C(CC(O)=O)c1ccc(c(CN2C[C@@H](C)Oc3ccccc3S2(=O)=O)c1)C(F)(F)F |r|	InChI=1S/C28H27F3N4O6S/c1-16-14-35(42(38,39)25-7-5-4-6-23(25)41-16)15-19-10-17(8-9-21(19)28(29,30)31)20(13-26(36)37)18-11-22-27(24(12-18)40-3)34(2)33-32-22/h4-12,16,20H,13-15H2,1-3H3,(H,36,37)	MVHXCKOOPXKCMR-UHFFFAOYSA-N	304831	3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-(trifluoromethyl)phenyl)propanoic acid::US10144731, Example 131	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304831	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304831&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170706	381753535							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584781	COc1cc(C(CC(O)=O)c2ccc(C)c(CN3C[C@@H](C)Oc4ccccc4S3(=O)=O)c2)c(C)c2nnn(C)c12 |r|	InChI=1S/C29H32N4O6S/c1-17-10-11-20(12-21(17)16-33-15-18(2)39-24-8-6-7-9-26(24)40(33,36)37)23(14-27(34)35)22-13-25(38-5)29-28(19(22)3)30-31-32(29)4/h6-13,18,23H,14-16H2,1-5H3,(H,34,35)	QVAILDBNBWBUPT-UHFFFAOYSA-N	304832	3-(7-Methoxy-1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 132	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304832	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304832&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			122653343	381753536							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584782	CCn1ccc(cc1=O)C(CC(O)=O)c1ccc(C)c(CN2C[C@@H](C)Oc3ccccc3S2(=O)=O)c1 |r|	InChI=1S/C27H30N2O6S/c1-4-28-12-11-21(14-26(28)30)23(15-27(31)32)20-10-9-18(2)22(13-20)17-29-16-19(3)35-24-7-5-6-8-25(24)36(29,33)34/h5-14,19,23H,4,15-17H2,1-3H3,(H,31,32)	SZRUZELXIPIZEX-UHFFFAOYSA-N	304833	3-(1-Ethyl-2-oxo-1,2-dihydropyridin-4-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 133	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304833	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304833&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170093	381753537							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584783	CCCn1ccc(cc1=O)C(CC(O)=O)c1ccc(C)c(CN2C[C@@H](C)Oc3ccccc3S2(=O)=O)c1 |r|	InChI=1S/C28H32N2O6S/c1-4-12-29-13-11-22(15-27(29)31)24(16-28(32)33)21-10-9-19(2)23(14-21)18-30-17-20(3)36-25-7-5-6-8-26(25)37(30,34)35/h5-11,13-15,20,24H,4,12,16-18H2,1-3H3,(H,32,33)	IPCDQJRZKHHXLK-UHFFFAOYSA-N	304834	3-(4-Methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)-3-(2-oxo-1-propyl-1,2-dihydropyridin-4-yl)propanoic acid::US10144731, Example 134	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304834	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304834&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			122653283	381753538							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584784	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2cccc(=O)n2C)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C26H28N2O6S/c1-17-11-12-19(21(14-26(30)31)22-7-6-10-25(29)27(22)3)13-20(17)16-28-15-18(2)34-23-8-4-5-9-24(23)35(28,32)33/h4-13,18,21H,14-16H2,1-3H3,(H,30,31)	SMTWIJIRLUEPLY-UHFFFAOYSA-N	304835	3-(4-Methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)-3-(1-methyl-6-oxo-1,6-dihydropyridin-2-yl)propanoic acid::US10144731, Example 135	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304835	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304835&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170210	381753539							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584785	CN(Cc1cc(ccc1Cl)C(CC(O)=O)c1ccc2n(C)nnc2c1)S(C)(=O)=O	InChI=1S/C19H21ClN4O4S/c1-23(29(3,27)28)11-14-8-12(4-6-16(14)20)15(10-19(25)26)13-5-7-18-17(9-13)21-22-24(18)2/h4-9,15H,10-11H2,1-3H3,(H,25,26)	USDLDJOPUXHGLC-UHFFFAOYSA-N	50180852	CHEMBL3819169::US10144731, Example 136	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50180852	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50180852&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170474	346549845		CHEMBL3819169					1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584786	COc1cc(cc2nnn(C)c12)C(CC(O)=O)c1ccc(C)c(CN(C)S(=O)(=O)c2ccccc2)c1	InChI=1S/C26H28N4O5S/c1-17-10-11-18(12-20(17)16-29(2)36(33,34)21-8-6-5-7-9-21)22(15-25(31)32)19-13-23-26(24(14-19)35-4)30(3)28-27-23/h5-14,22H,15-16H2,1-4H3,(H,31,32)	VVWDXVKKAYFKNL-UHFFFAOYSA-N	304837	3-(7-methoxy-1-methyl-1H-1,2,3-benzotriazol-5-yl)-3-{4-methyl-3-[(N-methylbenzenesulfonamido)methyl]phenyl}propanoic acid::US10144731, Example 145	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304837	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304837&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170044	381753541							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584787	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(CC)nnc3c2C)S(=O)(=O)c2cccnc2O1 |r|	InChI=1S/C29H33N5O5S/c1-5-22-17-33(40(37,38)26-8-7-13-30-29(26)39-22)16-21-14-20(10-9-18(21)3)24(15-27(35)36)23-11-12-25-28(19(23)4)31-32-34(25)6-2/h7-14,22,24H,5-6,15-17H2,1-4H3,(H,35,36)	FSVDYFNASNQHCE-UHFFFAOYSA-N	304755	US10144731, Example 40::BDBM304886::3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-3-(1-ethyl-4-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::BDBM304885::BDBM304838	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304755	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304755&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118169924	381753459							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584788	CCn1nnc2c(C)c(ccc12)C(CC(O)=O)c1ccc(c(CN2C[C@@H](C)Oc3ccccc3S2(=O)=O)c1)C(F)(F)F |r|	InChI=1S/C29H29F3N4O5S/c1-4-36-24-12-10-21(18(3)28(24)33-34-36)22(14-27(37)38)19-9-11-23(29(30,31)32)20(13-19)16-35-15-17(2)41-25-7-5-6-8-26(25)42(35,39)40/h5-13,17,22H,4,14-16H2,1-3H3,(H,37,38)	UYHZTQMYFLSOSC-UHFFFAOYSA-N	304839	3-(1-Ethyl-4-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-(trifluoromethyl)phenyl)propanoic acid::US10144731, Example 147	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304839	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304839&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170392	381753543							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584789	C[C@@H]1CN(Cc2cc(ccc2C)C(Cc2nnn[nH]2)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C28H30N8O3S/c1-17-9-10-20(13-21(17)16-36-15-18(2)39-25-7-5-6-8-26(25)40(36,37)38)23(14-27-29-32-33-30-27)22-11-12-24-28(19(22)3)31-34-35(24)4/h5-13,18,23H,14-16H2,1-4H3,(H,29,30,32,33)	BQUWAECBQDXVJF-UHFFFAOYSA-N	304840	(4R)-2-(5-(1-(1,4-Dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-2-(1H-tetrazol-5-yl)ethyl)-2-methylbenzyl)-4-methyl-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepine 1,1-dioxide::US10144731, Example 148	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304840	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304840&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170685	381753544							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584790	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ncccc2O1 |r|	InChI=1S/C27H29N5O5S/c1-16-7-8-19(22(13-25(33)34)21-9-10-23-26(18(21)3)29-30-31(23)4)12-20(16)15-32-14-17(2)37-24-6-5-11-28-27(24)38(32,35)36/h5-12,17,22H,13-15H2,1-4H3,(H,33,34)	WASOKHKOUNQOSK-UHFFFAOYSA-N	304841	3-(1,4-Dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-pyrido[3,2-b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 149	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304841	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304841&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170661	381753545							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584791	CCn1cc(CCC(CC(O)=O)c2ccc(C)c(CN3C[C@@H](C)Oc4cccnc4S3(=O)=O)c2)nn1 |r|	InChI=1S/C25H31N5O5S/c1-4-29-16-22(27-28-29)10-9-20(13-24(31)32)19-8-7-17(2)21(12-19)15-30-14-18(3)35-23-6-5-11-26-25(23)36(30,33)34/h5-8,11-12,16,18,20H,4,9-10,13-15H2,1-3H3,(H,31,32)	PPMXGPZSQLHUHK-UHFFFAOYSA-N	304842	5-(1-Ethyl-1H-1,2,3-triazol-4-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-pyrido[3,2-b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)pentanoic acid::US10144731, Example 150	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304842	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304842&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170323	381753546							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584792	CCn1cc(CCC(CC(O)=O)c2ccc(C)c(CN3CC(C)Oc4ncccc4S3(=O)=O)c2)nn1 |w:21.21|	InChI=1S/C25H31N5O5S/c1-4-29-16-22(27-28-29)10-9-20(13-24(31)32)19-8-7-17(2)21(12-19)15-30-14-18(3)35-25-23(36(30,33)34)6-5-11-26-25/h5-8,11-12,16,18,20H,4,9-10,13-15H2,1-3H3,(H,31,32)	HRXPLCSOQNEFRZ-UHFFFAOYSA-N	304843	5-(1-Ethyl-1H-1,2,3-triazol-4-yl)-3-(4-methyl-3-((4-methyl-1,1-dioxido-4,5-dihydropyrido[2,34][1,2]thiazepin-2(3H)-yl)methyl)phenyl)pentanoic acid::US10144731, Example 151	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304843	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304843&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			122660638	381753547							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584793	CCn1cc(CCC(CC(O)=O)c2ccc(C)c(CN3CC(C)Cc4ccncc4S3(=O)=O)c2)nn1 |w:21.21|	InChI=1S/C26H33N5O4S/c1-4-30-17-24(28-29-30)8-7-21(13-26(32)33)20-6-5-19(3)23(12-20)16-31-15-18(2)11-22-9-10-27-14-25(22)36(31,34)35/h5-6,9-10,12,14,17-18,21H,4,7-8,11,13,15-16H2,1-3H3,(H,32,33)	NVMUELBMBSCZMG-UHFFFAOYSA-N	304844	5-(1-Ethyl-1H-1,2,3-triazol-4-yl)-3-(4-methyl-3-((4-methyl-1,1-dioxido-4,5-dihydropyrido[4,3-f][1,2]thiazepin-2(3H)-yl)methyl)phenyl)pentanoic acid::US10144731, Example 152	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304844	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304844&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170312	381753548							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584794	CCn1cc(CCC(CC(O)=O)c2ccc(C)c(CN3C[C@@H](C)Oc4cnccc4S3(=O)=O)c2)nn1 |r|	InChI=1S/C25H31N5O5S/c1-4-29-16-22(27-28-29)8-7-20(12-25(31)32)19-6-5-17(2)21(11-19)15-30-14-18(3)35-23-13-26-10-9-24(23)36(30,33)34/h5-6,9-11,13,16,18,20H,4,7-8,12,14-15H2,1-3H3,(H,31,32)	GANBXEQLAOHECS-UHFFFAOYSA-N	304845	5-(1-Ethyl-1H-1,2,3-triazol-4-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-pyrido[3,4-b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)pentanoic acid::US10144731, Example 153	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304845	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304845&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170599	381753549							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584795	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccncc2O1 |r|	InChI=1S/C27H29N5O5S/c1-16-5-6-19(22(12-26(33)34)21-7-8-23-27(18(21)3)29-30-31(23)4)11-20(16)15-32-14-17(2)37-24-13-28-10-9-25(24)38(32,35)36/h5-11,13,17,22H,12,14-15H2,1-4H3,(H,33,34)	XGXKKQDKTWYURX-UHFFFAOYSA-N	304846	3-(1,4-Dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-pyrido[3,4-b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 154	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304846	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304846&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170563	381753550							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584796	COc1cc(cc2nnn(C)c12)C(CC(O)=O)c1ccc(C)c(CN2CC(C)c3ccccc3S2(=O)=O)c1	InChI=1S/C28H30N4O5S/c1-17-9-10-19(11-21(17)16-32-15-18(2)22-7-5-6-8-26(22)38(32,35)36)23(14-27(33)34)20-12-24-28(25(13-20)37-4)31(3)30-29-24/h5-13,18,23H,14-16H2,1-4H3,(H,33,34)	CEYWUMVWUJLPTE-UHFFFAOYSA-N	304847	3-(7-Methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[e][1,2]thiazin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 155	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304847	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304847&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170315	381753551							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584797	CCC1CN(Cc2cc(ccc2C)C(CC(O)=O)c2cc(OC)c3n(C)nnc3c2)S(=O)(=O)c2ccccc12	InChI=1S/C29H32N4O5S/c1-5-19-16-33(39(36,37)27-9-7-6-8-23(19)27)17-22-12-20(11-10-18(22)2)24(15-28(34)35)21-13-25-29(26(14-21)38-4)32(3)31-30-25/h6-14,19,24H,5,15-17H2,1-4H3,(H,34,35)	IMVRDTIUXGSVRZ-UHFFFAOYSA-N	304848	3-(3-((4-Ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[e][1,2]thiazin-2-yl)methyl)-4-methylphenyl)-3-(7-methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 156	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304848	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304848&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170823	381753552							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584798	C[C@H]1CN(Cc2cc(ccc2C)C(CCC(=O)N(C)Cc2ccccc2)CC(O)=O)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C31H36N2O6S/c1-22-13-14-25(26(18-31(35)36)15-16-30(34)32(3)20-24-9-5-4-6-10-24)17-27(22)21-33-19-23(2)39-28-11-7-8-12-29(28)40(33,37)38/h4-14,17,23,26H,15-16,18-21H2,1-3H3,(H,35,36)	VLUCKJQHVVDJRS-UHFFFAOYSA-N	304849	6-(Benzyl(methyl)amino)-3-(4-methyl-3-(((S)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)-6-oxohexanoic acid::US10144731, Example 157	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304849	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304849&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170050	381753553							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584799	CC1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc(F)cc2C)S(=O)(=O)c2ccc(CCCN(C)C)cc2C1	InChI=1S/C33H41FN2O4S/c1-22-15-27-17-25(7-6-14-35(4)5)9-13-32(27)41(39,40)36(20-22)21-28-18-26(10-8-23(28)2)31(19-33(37)38)30-12-11-29(34)16-24(30)3/h8-13,16-18,22,31H,6-7,14-15,19-21H2,1-5H3,(H,37,38)	BQKAFUSUOCKJSO-UHFFFAOYSA-N	304850	3-(3-((7-(3-(Dimethylamino)propyl)-4-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2]thiazepin-2(3H)-yl)methyl)-4-methylphenyl)-3-(4-fluoro-2-methylphenyl)propanoic acid::US10144731, Example 158	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304850	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304850&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170011	381753554							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584800	CNC(=O)CCC1CC(=O)O[C@H]2CN(Cc3cc1ccc3C)S(=O)(=O)c1ccccc1O2 |r|	InChI=1S/C23H26N2O6S/c1-15-7-8-16-11-18(15)13-25-14-23(30-19-5-3-4-6-20(19)32(25,28)29)31-22(27)12-17(16)9-10-21(26)24-2/h3-8,11,17,23H,9-10,12-14H2,1-2H3,(H,24,26)	CQOQRYVBFZKAPT-UHFFFAOYSA-N	304851	3-(4-Methyl-3-(((S)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)-6-(methylamino)-6-oxohexanoic acid::US10144731, Example 159	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304851	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304851&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118188811	381753555							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584801	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2c(C)cc(F)cc2CN(C)C)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C31H37FN2O5S/c1-6-26-19-34(40(37,38)29-10-8-7-9-28(29)39-26)18-23-14-22(12-11-20(23)2)27(16-30(35)36)31-21(3)13-25(32)15-24(31)17-33(4)5/h7-15,26-27H,6,16-19H2,1-5H3,(H,35,36)	JIZILTYHXGMOFC-UHFFFAOYSA-N	304852	3-(2-((Dimethylamino)methyl)-4-fluoro-6-methylphenyl)-3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)propanoic acid::US10144731, Example 160	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304852	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304852&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170381	381753556							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584802	COc1cnc(C)c(c1)C(CC(O)=O)c1ccc(C)c(CN2C[C@@H](C)Oc3ccccc3S2(=O)=O)c1 |r|	InChI=1S/C27H30N2O6S/c1-17-9-10-20(24(13-27(30)31)23-12-22(34-4)14-28-19(23)3)11-21(17)16-29-15-18(2)35-25-7-5-6-8-26(25)36(29,32)33/h5-12,14,18,24H,13,15-16H2,1-4H3,(H,30,31)	RRSZSRNHVNNEPA-UHFFFAOYSA-N	304853	3-(5-Methoxy-2-methylpyridin-3-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 161	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304853	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304853&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118169812	381753557							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584803	C[C@@H]1CN(Cc2cc(ccc2C)C(CCc2ccccc2C)CC(O)=O)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C29H33NO5S/c1-20-8-4-5-9-23(20)14-15-25(17-29(31)32)24-13-12-21(2)26(16-24)19-30-18-22(3)35-27-10-6-7-11-28(27)36(30,33)34/h4-13,16,22,25H,14-15,17-19H2,1-3H3,(H,31,32)	BBAQYZLFACJTEU-UHFFFAOYSA-N	304854	BDBM304862::3-(4-Methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)-5-(o-tolyl)pentanoic acid::US10144731, Example 162	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304854	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304854&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170697	381753558							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584804	CCn1cnc(c1)C(CC(O)=O)c1ccc(C)c(CN2C[C@@H](C)Oc3ccccc3S2(=O)=O)c1 |r|	InChI=1S/C25H29N3O5S/c1-4-27-15-22(26-16-27)21(12-25(29)30)19-10-9-17(2)20(11-19)14-28-13-18(3)33-23-7-5-6-8-24(23)34(28,31)32/h5-11,15-16,18,21H,4,12-14H2,1-3H3,(H,29,30)	JSTFODLCAFQDAZ-UHFFFAOYSA-N	304855	3-(1-Ethyl-1H-imidazol-4-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 163	Kelch-like ECH-associated protein 1 [321-609]	Human		 5500							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304855	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304855&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170556	381753559							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584805	CCn1cc(CCC(CC(O)=O)c2ccc(C)c(CN3C[C@@H](C)Oc4ccccc4S3(=O)=O)c2)cn1 |r|	InChI=1S/C27H33N3O5S/c1-4-29-17-21(15-28-29)10-12-23(14-27(31)32)22-11-9-19(2)24(13-22)18-30-16-20(3)35-25-7-5-6-8-26(25)36(30,33)34/h5-9,11,13,15,17,20,23H,4,10,12,14,16,18H2,1-3H3,(H,31,32)	KEWXNRYLPLVBKW-UHFFFAOYSA-N	304856	5-(1-Ethyl-1H-pyrazol-4-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)pentanoic acid::US10144731, Example 164	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304856	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304856&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170206	381753560							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584806	COCCCC(CC(O)=O)c1ccc(C)c(CN2C[C@@H](C)Oc3ccccc3S2(=O)=O)c1 |r|	InChI=1S/C24H31NO6S/c1-17-10-11-20(19(14-24(26)27)7-6-12-30-3)13-21(17)16-25-15-18(2)31-22-8-4-5-9-23(22)32(25,28)29/h4-5,8-11,13,18-19H,6-7,12,14-16H2,1-3H3,(H,26,27)	UGALCWYPMZIMJQ-UHFFFAOYSA-N	304857	6-Methoxy-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)hexanoic acid::US10144731, Example 165	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304857	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304857&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170410	381753561							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584807	CC1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2)S(=O)(=O)c2ccc(CCCNC(=O)OC(C)(C)C)cc2C1	InChI=1S/C36H45N5O6S/c1-23-16-28-17-25(8-7-15-37-35(44)47-36(3,4)5)10-14-33(28)48(45,46)41(21-23)22-29-18-26(11-9-24(29)2)30(20-34(42)43)27-12-13-32-31(19-27)38-39-40(32)6/h9-14,17-19,23,30H,7-8,15-16,20-22H2,1-6H3,(H,37,44)(H,42,43)	QVAJEJIFGDBUHQ-UHFFFAOYSA-N	304858	3-(3-((7-(3-((tert-Butoxycarbonyl)amino)propyl)-4-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2]thiazepin-2(3H)-yl)methyl)-4-methylphenyl)-3-(1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 166	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304858	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304858&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170543	381753562							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584808	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3CN(C)CCc3c2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C31H36N2O5S/c1-4-27-20-33(39(36,37)30-8-6-5-7-29(30)38-27)19-26-16-23(10-9-21(26)2)28(17-31(34)35)24-11-12-25-18-32(3)14-13-22(25)15-24/h5-12,15-16,27-28H,4,13-14,17-20H2,1-3H3,(H,34,35)	HTZLVFKYHDOFIL-UHFFFAOYSA-N	304859	3-(3-(((R)-4-Ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-3-(2-methyl-1,2,3,4-tetrahydroisoquinolin-6-yl)propanoic acid::US10144731, Example 167	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304859	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304859&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170632	381753563							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584809	CCn1cnc(CCC(CC(O)=O)c2ccc(C)c(CN3C[C@@H](C)Oc4ccccc4S3(=O)=O)c2)c1 |r|	InChI=1S/C27H33N3O5S/c1-4-29-17-24(28-18-29)12-11-22(14-27(31)32)21-10-9-19(2)23(13-21)16-30-15-20(3)35-25-7-5-6-8-26(25)36(30,33)34/h5-10,13,17-18,20,22H,4,11-12,14-16H2,1-3H3,(H,31,32)	NMVOOHUGPIZJBG-UHFFFAOYSA-N	304860	5-(1-Ethyl-1H-imidazol-4-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)pentanoic acid::US10144731, Example 168	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304860	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304860&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170528	381753564							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584810	C[C@@H]1CN(Cc2cc(ccc2C)C(CCc2cccnc2)CC(O)=O)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C27H30N2O5S/c1-19-9-11-22(23(15-27(30)31)12-10-21-6-5-13-28-16-21)14-24(19)18-29-17-20(2)34-25-7-3-4-8-26(25)35(29,32)33/h3-9,11,13-14,16,20,23H,10,12,15,17-18H2,1-2H3,(H,30,31)	GSFAKWDVAVVJHY-UHFFFAOYSA-N	304861	3-(4-Methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)-5-(pyridin-3-yl)pentanoic acid::US10144731, Example 169	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304861	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304861&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170785	381753565							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584811	C[C@@H]1CN(Cc2cc(ccc2C)C(CCc2ccccc2C)CC(O)=O)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C29H33NO5S/c1-20-8-4-5-9-23(20)14-15-25(17-29(31)32)24-13-12-21(2)26(16-24)19-30-18-22(3)35-27-10-6-7-11-28(27)36(30,33)34/h4-13,16,22,25H,14-15,17-19H2,1-3H3,(H,31,32)	BBAQYZLFACJTEU-UHFFFAOYSA-N	304854	BDBM304862::3-(4-Methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)-5-(o-tolyl)pentanoic acid::US10144731, Example 162	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304854	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304854&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170697	381753558							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584812	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2cc(CCN(C)C)c(F)cc2C)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C31H37FN2O5S/c1-20-10-11-23(27(17-31(35)36)26-16-24(12-13-33(4)5)28(32)14-21(26)2)15-25(20)19-34-18-22(3)39-29-8-6-7-9-30(29)40(34,37)38/h6-11,14-16,22,27H,12-13,17-19H2,1-5H3,(H,35,36)	WQULRZZFYDPKTH-UHFFFAOYSA-N	304863	3-(5-(2-(Dimethylamino)ethyl)-4-fluoro-2-methylphenyl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid::US10144731, Example 171	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304863	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304863&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170310	381753567							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584813	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3CN(C)Cc3c2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C30H34N2O5S/c1-4-26-19-32(38(35,36)29-8-6-5-7-28(29)37-26)18-24-13-21(10-9-20(24)2)27(15-30(33)34)22-11-12-23-16-31(3)17-25(23)14-22/h5-14,26-27H,4,15-19H2,1-3H3,(H,33,34)	PRPJMTIHQARBAD-UHFFFAOYSA-N	304864	3-(3-(((R)-4-Ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-3-(2-methylisoindolin-5-yl)propanoic acid::US10144731, Example 172	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304864	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304864&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170067	381753568							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584814	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2cc(CCCN(C)C)c(F)cc2C)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C33H41FN2O5S/c1-6-27-21-36(42(39,40)32-12-8-7-11-31(32)41-27)20-26-17-24(14-13-22(26)2)29(19-33(37)38)28-18-25(10-9-15-35(4)5)30(34)16-23(28)3/h7-8,11-14,16-18,27,29H,6,9-10,15,19-21H2,1-5H3,(H,37,38)	IDWGQXZQNPNHGS-UHFFFAOYSA-N	304865	3-(5-(3-(Dimethylamino)propyl)-4-fluoro-2-methylphenyl)-3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)propanoic acid::US10144731, Example 173	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304865	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304865&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170780	381753569							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584815	CC(C)CCC(CC(O)=O)c1ccc(C)c(CN2C[C@@H](C)Oc3ccccc3S2(=O)=O)c1 |r|	InChI=1S/C25H33NO5S/c1-17(2)9-11-21(14-25(27)28)20-12-10-18(3)22(13-20)16-26-15-19(4)31-23-7-5-6-8-24(23)32(26,29)30/h5-8,10,12-13,17,19,21H,9,11,14-16H2,1-4H3,(H,27,28)	SINSEALUHHRXQF-UHFFFAOYSA-N	304866	6-Methyl-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)heptanoic acid::US10144731, Example 174	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304866	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304866&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170490	381753570							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584816	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2)S(=O)(=O)c2cc(Cl)ccc2O1 |r|	InChI=1S/C27H27ClN4O5S/c1-16-4-5-18(22(13-27(33)34)19-6-8-24-23(11-19)29-30-31(24)3)10-20(16)15-32-14-17(2)37-25-9-7-21(28)12-26(25)38(32,35)36/h4-12,17,22H,13-15H2,1-3H3,(H,33,34)	JSKSTRUXUJHPPP-UHFFFAOYSA-N	304867	3-(3-(((R)-8-Chloro-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-3-(1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 175	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304867	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304867&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170275	381753571							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584817	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2)S(=O)(=O)c2cc(ccc2O1)C#N |r|	InChI=1S/C28H27N5O5S/c1-17-4-6-20(23(13-28(34)35)21-7-8-25-24(12-21)30-31-32(25)3)11-22(17)16-33-15-18(2)38-26-9-5-19(14-29)10-27(26)39(33,36)37/h4-12,18,23H,13,15-16H2,1-3H3,(H,34,35)	WMOGSKRCIKIOJQ-UHFFFAOYSA-N	304868	3-(3-(((R)-8-Cyano-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-3-(1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 176	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304868	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304868&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118169819	381753572							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584818	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2)S(=O)(=O)c2cc(ccc2O1)C(N)=O |r|	InChI=1S/C28H29N5O6S/c1-16-4-5-18(22(13-27(34)35)19-6-8-24-23(11-19)30-31-32(24)3)10-21(16)15-33-14-17(2)39-25-9-7-20(28(29)36)12-26(25)40(33,37)38/h4-12,17,22H,13-15H2,1-3H3,(H2,29,36)(H,34,35)	LPMRCDNUPGZGDF-UHFFFAOYSA-N	304869	3-(3-(((R)-8-carbamoyl-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-3-(1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 177	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304869	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304869&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170194	381753573							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584819	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2cc(CN(C)C)c(F)cc2C)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C31H37FN2O5S/c1-6-25-19-34(40(37,38)30-10-8-7-9-29(30)39-25)18-23-14-22(12-11-20(23)2)27(16-31(35)36)26-15-24(17-33(4)5)28(32)13-21(26)3/h7-15,25,27H,6,16-19H2,1-5H3,(H,35,36)	SPZRBRCBCSIHAO-UHFFFAOYSA-N	304870	3-(5-((Dimethylamino)methyl)-4-fluoro-2-methylphenyl)-3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)propanoic acid::US10144731, Example 178	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304870	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304870&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118169787	381753574							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584820	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2cc(CCN(C)C)c(F)cc2C)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C32H39FN2O5S/c1-6-26-20-35(41(38,39)31-10-8-7-9-30(31)40-26)19-25-16-23(12-11-21(25)2)28(18-32(36)37)27-17-24(13-14-34(4)5)29(33)15-22(27)3/h7-12,15-17,26,28H,6,13-14,18-20H2,1-5H3,(H,36,37)	ZKSQTPIKIPUMJG-UHFFFAOYSA-N	304871	3-(5-(2-(Dimethylamino)ethyl)-4-fluoro-2-methylphenyl)-3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)propanoic acid::US10144731, Example 179	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304871	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304871&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170470	381753575							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584821	CC[C@@H]1CN(Cc2cc(ccc2C)C(C(N)C(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C29H33N5O5S/c1-5-21-16-34(40(37,38)25-9-7-6-8-24(25)39-21)15-20-14-19(11-10-17(20)2)26(27(30)29(35)36)22-12-13-23-28(18(22)3)31-32-33(23)4/h6-14,21,26-27H,5,15-16,30H2,1-4H3,(H,35,36)	YHTUWMPWCLKWCC-UHFFFAOYSA-N	304872	2-Amino-3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)propanoic acid::US10144731, Example 180	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304872	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304872&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170169	381753576							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584822	Cc1ccc(cc1CN1Cc2ccccc2CCS1(=O)=O)C(CC(O)=O)c1ccc2n(C)nnc2c1C	InChI=1S/C28H30N4O4S/c1-18-8-9-21(25(15-27(33)34)24-10-11-26-28(19(24)2)29-30-31(26)3)14-23(18)17-32-16-22-7-5-4-6-20(22)12-13-37(32,35)36/h4-11,14,25H,12-13,15-17H2,1-3H3,(H,33,34)	SEWYDCQSWUDUNQ-UHFFFAOYSA-N	304873	3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-((3,3-dioxido-4,5-dihydrobenzo[d][1,2]thiazepin-2(1H)-yl)methyl)-4-methylphenyl)propanoic acid::US10144731, Example 181	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304873	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304873&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170489	381753577							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584823	Cc1ccc(cc1CN1CC2CCCCC2CS1(=O)=O)C(CC(O)=O)c1ccc2n(C)nnc2c1C	InChI=1S/C27H34N4O4S/c1-17-8-9-19(12-22(17)15-31-14-20-6-4-5-7-21(20)16-36(31,34)35)24(13-26(32)33)23-10-11-25-27(18(23)2)28-29-30(25)3/h8-12,20-21,24H,4-7,13-16H2,1-3H3,(H,32,33)	RXICIKJEPOJGIF-UHFFFAOYSA-N	304874	3-(1,4-Dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-((2,2-dioxidohexahydro-1H-benzo[d][1,2]thiazin-3(4H)-yl)methyl)-4-methylphenyl)propanoic acid::US10144731, Example 182	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304874	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304874&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170723	381753578							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584824	Cc1ccc(cc1CN1Cc2ccccc2CS1(=O)=O)C(CC(O)=O)c1ccc2n(C)nnc2c1C	InChI=1S/C27H28N4O4S/c1-17-8-9-19(12-22(17)15-31-14-20-6-4-5-7-21(20)16-36(31,34)35)24(13-26(32)33)23-10-11-25-27(18(23)2)28-29-30(25)3/h4-12,24H,13-16H2,1-3H3,(H,32,33)	QRYZXQWLCHRQQQ-UHFFFAOYSA-N	304875	US10144731, Example 183::3-(1,4-Dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-((2,2-dioxido-1H-benzo[d][1,2]thiazin-3(4H)-yl)methyl)-4-methylphenyl)propanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304875	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304875&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170119	381753579							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584825	Cc1ccc(cc1CN1CC2CCCCC2CCS1(=O)=O)C(CC(O)=O)c1ccc2n(C)nnc2c1C	InChI=1S/C28H36N4O4S/c1-18-8-9-21(25(15-27(33)34)24-10-11-26-28(19(24)2)29-30-31(26)3)14-23(18)17-32-16-22-7-5-4-6-20(22)12-13-37(32,35)36/h8-11,14,20,22,25H,4-7,12-13,15-17H2,1-3H3,(H,33,34)	GFQRQKUOFVNFKW-UHFFFAOYSA-N	304876	US10144731, Example 184::3-(1,4-Dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-((3,3-dioxidooctahydrobenzo[d][1,2]thiazepin-2(1H)-yl)methyl)-4-methylphenyl)propanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304876	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304876&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170296	381753580							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584826	C[C@@H]1CN(Cc2cc(ccc2C)C(CCc2ccc(C)cc2)CC(O)=O)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C29H33NO5S/c1-20-8-11-23(12-9-20)13-15-25(17-29(31)32)24-14-10-21(2)26(16-24)19-30-18-22(3)35-27-6-4-5-7-28(27)36(30,33)34/h4-12,14,16,22,25H,13,15,17-19H2,1-3H3,(H,31,32)	BAPMTSPSGNUDMN-UHFFFAOYSA-N	304877	US10144731, Example 185::3-(4-Methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)-5-(p-tolyl)pentanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304877	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304877&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170019	381753581							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584827	CC1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc(F)cc2F)S(=O)(=O)c2ccc(CCCN(C)C)cc2C1	InChI=1S/C32H38F2N2O4S/c1-21-14-25-15-23(6-5-13-35(3)4)8-12-31(25)41(39,40)36(19-21)20-26-16-24(9-7-22(26)2)29(18-32(37)38)28-11-10-27(33)17-30(28)34/h7-12,15-17,21,29H,5-6,13-14,18-20H2,1-4H3,(H,37,38)	WIHQYZMEMCQRKR-UHFFFAOYSA-N	304878	US10144731, Example 186::3-(2,4-Difluorophenyl)-3-(3-((7-(3-(dimethylamino)propyl)-4-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2]thiazepin-2(3H)-yl)methyl)-4-methylphenyl)propanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304878	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304878&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170005	381753582							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584828	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3CCN(C)Cc3c2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C31H36N2O5S/c1-4-27-20-33(39(36,37)30-8-6-5-7-29(30)38-27)19-25-15-23(10-9-21(25)2)28(17-31(34)35)24-12-11-22-13-14-32(3)18-26(22)16-24/h5-12,15-16,27-28H,4,13-14,17-20H2,1-3H3,(H,34,35)	QLBKVJGMFUFAFO-UHFFFAOYSA-N	304879	US10144731, Example 187::3-(3-(((R)-4-Ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-3-(2-methyl-1,2,3,4-tetrahydroisoquinolin-7-yl)propanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304879	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304879&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118169992	381753583							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584829	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)C2CC2c2cn(C)nn2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C26H30N4O5S/c1-16-8-9-18(20(12-26(31)32)21-11-22(21)23-15-29(3)28-27-23)10-19(16)14-30-13-17(2)35-24-6-4-5-7-25(24)36(30,33)34/h4-10,15,17,20-22H,11-14H2,1-3H3,(H,31,32)	TWSWLFZHICHMLD-UHFFFAOYSA-N	304880	US10144731, Example 188::3-(2-(1-Methyl-1H-1,2,3-triazol-4-yl)cyclopropyl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304880	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304880&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170278	381753584							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584830	CC(C(c1ccc(C)c(CN2CCN(C)c3ccccc3S2(=O)=O)c1)c1ccc2n(C)nnc2c1C)C(O)=O	InChI=1S/C29H33N5O4S/c1-18-10-11-21(27(20(3)29(35)36)23-12-13-25-28(19(23)2)30-31-33(25)5)16-22(18)17-34-15-14-32(4)24-8-6-7-9-26(24)39(34,37)38/h6-13,16,20,27H,14-15,17H2,1-5H3,(H,35,36)	GFARMNLPSPHGIR-UHFFFAOYSA-N	304881	US10144731, Example 189N1::US10144731, Example 189M1	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304881	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304881&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170111	381753585							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584831	CC(C(c1ccc(C)c(CN2CCN(C)c3ccccc3S2(=O)=O)c1)c1ccc2n(C)nnc2c1C)C(O)=O	InChI=1S/C29H33N5O4S/c1-18-10-11-21(27(20(3)29(35)36)23-12-13-25-28(19(23)2)30-31-33(25)5)16-22(18)17-34-15-14-32(4)24-8-6-7-9-26(24)39(34,37)38/h6-13,16,20,27H,14-15,17H2,1-5H3,(H,35,36)	GFARMNLPSPHGIR-UHFFFAOYSA-N	304881	US10144731, Example 189N1::US10144731, Example 189M1	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304881	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304881&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170111	381753585							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584832	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C29H32N4O5S/c1-5-22-17-33(39(36,37)27-9-7-6-8-26(27)38-22)16-21-14-20(11-10-18(21)2)24(15-28(34)35)23-12-13-25-29(19(23)3)30-31-32(25)4/h6-14,22,24H,5,15-17H2,1-4H3,(H,34,35)	PSAYWSGFKCURFC-UHFFFAOYSA-N	304758	BDBM304884::BDBM304883::3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)propanoic acid::US10144731, Example 43	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304758	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304758&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170027	381753462							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584833	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C29H32N4O5S/c1-5-22-17-33(39(36,37)27-9-7-6-8-26(27)38-22)16-21-14-20(11-10-18(21)2)24(15-28(34)35)23-12-13-25-29(19(23)3)30-31-32(25)4/h6-14,22,24H,5,15-17H2,1-4H3,(H,34,35)	PSAYWSGFKCURFC-UHFFFAOYSA-N	304758	BDBM304884::BDBM304883::3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)propanoic acid::US10144731, Example 43	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304758	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304758&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170027	381753462							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584834	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(CC)nnc3c2C)S(=O)(=O)c2cccnc2O1 |r|	InChI=1S/C29H33N5O5S/c1-5-22-17-33(40(37,38)26-8-7-13-30-29(26)39-22)16-21-14-20(10-9-18(21)3)24(15-27(35)36)23-11-12-25-28(19(23)4)31-32-34(25)6-2/h7-14,22,24H,5-6,15-17H2,1-4H3,(H,35,36)	FSVDYFNASNQHCE-UHFFFAOYSA-N	304755	US10144731, Example 40::BDBM304886::3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-3-(1-ethyl-4-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::BDBM304885::BDBM304838	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304755	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304755&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118169924	381753459							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584835	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(CC)nnc3c2C)S(=O)(=O)c2cccnc2O1 |r|	InChI=1S/C29H33N5O5S/c1-5-22-17-33(40(37,38)26-8-7-13-30-29(26)39-22)16-21-14-20(10-9-18(21)3)24(15-27(35)36)23-11-12-25-28(19(23)4)31-32-34(25)6-2/h7-14,22,24H,5-6,15-17H2,1-4H3,(H,35,36)	FSVDYFNASNQHCE-UHFFFAOYSA-N	304755	US10144731, Example 40::BDBM304886::3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-3-(1-ethyl-4-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::BDBM304885::BDBM304838	Kelch-like ECH-associated protein 1 [321-609]	Human		<10							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304755	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304755&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118169924	381753459							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584836	CC[C@@H]1CN(Cc2cc(ccc2C)C(CCc2cn(CC)nn2)C(C)C(O)=O)S(=O)(=O)c2ccccc2O1 |r,w:14.14,23.25|	InChI=1S/C28H36N4O5S/c1-5-24-18-32(38(35,36)27-10-8-7-9-26(27)37-24)16-22-15-21(12-11-19(22)3)25(20(4)28(33)34)14-13-23-17-31(6-2)30-29-23/h7-12,15,17,20,24-25H,5-6,13-14,16,18H2,1-4H3,(H,33,34)	IDANVQJFZXIQGM-UHFFFAOYSA-N	304887	US10144731, Example 192::3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-5-(1-ethyl-1H-1,2,3-triazol-4-yl)-2-methylpentanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		<10							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304887	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304887&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170028	381753590							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584837	CC[C@@H]1CN(Cc2cc(ccc2C)C(CCc2cn(CC)nn2)C(C)C(O)=O)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C28H36N4O5S/c1-5-24-18-32(38(35,36)27-10-8-7-9-26(27)37-24)16-22-15-21(12-11-19(22)3)25(20(4)28(33)34)14-13-23-17-31(6-2)30-29-23/h7-12,15,17,20,24-25H,5-6,13-14,16,18H2,1-4H3,(H,33,34)	IDANVQJFZXIQGM-UHFFFAOYSA-N	304888	US10144731, Example 193::3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-5-(1-ethyl-1H-1,2,3-triazol-4-yl)-2-methylpentanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304888	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304888&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170028	381753591							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584838	CC[C@@H]1CN(Cc2cc(ccc2C)C(CCc2cn(CC)nn2)CC(O)=O)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C27H34N4O5S/c1-4-24-18-31(37(34,35)26-9-7-6-8-25(26)36-24)16-22-14-20(11-10-19(22)3)21(15-27(32)33)12-13-23-17-30(5-2)29-28-23/h6-11,14,17,21,24H,4-5,12-13,15-16,18H2,1-3H3,(H,32,33)	OFFIZNQRXWXRFR-UHFFFAOYSA-N	304889	3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-5-(1-ethyl-1H-1,2,3-triazol-4-yl)pentanoic acid (isomer M1) and 3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-5-(1-ethyl-1H-1,2,3-triazol-4-yl)pentanoic acid (isomer N1)::BDBM304919::US10144731, Example 194	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304889	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304889&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170583	381753592							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584839	COCCC(CC(O)=O)c1ccc(C)c(CN2C[C@@H](C)Oc3ccccc3S2(=O)=O)c1 |r|	InChI=1S/C23H29NO6S/c1-16-8-9-18(19(10-11-29-3)13-23(25)26)12-20(16)15-24-14-17(2)30-21-6-4-5-7-22(21)31(24,27)28/h4-9,12,17,19H,10-11,13-15H2,1-3H3,(H,25,26)	MDMOGTPMLUHGBG-UHFFFAOYSA-N	304890	US10144731, Example 195::5-Methoxy-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)pentanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304890	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304890&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170075	381753593							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584840	C[C@@H]1CN(Cc2cc(ccc2C)C(CCC2CCCC2)CC(O)=O)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C27H35NO5S/c1-19-11-13-22(23(16-27(29)30)14-12-21-7-3-4-8-21)15-24(19)18-28-17-20(2)33-25-9-5-6-10-26(25)34(28,31)32/h5-6,9-11,13,15,20-21,23H,3-4,7-8,12,14,16-18H2,1-2H3,(H,29,30)	JWCCGAXRMNTCEB-UHFFFAOYSA-N	304891	US10144731, Example 196::5-Cyclopentyl-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)pentanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304891	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304891&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170092	381753594							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584841	CC[C@@H]1CN(Cc2cc(ccc2C(F)(F)F)C(CCc2cn(CC)nn2)CC(O)=O)S(=O)(=O)c2cnccc2O1 |r|	InChI=1S/C26H30F3N5O5S/c1-3-21-16-34(40(37,38)24-13-30-10-9-23(24)39-21)14-19-11-17(6-8-22(19)26(27,28)29)18(12-25(35)36)5-7-20-15-33(4-2)32-31-20/h6,8-11,13,15,18,21H,3-5,7,12,14,16H2,1-2H3,(H,35,36)	GNGJWPZEJKPGFY-UHFFFAOYSA-N	304892	US10144731, Example 197::3-(3-(((R)-4-Ethyl-1,1-dioxido-3,4-dihydro-2H-pyrido[4,3-b][1,4,5]oxathiazepin-2-yl)methyl)-4-(trifluoromethyl)phenyl)-5-(1-ethyl-1H-1,2,3-triazol-4-yl)pentanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304892	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304892&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170712	381753595							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584842	CCn1cc(CCC(CC(O)=O)c2ccc(c(CN3CC(C)Cc4ccccc4S3(=O)=O)c2)C(F)(F)F)nn1	InChI=1S/C27H31F3N4O4S/c1-3-33-17-23(31-32-33)10-8-20(14-26(35)36)19-9-11-24(27(28,29)30)22(13-19)16-34-15-18(2)12-21-6-4-5-7-25(21)39(34,37)38/h4-7,9,11,13,17-18,20H,3,8,10,12,14-16H2,1-2H3,(H,35,36)	LJYJNPDCJALUPO-UHFFFAOYSA-N	304893	US10144731, Example 198::5-(1-Ethyl-1H-1,2,3-triazol-4-yl)-3-(3-((4-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2]thiazepin-2(3H)-yl)methyl)-4-(trifluoromethyl)phenyl)pentanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304893	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304893&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170949	381753596							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584843	CC[C@@H]1CN(Cc2cc(ccc2C)C(CCc2cn(CC)nn2)CC(O)=O)S(=O)(=O)c2cnccc2C1 |r|	InChI=1S/C27H35N5O4S/c1-4-20-12-23-10-11-28-15-26(23)37(35,36)32(16-20)17-24-13-21(7-6-19(24)3)22(14-27(33)34)8-9-25-18-31(5-2)30-29-25/h6-7,10-11,13,15,18,20,22H,4-5,8-9,12,14,16-17H2,1-3H3,(H,33,34)	ZEXIQZWCZZOHLR-UHFFFAOYSA-N	304894	US10144731, Example 199::3-(3-(((R)-4-Ethyl-1,1-dioxido-3,4-dihydro-2H-pyrido[4,3-b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-5-(1-ethyl-1H-1,2,3-triazol-4-yl)pentanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304894	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304894&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			122660642	381753597							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584844	CC[C@@H]1CN(Cc2cc(ccc2C(F)(F)F)C(CCc2cn(CC)nn2)CC(O)=O)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C27H31F3N4O5S/c1-3-22-17-34(40(37,38)25-8-6-5-7-24(25)39-22)15-20-13-18(10-12-23(20)27(28,29)30)19(14-26(35)36)9-11-21-16-33(4-2)32-31-21/h5-8,10,12-13,16,19,22H,3-4,9,11,14-15,17H2,1-2H3,(H,35,36)	GJIAQUPOXRGEOW-UHFFFAOYSA-N	304895	US10144731, Example 200::3-(3-(((R)-4-Ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-(trifluoromethyl)phenyl)-5-(1-ethyl-1H-1,2,3-triazol-4-yl)pentanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304895	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304895&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170268	381753598							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584845	CCCn1cc(CCC(CC(O)=O)c2ccc(C)c(CN3C[C@@H](C)Oc4ccccc4S3(=O)=O)c2)nn1 |r|	InChI=1S/C27H34N4O5S/c1-4-13-30-18-24(28-29-30)12-11-22(15-27(32)33)21-10-9-19(2)23(14-21)17-31-16-20(3)36-25-7-5-6-8-26(25)37(31,34)35/h5-10,14,18,20,22H,4,11-13,15-17H2,1-3H3,(H,32,33)	DHXVRUGBGUAPNG-UHFFFAOYSA-N	304896	US10144731, Example 201::3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)-5-(1-propyl-1H-1,2,3-triazol-4-yl)pentanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304896	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304896&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118169970	381753599							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584846	CCCn1cc(CCC(CC(O)=O)c2ccc(C)c(CN3C[C@@H](CC)Oc4ccccc4S3(=O)=O)c2)nn1 |r|	InChI=1S/C28H36N4O5S/c1-4-14-31-18-24(29-30-31)13-12-22(16-28(33)34)21-11-10-20(3)23(15-21)17-32-19-25(5-2)37-26-8-6-7-9-27(26)38(32,35)36/h6-11,15,18,22,25H,4-5,12-14,16-17,19H2,1-3H3,(H,33,34)	FGASSPDBSDOEPX-UHFFFAOYSA-N	304897	US10144731, Example 202::3-(3-(((R)-4-Ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-5-(1-propyl-1H-1,2,3-triazol-4-yl)pentanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304897	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304897&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170142	381753600							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584847	CC(C)n1cc(CCC(CC(O)=O)c2ccc(C)c(CN3C[C@@H](C)Oc4ccccc4S3(=O)=O)c2)nn1 |r|	InChI=1S/C27H34N4O5S/c1-18(2)31-17-24(28-29-31)12-11-22(14-27(32)33)21-10-9-19(3)23(13-21)16-30-15-20(4)36-25-7-5-6-8-26(25)37(30,34)35/h5-10,13,17-18,20,22H,11-12,14-16H2,1-4H3,(H,32,33)	GNXFBTOJIPLCGB-UHFFFAOYSA-N	304898	US10144731, Example 203::5-(1-Isopropyl-1H-1,2,3-triazol-4-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)pentanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304898	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304898&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170243	381753601							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584848	CC[C@@H]1CN(Cc2cc(ccc2C)C(CCc2cn(nn2)C(C)C)CC(O)=O)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C28H36N4O5S/c1-5-25-18-31(38(35,36)27-9-7-6-8-26(27)37-25)16-23-14-21(11-10-20(23)4)22(15-28(33)34)12-13-24-17-32(19(2)3)30-29-24/h6-11,14,17,19,22,25H,5,12-13,15-16,18H2,1-4H3,(H,33,34)	JBWZTQKHRVJEFM-UHFFFAOYSA-N	304899	3-(3-(((R)-4-Ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-5-(1-isopropyl-1H-1,2,3-triazol-4-yl)pentanoic acid::US10144731, Example 204	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304899	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304899&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170074	381753602							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584849	CCCn1cc(CCC(CC(O)=O)c2ccc(C)c(CN3C[C@@H](CC)Oc4ccncc4S3(=O)=O)c2)nn1 |r|	InChI=1S/C27H35N5O5S/c1-4-12-31-17-23(29-30-31)9-8-21(14-27(33)34)20-7-6-19(3)22(13-20)16-32-18-24(5-2)37-25-10-11-28-15-26(25)38(32,35)36/h6-7,10-11,13,15,17,21,24H,4-5,8-9,12,14,16,18H2,1-3H3,(H,33,34)	YHMSHUNSVHSTSR-UHFFFAOYSA-N	304900	3-(3-(((R)-4-Ethyl-1,1-dioxido-3,4-dihydro-2H-pyrido[4,3-b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-5-(1-propyl-1H-1,2,3-triazol-4-yl)pentanoic acid::US10144731, Example 205	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304900	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304900&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170571	381753603							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584850	CC[C@@H]1CN(Cc2cc(ccc2C)C(CCc2cn(nn2)C(C)C)CC(O)=O)S(=O)(=O)c2cnccc2O1 |r|	InChI=1S/C27H35N5O5S/c1-5-24-17-31(38(35,36)26-14-28-11-10-25(26)37-24)15-22-12-20(7-6-19(22)4)21(13-27(33)34)8-9-23-16-32(18(2)3)30-29-23/h6-7,10-12,14,16,18,21,24H,5,8-9,13,15,17H2,1-4H3,(H,33,34)	OCRPAIWDRJKOTN-UHFFFAOYSA-N	304901	3-(3-(((R)-4-Ethyl-1,1-dioxido-3,4-dihydro-2H-pyrido[4,3-b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-5-(1-isopropyl-1H-1,2,3-triazol-4-yl)pentanoic acid::US10144731, Example 206	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304901	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304901&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170617	381753604							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584851	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(C)c2cn(CC)nn2)CC(O)=O)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C28H36N4O5S/c1-5-24-17-32(38(35,36)27-10-8-7-9-26(27)37-24)16-23-14-21(12-11-19(23)3)22(15-28(33)34)13-20(4)25-18-31(6-2)30-29-25/h7-12,14,18,20,22,24H,5-6,13,15-17H2,1-4H3,(H,33,34)	BKKIQOWFHQPZEE-UHFFFAOYSA-N	304902	US10144731, Example 207::BDBM304903::3-(3-(((R)-4-Ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-5-(1-ethyl-1H-1,2,3-triazol-4-yl)hexanoic acid (peak 1)::BDBM304904	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304902	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304902&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118169840	381753605							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584852	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(C)c2cn(CC)nn2)CC(O)=O)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C28H36N4O5S/c1-5-24-17-32(38(35,36)27-10-8-7-9-26(27)37-24)16-23-14-21(12-11-19(23)3)22(15-28(33)34)13-20(4)25-18-31(6-2)30-29-25/h7-12,14,18,20,22,24H,5-6,13,15-17H2,1-4H3,(H,33,34)	BKKIQOWFHQPZEE-UHFFFAOYSA-N	304902	US10144731, Example 207::BDBM304903::3-(3-(((R)-4-Ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-5-(1-ethyl-1H-1,2,3-triazol-4-yl)hexanoic acid (peak 1)::BDBM304904	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304902	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304902&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118169840	381753605							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584853	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(C)c2cn(CC)nn2)CC(O)=O)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C28H36N4O5S/c1-5-24-17-32(38(35,36)27-10-8-7-9-26(27)37-24)16-23-14-21(12-11-19(23)3)22(15-28(33)34)13-20(4)25-18-31(6-2)30-29-25/h7-12,14,18,20,22,24H,5-6,13,15-17H2,1-4H3,(H,33,34)	BKKIQOWFHQPZEE-UHFFFAOYSA-N	304902	US10144731, Example 207::BDBM304903::3-(3-(((R)-4-Ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-5-(1-ethyl-1H-1,2,3-triazol-4-yl)hexanoic acid (peak 1)::BDBM304904	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304902	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304902&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118169840	381753605							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584854	Cc1ccc(cc1CN1CCCc2ccccc2S1(=O)=O)C(CC(O)=O)c1ccc2n(C)nnc2c1C	InChI=1S/C28H30N4O4S/c1-18-10-11-21(24(16-27(33)34)23-12-13-25-28(19(23)2)29-30-31(25)3)15-22(18)17-32-14-6-8-20-7-4-5-9-26(20)37(32,35)36/h4-5,7,9-13,15,24H,6,8,14,16-17H2,1-3H3,(H,33,34)	QWBZFCSPMMQPPO-UHFFFAOYSA-N	304905	3-(1,4-Dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-((1,1-dioxido-4,5-dihydrobenzo[f][1,2]thiazepin-2(3H)-yl)methyl)-4-methylphenyl)propanoic acid::US10144731, Example 209	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304905	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304905&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118169769	381753608							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584855	CC1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc2C1	InChI=1S/C29H32N4O4S/c1-18-13-22-7-5-6-8-27(22)38(36,37)33(16-18)17-23-14-21(10-9-19(23)2)25(15-28(34)35)24-11-12-26-29(20(24)3)30-31-32(26)4/h5-12,14,18,25H,13,15-17H2,1-4H3,(H,34,35)	BIHHECVWYUSKTL-UHFFFAOYSA-N	304906	3-(1,4-Dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-((4-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2]thiazepin-2(3H)-yl)methyl)phenyl)propanoic acid::US10144731, Example 210	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304906	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304906&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170885	381753609							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584856	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2c(F)cccc2O1 |r|	InChI=1S/C28H29FN4O5S/c1-16-8-9-19(22(13-26(34)35)21-10-11-24-27(18(21)3)30-31-32(24)4)12-20(16)15-33-14-17(2)38-25-7-5-6-23(29)28(25)39(33,36)37/h5-12,17,22H,13-15H2,1-4H3,(H,34,35)	JKDFOYSIKNRLTR-UHFFFAOYSA-N	304907	3-(1,4-Dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-(((R)-9-fluoro-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)propanoic acid::US10144731, Example 211	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304907	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304907&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170032	381753610							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584857	COc1cc(cc2nnn(C)c12)[C@@H](CC(O)=O)c1ccc(C)c(CN2C[C@H](C)Cc3ccccc3S2(=O)=O)c1 |r|	InChI=1S/C29H32N4O5S/c1-18-11-21-7-5-6-8-27(21)39(36,37)33(16-18)17-23-12-20(10-9-19(23)2)24(15-28(34)35)22-13-25-29(26(14-22)38-4)32(3)31-30-25/h5-10,12-14,18,24H,11,15-17H2,1-4H3,(H,34,35)	HSPMCXSTLBKXFP-UHFFFAOYSA-N	304908	(S)-3-(7-Methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2]thiazepin-2(3H)-yl)methyl)phenyl)propanoic acid::US10144731, Example 212	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304908	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304908&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170319	381753611							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584858	COc1cc(cc2nnn(C)c12)[C@@H](CC(O)=O)c1ccc(C)c(CN2C[C@@H](C)Cc3ccccc3S2(=O)=O)c1 |r|	InChI=1S/C29H32N4O5S/c1-18-11-21-7-5-6-8-27(21)39(36,37)33(16-18)17-23-12-20(10-9-19(23)2)24(15-28(34)35)22-13-25-29(26(14-22)38-4)32(3)31-30-25/h5-10,12-14,18,24H,11,15-17H2,1-4H3,(H,34,35)	HSPMCXSTLBKXFP-UHFFFAOYSA-N	304909	(S)-3-(7-Methoxy-1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((S)-4-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2]thiazepin-2(3H)-yl)methyl)phenyl)propanoic acid::US10144731, Example 213	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304909	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304909&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170404	381753612							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584859	CC1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc(cc2C)C#N)S(=O)(=O)c2ccccc2C1	InChI=1S/C29H30N2O4S/c1-19-12-24-6-4-5-7-28(24)36(34,35)31(17-19)18-25-14-23(10-8-20(25)2)27(15-29(32)33)26-11-9-22(16-30)13-21(26)3/h4-11,13-14,19,27H,12,15,17-18H2,1-3H3,(H,32,33)	QXXYHMOQLMDKMF-UHFFFAOYSA-N	304910	3-(4-Cyano-2-methylphenyl)-3-(4-methyl-3-((4-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2]thiazepin-2(3H)-yl)methyl)phenyl)propanoic acid::US10144731, Example 214	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304910	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304910&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170133	381753613							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584860	CC1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc(cc2C)C#N)S(=O)(=O)c2ccc(F)cc2C1	InChI=1S/C29H29FN2O4S/c1-18-10-23-13-25(30)7-9-28(23)37(35,36)32(16-18)17-24-12-22(6-4-19(24)2)27(14-29(33)34)26-8-5-21(15-31)11-20(26)3/h4-9,11-13,18,27H,10,14,16-17H2,1-3H3,(H,33,34)	HBNAUONLWDFYEA-UHFFFAOYSA-N	304911	3-(4-Cyano-2-methylphenyl)- 3-(3-((7-fluoro-4-methyl-1,1- dioxido-4,5-dihydrobenzo[f] [1,2]thiazepin-2(3H)-yl) methyl)-4-methylphenyl) propanoic acid::US10144731, Example 215	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304911	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304911&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170263	381753614							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584861	COc1ccc2c(CC(C)CN(Cc3cc(ccc3C)C(CC(O)=O)c3ccc(cc3C)C#N)S2(=O)=O)c1	InChI=1S/C30H32N2O5S/c1-19-11-24-14-26(37-4)8-10-29(24)38(35,36)32(17-19)18-25-13-23(7-5-20(25)2)28(15-30(33)34)27-9-6-22(16-31)12-21(27)3/h5-10,12-14,19,28H,11,15,17-18H2,1-4H3,(H,33,34)	GIPUEKGFFDJJJJ-UHFFFAOYSA-N	304912	3-(4-Cyano-2-methylphenyl)- 3-(3-((7-methoxy-4-methyl- 1,1-dioxido-4,5-dihydrobenzo [f][1,2]thiazepin-2(3H)-yl) methyl)-4-methylphenyl) propanoic acid::US10144731, Example 216	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304912	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304912&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			122653261	381753615							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584862	CC1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc(cc2C)C#N)S(=O)(=O)c2ccc(cc2C1)C(F)(F)F	InChI=1S/C30H29F3N2O4S/c1-18-10-23-13-25(30(31,32)33)7-9-28(23)40(38,39)35(16-18)17-24-12-22(6-4-19(24)2)27(14-29(36)37)26-8-5-21(15-34)11-20(26)3/h4-9,11-13,18,27H,10,14,16-17H2,1-3H3,(H,36,37)	IARGPHHSZQXOSH-UHFFFAOYSA-N	304913	3-(4-Cyano-2-methylphenyl)- 3-(4-methyl-3-((4-methyl-1,1- dioxido-7-(trifluoromethyl)- 4,5-dihydrobenzo[f][1,2] thiazepin-2(3H)-yl)methyl) phenyl)propanoic acid::US10144731, Example 217	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304913	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304913&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			122653400	381753616							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584863	CC1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc(cc2C)C#N)S(=O)(=O)c2ccc(OC(F)(F)F)cc2C1	InChI=1S/C30H29F3N2O5S/c1-18-10-23-13-25(40-30(31,32)33)7-9-28(23)41(38,39)35(16-18)17-24-12-22(6-4-19(24)2)27(14-29(36)37)26-8-5-21(15-34)11-20(26)3/h4-9,11-13,18,27H,10,14,16-17H2,1-3H3,(H,36,37)	YEJSAJHUMWAUBV-UHFFFAOYSA-N	304914	3-(4-Cyano-2-methylphenyl)- 3-(4-methyl-3-((4-methyl-1,1- dioxido-7-(trifluoromethoxy)- 4,5-dihydrobenzo[f][1,2] thiazepin-2(3H)-yl)methyl) phenyl)propanoic acid::US10144731, Example 218	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304914	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304914&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			122653290	381753617							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584864	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc(cc2OC)C#N)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C29H30N2O6S/c1-4-23-18-31(38(34,35)28-8-6-5-7-26(28)37-23)17-22-14-21(11-9-19(22)2)25(15-29(32)33)24-12-10-20(16-30)13-27(24)36-3/h5-14,23,25H,4,15,17-18H2,1-3H3,(H,32,33)	UANMOFVJIKFJJT-UHFFFAOYSA-N	304915	3-(4-Cyano-2-methoxyphenyl)-3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)propanoic acid::US10144731, Example 219	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304915	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304915&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170060	381753618							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584865	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc(C#N)c(OC)c2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C29H30N2O6S/c1-4-24-18-31(38(34,35)28-8-6-5-7-26(28)37-24)17-23-13-20(10-9-19(23)2)25(15-29(32)33)21-11-12-22(16-30)27(14-21)36-3/h5-14,24-25H,4,15,17-18H2,1-3H3,(H,32,33)	HZDUCHHJWUKSCD-UHFFFAOYSA-N	304916	3-(4-Cyano-3-methoxyphenyl)-3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)propanoic acid::US10144731, Example 220	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304916	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304916&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170248	381753619							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584866	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc(cc2F)C#N)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C28H27FN2O5S/c1-3-22-17-31(37(34,35)27-7-5-4-6-26(27)36-22)16-21-13-20(10-8-18(21)2)24(14-28(32)33)23-11-9-19(15-30)12-25(23)29/h4-13,22,24H,3,14,16-17H2,1-2H3,(H,32,33)	FVNHWMOCBZQTBI-UHFFFAOYSA-N	304917	3-(4-Cyano-2-fluorophenyl)-3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)propanoic acid::US10144731, Example 221	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304917	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304917&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170710	381753620							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584867	CCn1cc(CCC(CC(O)=O)c2ccc(C)c(CN3C[C@@H](C)Cc4ccccc4S3(=O)=O)c2)nn1 |r|	InChI=1S/C27H34N4O4S/c1-4-30-18-25(28-29-30)12-11-22(15-27(32)33)21-10-9-20(3)24(14-21)17-31-16-19(2)13-23-7-5-6-8-26(23)36(31,34)35/h5-10,14,18-19,22H,4,11-13,15-17H2,1-3H3,(H,32,33)	NZGGZISVMMEMJX-UHFFFAOYSA-N	304918	5-(1-Ethyl-1H-1,2,3-triazol-4-yl)-3-(4-methyl-3-(((S)-4-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2]thiazepin-2(3H)-yl)methyl)phenyl)pentanoic acid::US10144731, Example 222	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304918	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304918&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170380	381753621							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584868	CC[C@@H]1CN(Cc2cc(ccc2C)C(CCc2cn(CC)nn2)CC(O)=O)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C27H34N4O5S/c1-4-24-18-31(37(34,35)26-9-7-6-8-25(26)36-24)16-22-14-20(11-10-19(22)3)21(15-27(32)33)12-13-23-17-30(5-2)29-28-23/h6-11,14,17,21,24H,4-5,12-13,15-16,18H2,1-3H3,(H,32,33)	OFFIZNQRXWXRFR-UHFFFAOYSA-N	304889	3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-5-(1-ethyl-1H-1,2,3-triazol-4-yl)pentanoic acid (isomer M1) and 3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-5-(1-ethyl-1H-1,2,3-triazol-4-yl)pentanoic acid (isomer N1)::BDBM304919::US10144731, Example 194	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304889	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304889&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170583	381753592							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584869	CCn1cc(CCC(CC(O)=O)c2ccc(C)c(CN3CCCc4ccccc4S3(=O)=O)c2)nn1	InChI=1S/C26H32N4O4S/c1-3-29-18-24(27-28-29)13-12-22(16-26(31)32)21-11-10-19(2)23(15-21)17-30-14-6-8-20-7-4-5-9-25(20)35(30,33)34/h4-5,7,9-11,15,18,22H,3,6,8,12-14,16-17H2,1-2H3,(H,31,32)	FROVAICQVUYMQU-UHFFFAOYSA-N	304920	3-(3-((1,1-Dioxido-4,5-dihydrobenzo[f][1,2]thiazepin-2(3H)-yl)methyl)-4-methylphenyl)-5-(1-ethyl-1H-1,2,3-triazol-4-yl)pentanoic acid::US10144731, Example 224	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304920	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304920&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118188921	381753623							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584870	CC[C@@H]1CN(Cc2cc(ccc2C)C(CCc2cn(CC)nn2)CC(O)=O)S(=O)(=O)c2cccnc2O1 |r|	InChI=1S/C26H33N5O5S/c1-4-23-17-31(37(34,35)24-7-6-12-27-26(24)36-23)15-21-13-19(9-8-18(21)3)20(14-25(32)33)10-11-22-16-30(5-2)29-28-22/h6-9,12-13,16,20,23H,4-5,10-11,14-15,17H2,1-3H3,(H,32,33)	CAJHFKZCUUGUSQ-UHFFFAOYSA-N	304921	3-(3-(((R)-4-Ethyl-1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-5-(1-ethyl-1H-1,2,3-triazol-4-yl)pentanoic acid::US10144731, Example 225	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304921	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304921&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118188834	381753624							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584871	CCn1cc(CCC(CC(O)=O)c2ccc(C)c(CN3C[C@H](C)Cc4ccccc4S3(=O)=O)c2)nn1 |r|	InChI=1S/C27H34N4O4S/c1-4-30-18-25(28-29-30)12-11-22(15-27(32)33)21-10-9-20(3)24(14-21)17-31-16-19(2)13-23-7-5-6-8-26(23)36(31,34)35/h5-10,14,18-19,22H,4,11-13,15-17H2,1-3H3,(H,32,33)	NZGGZISVMMEMJX-UHFFFAOYSA-N	304922	5-(1-Ethyl-1H-1,2,3-triazol-4-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2]thiazepin-2(3H)-yl)methyl)phenyl)pentanoic acid::US10144731, Example 226	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304922	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304922&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170730	381753625							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584872	CCn1cc(CCC(CC(O)=O)c2ccc(C)c(CN3CC(C)Cc4ccc(F)cc4S3(=O)=O)c2)nn1	InChI=1S/C27H33FN4O4S/c1-4-31-17-25(29-30-31)10-8-21(13-27(33)34)20-6-5-19(3)23(12-20)16-32-15-18(2)11-22-7-9-24(28)14-26(22)37(32,35)36/h5-7,9,12,14,17-18,21H,4,8,10-11,13,15-16H2,1-3H3,(H,33,34)	KWDUEIBJQOEQJN-UHFFFAOYSA-N	304923	5-(1-Ethyl-1H-1,2,3-triazol-4-yl)-3-(3-((8-fluoro-4-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2]thiazepin-2(3H)-yl)methyl)-4-methylphenyl)pentanoic acid::US10144731, Example 227	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304923	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304923&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170581	381753626							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584873	CC1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(C)nnc3c2)S(=O)(=O)c2ccc(CCCN)cc2C1	InChI=1S/C31H37N5O4S/c1-20-13-25-14-22(5-4-12-32)7-11-30(25)41(39,40)36(18-20)19-26-15-23(8-6-21(26)2)27(17-31(37)38)24-9-10-29-28(16-24)33-34-35(29)3/h6-11,14-16,20,27H,4-5,12-13,17-19,32H2,1-3H3,(H,37,38)	HQLFULDUYCCJPE-UHFFFAOYSA-N	304924	3-(3-((7-(3-Aminopropyl)-4-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2]thiazepin-2(3H)-yl)methyl)-4-methylphenyl)-3-(1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid trifluoroacetic acid salt::US10144731, Example 228	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304924	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304924&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170512	381753627							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584874	CCC1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc(cc2C)C#N)S(=O)(=O)c2ccccc2O1	InChI=1S/C29H30N2O5S/c1-4-24-18-31(37(34,35)28-8-6-5-7-27(28)36-24)17-23-14-22(11-9-19(23)2)26(15-29(32)33)25-12-10-21(16-30)13-20(25)3/h5-14,24,26H,4,15,17-18H2,1-3H3,(H,32,33)	SFIXUCDVNKADGU-UHFFFAOYSA-N	304925	3-(4-Cyano-2-methylphenyl)-3-(3-((4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)propanoic acid::US10144731, Example 229	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304925	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304925&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170894	381753628							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584875	CCC1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc(cc2C)C#N)S(=O)(=O)c2cccnc2O1	InChI=1S/C28H29N3O5S/c1-4-23-17-31(37(34,35)26-6-5-11-30-28(26)36-23)16-22-13-21(9-7-18(22)2)25(14-27(32)33)24-10-8-20(15-29)12-19(24)3/h5-13,23,25H,4,14,16-17H2,1-3H3,(H,32,33)	ZSYJPILCQQZFGC-UHFFFAOYSA-N	304926	US10144731, Example 230::3-(4-Cyano-2-methylphenyl)-3-(3-((4-ethyl-1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)propanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304926	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304926&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			122653388	381753629							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584876	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc(cc2C)C#N)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C28H28N2O5S/c1-18-8-10-22(25(14-28(31)32)24-11-9-21(15-29)12-19(24)2)13-23(18)17-30-16-20(3)35-26-6-4-5-7-27(26)36(30,33)34/h4-13,20,25H,14,16-17H2,1-3H3,(H,31,32)	WSAJFKZPNGAKAD-UHFFFAOYSA-N	304927	US10144731, Example 231::3-(4-Cyano-2-methylphenyl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304927	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304927&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118169745	381753630							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584877	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc(F)c(F)c2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C26H25F2NO5S/c1-16-7-8-18(21(13-26(30)31)19-9-10-22(27)23(28)12-19)11-20(16)15-29-14-17(2)34-24-5-3-4-6-25(24)35(29,32)33/h3-12,17,21H,13-15H2,1-2H3,(H,30,31)	MGIAJNGRXJICFA-UHFFFAOYSA-N	304928	US10144731, Example 232::3-(3,4-Difluorophenyl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304928	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304928&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170238	381753631							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584878	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2cc(F)c(F)c(F)c2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C26H24F3NO5S/c1-15-7-8-17(20(12-25(31)32)18-10-21(27)26(29)22(28)11-18)9-19(15)14-30-13-16(2)35-23-5-3-4-6-24(23)36(30,33)34/h3-11,16,20H,12-14H2,1-2H3,(H,31,32)	FRPGONVMQZYDCC-UHFFFAOYSA-N	304929	US10144731, Example 233::3-(4-Methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)-3-(3,4,5-trifluorophenyl)propanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304929	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304929&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170539	381753632							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584879	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2cccc(F)c2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C26H26FNO5S/c1-17-10-11-20(23(14-26(29)30)19-6-5-7-22(27)13-19)12-21(17)16-28-15-18(2)33-24-8-3-4-9-25(24)34(28,31)32/h3-13,18,23H,14-16H2,1-2H3,(H,29,30)	OYZIJXYHWRIKIW-UHFFFAOYSA-N	304930	US10144731, Example 234::3-(3-Fluorophenyl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304930	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304930&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118169870	381753633							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584880	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccccc2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C26H27NO5S/c1-18-12-13-21(23(15-26(28)29)20-8-4-3-5-9-20)14-22(18)17-27-16-19(2)32-24-10-6-7-11-25(24)33(27,30)31/h3-14,19,23H,15-17H2,1-2H3,(H,28,29)	CUENPUOZILZXSI-UHFFFAOYSA-N	304931	US10144731, Example 235::3-(4-Methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)-3-phenylpropanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304931	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304931&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			122653304	381753634							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584881	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccccc2C)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C27H29NO5S/c1-18-12-13-21(24(15-27(29)30)23-9-5-4-8-19(23)2)14-22(18)17-28-16-20(3)33-25-10-6-7-11-26(25)34(28,31)32/h4-14,20,24H,15-17H2,1-3H3,(H,29,30)	AKQXWJHIWSZQPZ-UHFFFAOYSA-N	304932	US10144731, Example 236::3-(4-Methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)-3-(o-tolyl)propanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304932	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304932&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			122653333	381753635							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584882	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc(F)cc2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C26H26FNO5S/c1-17-7-8-20(23(14-26(29)30)19-9-11-22(27)12-10-19)13-21(17)16-28-15-18(2)33-24-5-3-4-6-25(24)34(28,31)32/h3-13,18,23H,14-16H2,1-2H3,(H,29,30)	PCWFDFLFSSELHV-UHFFFAOYSA-N	304933	US10144731, Example 237::3-(4-Fluorophenyl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304933	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304933&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170000	381753636							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584883	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc(F)cc2C)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C27H28FNO5S/c1-17-8-9-20(24(14-27(30)31)23-11-10-22(28)12-18(23)2)13-21(17)16-29-15-19(3)34-25-6-4-5-7-26(25)35(29,32)33/h4-13,19,24H,14-16H2,1-3H3,(H,30,31)	UAWAVHLCYBVILD-UHFFFAOYSA-N	304934	US10144731, Example 238::3-(4-Fluoro-2-methylphenyl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304934	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304934&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170335	381753637							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584884	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc(Cl)cc2C)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C27H28ClNO5S/c1-17-8-9-20(24(14-27(30)31)23-11-10-22(28)12-18(23)2)13-21(17)16-29-15-19(3)34-25-6-4-5-7-26(25)35(29,32)33/h4-13,19,24H,14-16H2,1-3H3,(H,30,31)	ROWJVYNPLUSZIZ-UHFFFAOYSA-N	304935	US10144731, Example 239::3-(4-Chloro-2-methylphenyl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304935	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304935&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			122653244	381753638							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584885	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc(Cl)cc2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C26H26ClNO5S/c1-17-7-8-20(23(14-26(29)30)19-9-11-22(27)12-10-19)13-21(17)16-28-15-18(2)33-24-5-3-4-6-25(24)34(28,31)32/h3-13,18,23H,14-16H2,1-2H3,(H,29,30)	JERKNUJOWYNDMT-UHFFFAOYSA-N	304936	US10144731, Example 240::3-(4-Chlorophenyl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304936	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304936&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170680	381753639							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584886	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc(NC=O)cc2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C28H30N2O6S/c1-3-24-17-30(37(34,35)27-7-5-4-6-26(27)36-24)16-22-14-21(9-8-19(22)2)25(15-28(32)33)20-10-12-23(13-11-20)29-18-31/h4-14,18,24-25H,3,15-17H2,1-2H3,(H,29,31)(H,32,33)	JHJVCRPWCAVTKW-UHFFFAOYSA-N	304937	US10144731, Example 241::3-(4-Carbamoyl-2-methylphenyl)-3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)propanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304937	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304937&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			122660649	381753640					C06049		1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584887	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc(cc2)C(C)=O)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C28H29NO6S/c1-18-8-9-23(25(15-28(31)32)22-12-10-21(11-13-22)20(3)30)14-24(18)17-29-16-19(2)35-26-6-4-5-7-27(26)36(29,33)34/h4-14,19,25H,15-17H2,1-3H3,(H,31,32)	FUOCXMOMJRLFAS-UHFFFAOYSA-N	304938	US10144731, Example 242::3-(4-Acetylphenyl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304938	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304938&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170225	381753641							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584888	CCNC(=O)c1cc(ccc1C(O)=O)C(CC(O)=O)c1ccc(C)c(CN2C[C@@H](C)Oc3ccccc3S2(=O)=O)c1 |r|	InChI=1S/C30H32N2O8S/c1-4-31-29(35)25-14-21(11-12-23(25)30(36)37)24(15-28(33)34)20-10-9-18(2)22(13-20)17-32-16-19(3)40-26-7-5-6-8-27(26)41(32,38)39/h5-14,19,24H,4,15-17H2,1-3H3,(H,31,35)(H,33,34)(H,36,37)	MQSQNZXYSKOZIF-UHFFFAOYSA-N	304939	US10144731, Example 243::4-(2-Carboxy-1-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)ethyl)-2-(ethylcarbamoyl)benzoic acid; 5-(2-carboxy-1-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)ethyl)-2-(ethylcarbamoyl)benzoic acid (unknown ratio mixture)	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304939	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304939&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170347	381753642							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584889	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(CCNC(=O)OC(C)(C)C)nnc3c2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C33H39N5O7S/c1-21-10-11-23(16-25(21)20-37-19-22(2)44-29-8-6-7-9-30(29)46(37,42)43)26(18-31(39)40)24-12-13-28-27(17-24)35-36-38(28)15-14-34-32(41)45-33(3,4)5/h6-13,16-17,22,26H,14-15,18-20H2,1-5H3,(H,34,41)(H,39,40)	DXTPGWQAXLDDNL-UHFFFAOYSA-N	304940	US10144731, Example 244::3-(1-(2-((Tert-butoxycarbonyl)amino)ethyl)-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304940	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304940&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170224	381753643							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584890	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3CCC(=O)c3c2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C29H29NO6S/c1-18-7-8-21(24(15-29(32)33)22-10-9-20-11-12-26(31)25(20)14-22)13-23(18)17-30-16-19(2)36-27-5-3-4-6-28(27)37(30,34)35/h3-10,13-14,19,24H,11-12,15-17H2,1-2H3,(H,32,33)	UMAXIEJXCLMIAQ-UHFFFAOYSA-N	304941	US10144731, Example 245::3-(4-Methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)-3-(3-oxo-2,3-dihydro-1H-inden-5-yl)propanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304941	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304941&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			122653291	381753644							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584891	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3n(CCCNC(=O)OC(C)(C)C)nnc3c2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C34H41N5O7S/c1-22-11-12-24(17-26(22)21-38-20-23(2)45-30-9-6-7-10-31(30)47(38,43)44)27(19-32(40)41)25-13-14-29-28(18-25)36-37-39(29)16-8-15-35-33(42)46-34(3,4)5/h6-7,9-14,17-18,23,27H,8,15-16,19-21H2,1-5H3,(H,35,42)(H,40,41)	YYIAYPKFORFCIY-UHFFFAOYSA-N	304942	US10144731, Example 246::3-(1-(3-((Tert-butoxycarbonyl)amino)propyl)-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304942	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304942&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170026	381753645							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584892	CSc1ccc(cc1)C(CC(O)=O)c1ccc(C)c(CN2C[C@@H](C)Oc3ccccc3S2(=O)=O)c1 |r|	InChI=1S/C27H29NO5S2/c1-18-8-9-21(24(15-27(29)30)20-10-12-23(34-3)13-11-20)14-22(18)17-28-16-19(2)33-25-6-4-5-7-26(25)35(28,31)32/h4-14,19,24H,15-17H2,1-3H3,(H,29,30)	QLPRJBMOBGFKTF-UHFFFAOYSA-N	304943	US10144731, Example 247::3-(4-Methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)-3-(4-(methylthio)phenyl)propanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304943	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304943&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170951	381753646							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584893	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3C(=O)CCc3c2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C29H29NO6S/c1-18-7-8-21(25(15-29(32)33)22-9-11-24-20(13-22)10-12-26(24)31)14-23(18)17-30-16-19(2)36-27-5-3-4-6-28(27)37(30,34)35/h3-9,11,13-14,19,25H,10,12,15-17H2,1-2H3,(H,32,33)	UAQJDVHSQSTTOA-UHFFFAOYSA-N	304944	US10144731, Example 248::3-(4-Methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)-3-(1-oxo-2,3-dihydro-1H-inden-5-yl)propanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304944	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304944&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170385	381753647							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584894	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc(F)cc2F)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C27H27F2NO5S/c1-3-21-16-30(36(33,34)26-7-5-4-6-25(26)35-21)15-19-12-18(9-8-17(19)2)23(14-27(31)32)22-11-10-20(28)13-24(22)29/h4-13,21,23H,3,14-16H2,1-2H3,(H,31,32)	MBIUESTWBZOSJW-UHFFFAOYSA-N	304945	US10144731, Example 249::3-(2,4-Difluorophenyl)-3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)propanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304945	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304945&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118169939	381753648							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584895	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc(F)cc2F)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C26H25F2NO5S/c1-16-7-8-18(22(13-26(30)31)21-10-9-20(27)12-23(21)28)11-19(16)15-29-14-17(2)34-24-5-3-4-6-25(24)35(29,32)33/h3-12,17,22H,13-15H2,1-2H3,(H,30,31)	CYOBABBSHLGCGY-UHFFFAOYSA-N	304946	US10144731, Example 250::3-(2,4-Difluorophenyl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304946	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304946&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170719	381753649							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584896	COC(=O)CC(c1ccc(C)c(CN2C[C@@H](C)Oc3ccccc3S2(=O)=O)c1)c1ccc2n(C)nnc2c1 |r|	InChI=1S/C28H30N4O5S/c1-18-9-10-20(23(15-28(33)36-4)21-11-12-25-24(14-21)29-30-31(25)3)13-22(18)17-32-16-19(2)37-26-7-5-6-8-27(26)38(32,34)35/h5-14,19,23H,15-17H2,1-4H3	QZJNRQLKRKBRDX-UHFFFAOYSA-N	304947	US10144731, Example 251::Methyl 3-(1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoate	Kelch-like ECH-associated protein 1 [321-609]	Human		 55000							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304947	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304947&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			122653233	381753650							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584897	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc(cc2C)C(C)=O)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C29H31NO6S/c1-18-9-10-23(26(15-29(32)33)25-12-11-22(21(4)31)13-19(25)2)14-24(18)17-30-16-20(3)36-27-7-5-6-8-28(27)37(30,34)35/h5-14,20,26H,15-17H2,1-4H3,(H,32,33)	HSZYGMSIEGUWCB-UHFFFAOYSA-N	304948	US10144731, Example 252::3-(4-Acetyl-2-methylphenyl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304948	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304948&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118169978	381753651							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584898	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc(cc2C)C(C)=O)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C30H33NO6S/c1-5-25-18-31(38(35,36)29-9-7-6-8-28(29)37-25)17-24-15-23(11-10-19(24)2)27(16-30(33)34)26-13-12-22(21(4)32)14-20(26)3/h6-15,25,27H,5,16-18H2,1-4H3,(H,33,34)	FMVABZINBVIDQL-UHFFFAOYSA-N	304949	US10144731, Example 253::3-(4-Acetyl-2-methylphenyl)-3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)propanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304949	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304949&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170038	381753652							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584899	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3C(=O)N(C)Cc3c2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C29H30N2O6S/c1-18-8-9-20(25(14-28(32)33)21-10-11-24-23(13-21)16-30(3)29(24)34)12-22(18)17-31-15-19(2)37-26-6-4-5-7-27(26)38(31,35)36/h4-13,19,25H,14-17H2,1-3H3,(H,32,33)	WWEHRWVLQHYSHD-UHFFFAOYSA-N	304950	US10144731, Example 254::3-(2-Methyl-1-oxoisoindolin-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304950	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304950&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170253	381753653							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584900	C[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3C(=O)C(C)(C)Cc3c2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C31H33NO6S/c1-19-9-10-21(26(15-29(33)34)22-11-12-25-23(13-22)16-31(3,4)30(25)35)14-24(19)18-32-17-20(2)38-27-7-5-6-8-28(27)39(32,36)37/h5-14,20,26H,15-18H2,1-4H3,(H,33,34)	FOIMBMUQCPZLMT-UHFFFAOYSA-N	304951	US10144731, Example 255::3-(2,2-Dimethyl-1-oxo-2,3-dihydro-1H-inden-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304951	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304951&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170295	381753654							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584901	CCN1C(=O)c2ccc(cc2C1=O)C(CC(O)=O)c1ccc(C)c(CN2C[C@@H](C)Oc3ccccc3S2(=O)=O)c1 |r|	InChI=1S/C30H30N2O7S/c1-4-32-29(35)23-12-11-21(14-25(23)30(32)36)24(15-28(33)34)20-10-9-18(2)22(13-20)17-31-16-19(3)39-26-7-5-6-8-27(26)40(31,37)38/h5-14,19,24H,4,15-17H2,1-3H3,(H,33,34)	UHGIIBFHIWYASA-UHFFFAOYSA-N	304952	US10144731, Example 256::3-(2-Ethyl-1,3-dioxoisoindolin-5-yl)-3-(4-methyl-3-(((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)phenyl)propanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304952	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304952&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170633	381753655							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584902	CC[C@@H]1CN(Cc2cc(ccc2C)C(CC(O)=O)c2ccc3C(=O)N(CC)C(=O)c3c2)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C31H32N2O7S/c1-4-23-18-32(41(38,39)28-9-7-6-8-27(28)40-23)17-22-14-20(11-10-19(22)3)25(16-29(34)35)21-12-13-24-26(15-21)31(37)33(5-2)30(24)36/h6-15,23,25H,4-5,16-18H2,1-3H3,(H,34,35)	CPMDCWKBUNBNCQ-UHFFFAOYSA-N	304953	US10144731, Example 257::3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-3-(2-ethyl-1,3-dioxoisoindolin-5-yl)propanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304953	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304953&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170041	381753656							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584903	C[C@@H]1CN(C2CCc3ccc(cc23)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C29H30N4O5S/c1-17-16-33(39(36,37)27-7-5-4-6-26(27)38-17)24-12-10-19-8-9-20(14-23(19)24)22(15-28(34)35)21-11-13-25-29(18(21)2)30-31-32(25)3/h4-9,11,13-14,17,22,24H,10,12,15-16H2,1-3H3,(H,34,35)	CXZPRQFTYURHET-UHFFFAOYSA-N	304954	US10144731, Example 258::3-(1,4-Dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-((R)-4-methyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)-2,3-dihydro-1H-inden-5-yl)propanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304954	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304954&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118169832	381753657							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584904	CC[C@@H]1CN(C2CCc3ccc(cc23)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C30H32N4O5S/c1-4-21-17-34(40(37,38)28-8-6-5-7-27(28)39-21)25-13-11-19-9-10-20(15-24(19)25)23(16-29(35)36)22-12-14-26-30(18(22)2)31-32-33(26)3/h5-10,12,14-15,21,23,25H,4,11,13,16-17H2,1-3H3,(H,35,36)	YFUKZAAYGLSBNI-UHFFFAOYSA-N	304955	US10144731, Example 259::3-(1,4-Dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)-2,3-dihydro-1H-inden-5-yl)propanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304955	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304955&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170283	381753658							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584905	CC1CN(C2CCc3ccc(cc23)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2ccccc2C1	InChI=1S/C30H32N4O4S/c1-18-14-22-6-4-5-7-28(22)39(37,38)34(17-18)26-12-10-20-8-9-21(15-25(20)26)24(16-29(35)36)23-11-13-27-30(19(23)2)31-32-33(27)3/h4-9,11,13,15,18,24,26H,10,12,14,16-17H2,1-3H3,(H,35,36)	FGIULSJBSODLAD-UHFFFAOYSA-N	304956	US10144731, Example 260::3-(1,4-Dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-(4-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2]thiazepin-2(3H)-yl)-2,3-dihydro-1H-inden-5-yl)propanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304956	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304956&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170167	381753659							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584906	CC1CN(C2CCc3ccc(cc23)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2cc(Br)ccc2C1	InChI=1S/C30H31BrN4O4S/c1-17-12-21-6-8-22(31)14-28(21)40(38,39)35(16-17)26-10-7-19-4-5-20(13-25(19)26)24(15-29(36)37)23-9-11-27-30(18(23)2)32-33-34(27)3/h4-6,8-9,11,13-14,17,24,26H,7,10,12,15-16H2,1-3H3,(H,36,37)	ZHMFLGKJTRLMKZ-UHFFFAOYSA-N	304957	3-(3-(8-Bromo-4-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2]thiazepin-2(3H)-yl)-2,3-dihydro-1H-inden-5-yl)-3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 262::US10144731, Example 261	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304957	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304957&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170640	381753660							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584907	CC1CN(C2CCc3ccc(cc23)C(CC(O)=O)c2ccc3n(C)nnc3c2C)S(=O)(=O)c2cc(Br)ccc2C1	InChI=1S/C30H31BrN4O4S/c1-17-12-21-6-8-22(31)14-28(21)40(38,39)35(16-17)26-10-7-19-4-5-20(13-25(19)26)24(15-29(36)37)23-9-11-27-30(18(23)2)32-33-34(27)3/h4-6,8-9,11,13-14,17,24,26H,7,10,12,15-16H2,1-3H3,(H,36,37)	ZHMFLGKJTRLMKZ-UHFFFAOYSA-N	304957	3-(3-(8-Bromo-4-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2]thiazepin-2(3H)-yl)-2,3-dihydro-1H-inden-5-yl)-3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid::US10144731, Example 262::US10144731, Example 261	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304957	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304957&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170640	381753660							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584908	Cc1c2ccc3n(CCCCCC4CN(C5CCc6ccc(cc56)C2CC(O)=O)S(=O)(=O)c2ccccc2O4)nnc13	InChI=1S/C32H34N4O5S/c1-20-24-13-15-28-32(20)33-34-35(28)16-6-2-3-7-23-19-36(42(39,40)30-9-5-4-8-29(30)41-23)27-14-12-21-10-11-22(17-26(21)27)25(24)18-31(37)38/h4-5,8-11,13,15,17,23,25,27H,2-3,6-7,12,14,16,18-19H2,1H3,(H,37,38)	VMBGZHLUBXWENN-UHFFFAOYSA-N	304959	2-{34-Methyl-3,3-dioxo-10-oxa-3&#955;6-thia-2,17,18,19-tetraazaheptacyclo[24.5.2.12,11.120,24.04,9.017,21.029,32]pentatriaconta-4(9),5,7,18,20(34),21,23,26(33),27,29(32)-decaen-25-yl}acetic acid::BDBM304960::US10144731, Example 263	Kelch-like ECH-associated protein 1 [321-609]	Human		 5500							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304959	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304959&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			122660654	381753661							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584909	Cc1c2ccc3n(CCCCCC4CN(C5CCc6ccc(cc56)C2CC(O)=O)S(=O)(=O)c2ccccc2O4)nnc13	InChI=1S/C32H34N4O5S/c1-20-24-13-15-28-32(20)33-34-35(28)16-6-2-3-7-23-19-36(42(39,40)30-9-5-4-8-29(30)41-23)27-14-12-21-10-11-22(17-26(21)27)25(24)18-31(37)38/h4-5,8-11,13,15,17,23,25,27H,2-3,6-7,12,14,16,18-19H2,1H3,(H,37,38)	VMBGZHLUBXWENN-UHFFFAOYSA-N	304959	2-{34-Methyl-3,3-dioxo-10-oxa-3&#955;6-thia-2,17,18,19-tetraazaheptacyclo[24.5.2.12,11.120,24.04,9.017,21.029,32]pentatriaconta-4(9),5,7,18,20(34),21,23,26(33),27,29(32)-decaen-25-yl}acetic acid::BDBM304960::US10144731, Example 263	Kelch-like ECH-associated protein 1 [321-609]	Human		 5500							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304959	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304959&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			122660654	381753661							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584910	Cc1ccc2cc1CN1CC(CCCCCn3nnc4c(C)c(ccc34)C2CC(O)=O)Oc2ccccc2S1(=O)=O	InChI=1S/C31H34N4O5S/c1-20-11-12-22-16-23(20)18-34-19-24(40-28-9-5-6-10-29(28)41(34,38)39)8-4-3-7-15-35-27-14-13-25(26(22)17-30(36)37)21(2)31(27)32-33-35/h5-6,9-14,16,24,26H,3-4,7-8,15,17-19H2,1-2H3,(H,36,37)	FEAUSMUUPSCPKO-UHFFFAOYSA-N	304961	US10144731, Example 265::2-{4,32-Dimethyl-30,30-dioxo-23-oxa-30&#955;6-thia-1,14,15,16-tetraazahexacyclo[20.8.1.13,7.19,13.012,16.024,29]tritriaconta-3,5,7(33),9,11,13(32),14,24(29),25,27-decaen-8-yl}acetic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304961	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304961&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			122660656	381753663							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584911	Cc1ccc2cc1CN1CC(CCC=CCn3nnc4c(C)c(ccc34)C2CC(O)=O)Oc2ccccc2S1(=O)=O |w:13.13|	InChI=1S/C31H32N4O5S/c1-20-11-12-22-16-23(20)18-34-19-24(40-28-9-5-6-10-29(28)41(34,38)39)8-4-3-7-15-35-27-14-13-25(26(22)17-30(36)37)21(2)31(27)32-33-35/h3,5-7,9-14,16,24,26H,4,8,15,17-19H2,1-2H3,(H,36,37)	UOLHWQPOVKEGJH-UHFFFAOYSA-N	304962	US10144731, Example 266::2-{4,32-Dimethyl-30,30-dioxo-23-oxa-30&#955;6-thia-1,14,15,16-tetraazahexacyclo[20.8.1.13,7.19,13.012,16.024,29]tritriaconta-3,5,7(33),9,11,13(32),14,18,24(29),25,27-undecaen-8-yl}acetic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304962	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304962&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			137554661	381753664							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584912	Cc1c2ccc3n(CC=CCCC4CN(C5CCc6ccc(cc56)C2CC(O)=O)S(=O)(=O)c2ccccc2O4)nnc13 |w:9.9|	InChI=1S/C32H32N4O5S/c1-20-24-13-15-28-32(20)33-34-35(28)16-6-2-3-7-23-19-36(42(39,40)30-9-5-4-8-29(30)41-23)27-14-12-21-10-11-22(17-26(21)27)25(24)18-31(37)38/h2,4-6,8-11,13,15,17,23,25,27H,3,7,12,14,16,18-19H2,1H3,(H,37,38)	HHKMNRGIWAHEIR-UHFFFAOYSA-N	304963	US10144731, Example 267::2-{34-Methyl-3,3-dioxo-10-oxa-3&#955;6-thia-2,17,18,19-tetraazaheptacyclo[24.5.2.12,11.120,24.04,9.017,21.029,32]pentatriaconta-4(9), 5,7,14,18,20(34),21,23,26(33),27,29(32)-undecaen-25-yl}acetic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 5500							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304963	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304963&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			137554662	381753665							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584913	CC[C@@H]1CN(Cc2cc(ccc2C)C(c2ccc3n(C)nnc3c2C)C(C)(C)C(O)=O)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C31H36N4O5S/c1-7-23-18-35(41(38,39)27-11-9-8-10-26(27)40-23)17-22-16-21(13-12-19(22)2)28(31(4,5)30(36)37)24-14-15-25-29(20(24)3)32-33-34(25)6/h8-16,23,28H,7,17-18H2,1-6H3,(H,36,37)	JXCOERQLGLXVIK-UHFFFAOYSA-N	304964	US10144731, Example 268::3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-2,2-dimethylpropanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304964	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304964&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118169900	381753666							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584914	CC[C@@H]1CN(Cc2cc(ccc2C)[C@@H](c2ccc3n(C)nnc3c2C)C(C)(C)C(O)=O)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C31H36N4O5S/c1-7-23-18-35(41(38,39)27-11-9-8-10-26(27)40-23)17-22-16-21(13-12-19(22)2)28(31(4,5)30(36)37)24-14-15-25-29(20(24)3)32-33-34(25)6/h8-16,23,28H,7,17-18H2,1-6H3,(H,36,37)	JXCOERQLGLXVIK-UHFFFAOYSA-N	304965	US10144731, Example 269::(S)-3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-2,2-dimethylpropanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 55							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304965	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304965&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170079	381753667							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584915	CC[C@@H]1CN(Cc2cc(ccc2C)[C@H](c2ccc3n(C)nnc3c2C)C(C)(C)C(O)=O)S(=O)(=O)c2ccccc2O1 |r|	InChI=1S/C31H36N4O5S/c1-7-23-18-35(41(38,39)27-11-9-8-10-26(27)40-23)17-22-16-21(13-12-19(22)2)28(31(4,5)30(36)37)24-14-15-25-29(20(24)3)32-33-34(25)6/h8-16,23,28H,7,17-18H2,1-6H3,(H,36,37)	JXCOERQLGLXVIK-UHFFFAOYSA-N	304966	US10144731, Example 270::(R)-3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-(((R)-4-ethyl-1,1-dioxido-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepin-2-yl)methyl)-4-methylphenyl)-2,2-dimethylpropanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796185	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304966	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304966&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170505	381753668							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584916	CCCN(Cc1cc(ccc1Cl)C(CC(=O)OC)c1ccc2n(C)nnc2c1)S(=O)(=O)c1cccnc1	InChI=1S/C26H28ClN5O4S/c1-4-12-32(37(34,35)21-6-5-11-28-16-21)17-20-13-18(7-9-23(20)27)22(15-26(33)36-3)19-8-10-25-24(14-19)29-30-31(25)2/h5-11,13-14,16,22H,4,12,15,17H2,1-3H3	WWDNVVZHWDONPM-UHFFFAOYSA-N	304981	US10144731, Example 137::Methyl 3-{4-chloro-3-[(N-propylpyridine-3-sulfonamido)methyl]phenyl}-3-(1-methyl-1H-1,2,3-benzotriazol-5-yl)propanoate	Kelch-like ECH-associated protein 1 [321-609]	Human		 5500							US Patent		10.7270/Q25X2C17		aid1796186	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304981	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304981&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118169934	381753683							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584917	CCCN(Cc1cc(ccc1Cl)C(CC(O)=O)c1ccc2n(C)nnc2c1)S(=O)(=O)c1cccnc1	InChI=1S/C25H26ClN5O4S/c1-3-11-31(36(34,35)20-5-4-10-27-15-20)16-19-12-17(6-8-22(19)26)21(14-25(32)33)18-7-9-24-23(13-18)28-29-30(24)2/h4-10,12-13,15,21H,3,11,14,16H2,1-2H3,(H,32,33)	FRBDZDVSXHHBHW-UHFFFAOYSA-N	304982	US10144731, Example 138::3-{4-chloro-3-[(N-propylpyridine-3-sulfonamido)methyl]phenyl}-3-(1-methyl-1H-1,2,3-benzotriazol-5-yl)propanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796186	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304982	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304982&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170239	381753684							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584918	CCN(Cc1cc(ccc1Cl)C(CC(O)=O)c1ccc2n(C)nnc2c1)S(=O)(=O)c1cccnc1	InChI=1S/C24H24ClN5O4S/c1-3-30(35(33,34)19-5-4-10-26-14-19)15-18-11-16(6-8-21(18)25)20(13-24(31)32)17-7-9-23-22(12-17)27-28-29(23)2/h4-12,14,20H,3,13,15H2,1-2H3,(H,31,32)	XDOGAMNAMXXKOO-UHFFFAOYSA-N	304983	US10144731, Example 139::3-{4-chloro-3-[(N-ethylpyridine-3-sulfonamido)methyl]phenyl}-3-(1-methyl-1H-1,2,3-benzotriazol-5-yl)propanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796186	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304983	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304983&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118169860	381753685							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584919	CN(Cc1cc(ccc1Cl)C(CC(O)=O)c1ccc2n(C)nnc2c1)S(=O)(=O)c1cccnc1	InChI=1S/C23H22ClN5O4S/c1-28(34(32,33)18-4-3-9-25-13-18)14-17-10-15(5-7-20(17)24)19(12-23(30)31)16-6-8-22-21(11-16)26-27-29(22)2/h3-11,13,19H,12,14H2,1-2H3,(H,30,31)	MFYPHSBKCCZZFC-UHFFFAOYSA-N	304984	US10144731, Example 140::3-{4-chloro-3-[(N-methylpyridine-3-sulfonamido)methyl]phenyl}-3-(1-methyl-1H-1,2,3-benzotriazol-5-yl)propanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796186	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304984	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304984&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170752	381753686							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584920	CN(Cc1cc(ccc1Cl)C(CC(O)=O)c1ccc2n(C)nnc2c1)S(=O)(=O)c1cnn(C)c1C	InChI=1S/C23H25ClN6O4S/c1-14-22(12-25-29(14)3)35(33,34)28(2)13-17-9-15(5-7-19(17)24)18(11-23(31)32)16-6-8-21-20(10-16)26-27-30(21)4/h5-10,12,18H,11,13H2,1-4H3,(H,31,32)	SRPXGGSRYJJWSO-UHFFFAOYSA-N	304985	US10144731, Example 141::3-{4-chloro-3-[(N-methyl-1,5-dimethyl-1H-pyrazole-4-sulfonamido)methyl]phenyl}-3-(1-methyl-1H-1,2,3-benzotriazol-5-yl)propanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796186	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304985	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304985&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118170531	381753687							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
584921	CN1CCN(Cc2cc(ccc2Cl)C(CC(O)=O)c2ccc3n(C)nnc3c2)S(=O)(=O)c2ccccc12	InChI=1S/C26H26ClN5O4S/c1-30-11-12-32(37(35,36)25-6-4-3-5-24(25)30)16-19-13-17(7-9-21(19)27)20(15-26(33)34)18-8-10-23-22(14-18)28-29-31(23)2/h3-10,13-14,20H,11-12,15-16H2,1-2H3,(H,33,34)	WMFNTTPHZCWVFH-UHFFFAOYSA-N	304986	US10144731, Example 142::3-(4-chloro-3-((5-methyl-1,1-dioxido-4,5-dihydrobenzo[f][1,2,5]thiadiazepin-2(3H)-yl)methyl)phenyl)-3-(1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)propanoic acid	Kelch-like ECH-associated protein 1 [321-609]	Human		 550							US Patent		10.7270/Q25X2C17		aid1796186	US10144731	Davies, TG; Woolford, AJ; Willems, HM; Norton, D; Heightman, TD; Kerns, JK	12/4/2018	3/30/2019	Glaxosmithkline	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=304986	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=505&target=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=304986&enzyme=Kelch-like+ECH-associated+protein+1+%5B321-609%5D&column=ki&startPg=0&Increment=50&submit=Search			118169851	381753688							1	APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT	6WCQ,6FMQ,6FMP,7K2F,6TYP,6TYM,4IFN,4IFL,4IFJ,3VNH,3VNG,2FLU,1U6D,8XGV,8XGK,8IXS,8IVR,8IVG,7XOT,7XM5,7XM4,7XM3,7XM2,6ROG,6HWS,4XMB,4IN4,5X54,9J7G,9J7F,9J71,9J70,6TG8,7K2I,7K2D,7K2P,7K2O,7K2N,7K2H,8X34,7K2M,7K2L,8PKS	Kelch-like ECH-associated protein 1	KEAP1_HUMAN	Q14145	B3KPD5 Q6LEP0 Q8WTX1 Q9BPY9